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Abstract
The aim of this programme of work was to examine the role of bacterial
infection in the aetiology of the Overactive Bladder (OAB). Recent studies in
OAB have identified urinary inflammatory exudates occurring despite negative
routine urine cultures. Detection of pyuria by microscopy of fresh unspun urine
is established as the best surrogate marker of infection and pyuria has been
described in over 33% of people with OAB.
The routine methods of urinalysis; dipstick of mid-stream urine (MSU)
specimens and MSU culture were scrutinised. New techniques of urine culture
were sought by culturing the urinary sediment. Intracellular colonisation of
urothelial cells was tested in patients and verified further by using a bladder
epithelial cell line. In addition, a cytokine response in the urine was examined
as surrogate evidence of an urothelial inflammatory reaction in patients with
OAB.
The dipstick test was found to have a low sensitivity and specificity in the
context of OAB. In addition, culture of the urine sediment using non-selective
culture media enhanced the isolation of bacteria from patients with OAB. The
bacterial species isolated were predominantly Streptococcus spp and
Enterococcus spp.IL-6 was found in higher concentrations in the urine
specimens of patients with OAB symptoms and pyuria. Intracellular invasion
assays and microscopic methods of identifying intracellular bacteria in this
patient group identified adherent and intracellular bacteria.
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1.1 Epidemiology of Incontinence
The International Continence Society (ICS) defines urinary incontinence as
the ‘complaint of any involuntary leakage of urine.’ The prevalence of all
incontinence in women shows great variation in the literature, between 14% to
40.5% (1). The peak ages of prevalence also vary between studies and can
be broadly divided into those that report the highest prevalence in old age (2)
(3;4) and those that report the highest prevalence at the time of the
menopause (5). The prevalence of urinary incontinence has also been
investigated in different clinical settings and selected populations. Surveys of
female patients visiting their general practitioner have shown 43% were
incontinent in a USA based study (1) and 44% in a large study in Sweden (4).
Fewer studies have addressed the natural course of incontinence in women.
In a retrospective Danish study, yearly incidences between 0.5% and 1.4%
were estimated for women aged 20-59 years (6). However, in a prospective
community based American study of women aged 60, a yearly incidence of
about 20% and a remission of 12% were reported (7).
Some review papers have focused on understanding the problem of
estimating prevalence (8-10). In addition to the biases induced by
investigating different age groups or selected populations, a significant
problem has been defining the term "incontinence". The ICS definition implies
an objective demonstration of urine loss, and is rarely used in community
based surveys (1). Some population based studies have included
institutionalised patients, some have excluded them (4;11). This will obviously
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explain some of the differing prevalence’s found among older women. Some
surveys have taken their samples from lists of patients generated in general
practice (12). These surveys usually achieve response rates of around 80%,
but they may not be representative of the population as a whole.
Incontinence can be further divided into stress urinary incontinence and urge
incontinence. The ICS defines stress urinary incontinence as ‘the complaint of
involuntary leakage of urine on effort or exertion’. Urge urinary incontinence is
the complaint of involuntary leakage, accompanied by, or preceded by, a
strong desire to void (13;14)
1.1.1 Risk factors for incontinence
The risk factors for incontinence are thought to be multi-factorial, including
ethnicity, pregnancy and childhood enuresis. These are discussed in further
detail below.
Ethnic factors influencing the prevalence of urinary incontinence have not
been well explored. Most studies report Caucasian women to have increased
prevalence of urinary incontinence (7;8;15) whereas some have reported
similar rates between white and black women (9;10). The prevalence of
stress incontinence seems to be increased in Caucasian women (7) and that
of urge incontinence and mixed incontinence increased in the black
population(7). Most of the studies of risk factors have included parity, age,
and obesity (7). Childhood enuresis and pregnancy and/or delivery seem to
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be the most important risk factors for lifetime incontinence in women (16;17).
(Table1.1). Few women begin pregnancy with pre-existing urinary
incontinence (18). About 30% of new mothers become incontinent after a first
vaginal delivery (19;20) (21) and current epidemiological studies suggest that
caesarean delivery is partly protective (22;23). Parity is a risk factor for both
stress and urge incontinence in women (24); (25).
In most studies, age has been strongly associated with the prevalence of both
stress and urge incontinence and it is recognised that some factors
contributing to incontinence are increased with age (26). Obesity is a well-
established risk factor for stress incontinence and urgency, reported with an
increased frequency in overweight women (27) (28;29).
The contribution of oestrogen deficiency post-menopause is not clear.
Suspicion may arise through the coincidence of two common conditions of
late life; menopause and incontinence. Oestrogen replacement is frequently
recommended but has not demonstrated benefit in clinical trials. In fact, one
large controlled multicentre study showed that treatment with a combination of
oestrogen and progesterone increased the severity of incontinence episodes
(30). Oestrogen might have some role in improving lower urinary tract
symptoms through achieving greater comfort in the tissues, but is not
suggested as a primary treatment (31-33).
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Table 1.1 Predictors of severe incontinence in British Women, adapted from “Urinary
incontinence in middle aged women: childhood enuresis and other lifetime risk factors in a British
prospective cohort. Diana Kuh et al. 1999
Unadjusted odds
ratio (95% CI) p
value
p value
Enuresis (6 y)
No 1.0
Yes 3.5 (1.6,7.7) 0.001
Urinary or kidney
infections (15–43 y)
No 1.0 0.028
Yes 1.7 (1.1,2.8)
Hysterectomy by
(48 y)
No 1.0 0.005
Yes 1.6 (1.2,2.4)
Body mass index*
(43 y) 1.5 (1.2,1.8) 0.003
GP consultations
(47 y)
Low 1.0 <0.001
High 2.7 (1.7,4.3)
Number of Children 1.2 (1.0, 1.5) 0.045
Educational Level† 0.77 (0.65,0.91) <0.001
*Per 5 units (kg/m2).
†Fitted as a continuous variable taking values 0 (no qualifications) to
4 (degree level)
1.2 The Overactive Bladder-Definition and prevalence
The Overactive Bladder (OAB) syndrome has been defined by the
International Continence Society as a spectrum of symptoms in which
incontinence may or may not overlap with urgency, frequency, and
nocturia(1). Urgency, the hallmark of OAB, is defined as the sudden
compelling desire to urinate, a sensation that is difficult to defer. Urinary
frequency is denoted as voiding eight or more times in a 24-hour period.
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Nocturia is delineated as the need to wake one or more times per night to
void. OAB is an unpleasant condition with high morbidity, patients consistently
reporting a negative effect on the quality of life, particularly, less self-
assurance and reduced social activity (4;14;34).
The estimated prevalence of OAB is between 8- 11% (4;35) higher than that
of asthma and ischaemic heart disease. The occurrence of this condition
increases with age and it affects both sexes equally (35). It is independently
associated with falls and fractures in the elderly, urinary tract and skin
infections, sleep disturbances and depression. One study estimated the
financial burden of OAB in five EEC countries to be in excess of €4.2 billion in
2000 (11).
1.2.1 Aetiology and pathophysiology of OAB
Not everyone is happy with the term “OAB”. The term OAB does not sit
comfortably in the lexicon of all clinicians. It is a symptomatic diagnosis in
contrast to “detrusor over-activity” which is diagnosed by the use of
urodynamic studies. Despite the best efforts of the purists, the two terms have
become synonymous in the literature, perhaps because the treatment
strategies are the same. The aetiology and natural history are not yet fully
described and varying hypotheses are mooted (36). It is assumed by many
that a number of different pathophysiological factors contribute (37).
Regrettably, much of our current data are gleaned from animal experiments,
the preferred models being guinea-pig, rat and pig. Species differences make
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extrapolation to the human unreliable. Nevertheless, there are three
pathophysiological hypotheses for OAB. In the literature, an etymological error
results in them being given the status of theory: The “myogenic theory”, the
“neurogenic theory” and the “autonomous bladder theory” (38). The scientific
definition of Theory is “A set of statements or principles devised to explain a
group of facts or phenomena, especially one that has been repeatedly tested
or is widely accepted and can be used to make predictions about natural
phenomena”. Colloquially, it is more often used to describe “A proposed
explanation whose status is still conjectural” (see Dictionary.com)
1.2.2 The Anatomy and physiology of the bladder and the
overactive bladder
The lower urinary tract comprises of the urinary bladder and the urethra. The
urethra contains both smooth and striated muscles and the bladder can be
divided into two parts: the bladder body, above the ureteral orifices, and the
base, consisting of the trigone, urethrovesical junction, deep detrusor, and the
anterior wall (figure 1.1). The bladder is lined by a mucous membrane and
covered on the outer aspect in part by peritoneal serosa and by fascia. The
wall is formed of smooth muscle cells, also referred to as the detrusor muscle.
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Figure 1.1 Anatomy of the human bladder. Taken from McGraw-Hill
There are three layers of smooth muscle. The cells of the outer and inner
layers are mostly oriented longitudinally, and those of the middle layer
circularly. In the human detrusor, bundles of muscle cells of varying size are
surrounded by connective tissue which is rich in collagen. The bundles are not
clearly arranged in distinct layers, but run in all directions (Figure 1.2).
Figure 1.2 The lumen of the urinary bladder showing the detrusor muscle layer. Taken from
www.iupucanatomy.com/chapter
Within the main bundles, the smooth muscle cells may exist in groups of small
functional units, or fascicles (39).The orientation and interaction between the
smooth muscle cells in the bladder are important as this determines how the
bladder wall behaves and what effect activity in the cells have on the
intraluminal pressure.
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1.2.3 Micturition and the myogenic theory
The storage and expulsion of urine during micturition, involve a complex
interaction between the elements of the urinary tract and nervous control
systems. During filling of the urinary bladder, the smooth muscle cells relax
and elongate. Micturition is a highly synchronised process of detrusor
contraction. Synchronisation of each part of the urinary tract musculature is
mediated by specific transmitters which are released from nerves or
generated locally to activate downstream second messenger cascades
(Figure 1.3).
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Figure 1.3 The micturition cycle. The diagram depicts the micturition cycle under normal
physiological conditions. Adapted from “Pathophysiology of Overactive Bladder” (Chu et al. 2006).
The myogenic theory (Brading et al) (40;41), suggests that denervation of the
detrusor smooth muscle leads to increased cell excitability leading to
involuntary contractions of the detrusor muscle which manifests as urinary
urgency and urgency incontinence. This is most applicable to patients with
bladder outlet obstruction, in which chronic increases in intravesical pressure,
cause partial neurological denervation of the bladder smooth muscle.
Spontaneous action potentials can be propagated from cell to cell in the
bladder via gap junctions. When the smooth muscle is denervated, there is an
increase in the number of spontaneous action potentials and in the ability of
the action potentials to propagate from cell to cell which is also supported by
increased gap junction density (42). As a result repeated small contractions of
Bladder fillingBladder filling
First sensation to void Normal desire to void
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the detrusor muscle also stimulate afferent receptors providing feedback to
the CNS and cause the symptoms of OAB.
1.2.4 Neural and hormonal control and the autonomous theory.
Various efferent and afferent neural pathways and neurotransmitters are
involved in the storage of urine and emptying of the bladder. Central
neurotransmitters, such as glutamate, serotonin, and dopamine, are thought
to play a role in urination. For example, serotonergic pathways facilitate urine
storage. Dopaminergic pathways may have both inhibitory and excitatory
effects on urination. Dopamine D1 receptors appear to have a role in
suppressing bladder activity, whereas dopamine D2 receptors appear to
facilitate voiding.
Acetylcholine, which is the predominant peripheral neurotransmitter
responsible for detrusor contractions, is released from the parasympathetic
nerve terminal and binds to muscarinic receptors on the detrusor muscle. Five
muscarinic receptor subtypes have been identified (43). The M3 muscarinic
receptor appears to be responsible for detrusor contractility in the normal
bladder. The M2 receptor is negatively coupled to the adenyl cyclase
mechanism and may act to suppress sympathetic effects (44). Its influence
appears to be much less overt than that of the M3 receptor. Data from small
studies demonstrate up-regulation of the M2 receptor in obstruction and
spinal-cord injury and may contribute to detrusor overactivity in those
conditions (44;45). Binding of acetylcholine to the M3 receptor activates
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phospholipase C via coupling with G proteins. This action causes the release
of calcium from the sarcoplasmic reticulum and contraction of the bladder
smooth muscle. Increased sensitivity to stimulation by muscarinic receptors
has been mooted as a mechanism leading to OAB. Leakage of acetylcholine
from the parasympathetic nerve terminal may lead to small contractions of the
detrusor, which may activate sensory afferent fibres, leading to the sensation
of urgency. This is the basis of the autonomous theory of the OAB (46).
Unsolicited activation of sensory afferent nerves may also play a role in OAB,
especially in neurological disorders. Neuroreceptors such as vanilloid,
purinergic, neurokinin A, and nerve growth factor receptors are associated
with these afferents and are mediated by neurotransmitters including nitric
oxide, calcitonin gene-related protein, and brain-derived neurotropic factor.
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1.2.5 The neurogenic Theory
De Groat (47), describes decreased suprapontine inhibition of the micturition
reflex, following, for example, a cerebrovascular accident as a cause of the
OAB. Other neurogenic aetiologies of OAB proposed include damage to
axonal paths in the spinal cord, loss of peripheral inhibition, and enhancement
of excitatory neurotransmission in the micturition reflex pathway such as seen
in stroke, spinal cord injury and multiple sclerosis.
1.2.6 The role of the urothelium in OAB
Although once thought to be a simple water resistant epithelial lining, it is now
thought that the urothelium performs an important sensory role in bladder
function and may be implicated in OAB (Figures 1.5). The urothelium is
thought to exhibit neuron-like properties by releasing several
neurotransmitters in addition to expressing receptors for other messenger
molecules (47). Moreover, there is direct communication with sub-urothelial
afferents. Ferguson et al showed that when mouse detrusor muscle is
stretched, flux of calcium intracellularly results in the release of ATP on the
serosal aspect of urothelium (48). It is now known that ATP is released by
both surfaces of the urothelium (49). This ATP activates the purinergic
receptors, P2X3 and/or P2X2/3, on suburothelial afferent nerves and relays
information to the central nervous system to produce a sensation of bladder
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fullness and urgency (50). Thus, purinergic signalling has a function in the
mechano-sensory transduction in the bladder (51;52) (figure 1.4).
Figure 1.4 P2 receptors in the bladder; response to stretch.
P2X3 receptor knock- out mice display reduced pain related behaviour in
response to chemical irritation of the bladder with formalin and ATP injection.
Furthermore, these mice also exhibit marked bladder hyporeflexia
characterized by a decreased micturition frequency and an increased bladder
capacity under normal bladder pressures (53). In another study that also
made use of the P2X3 knockout mice, ATP release was shown to be
proportional to the extent of bladder distension. It was also noted that gradual
bladder distension resulted in a progressive increase in the activity of afferent
bladder
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nerves (54). In one study, intravesical ATP was demonstrated to induce
detrusor overactivity when the urothelial barrier was compromised by
chemical treatment with protamine sulphate to increase its permeability at pH
6.0. This was a very interesting finding as previous studies have shown
exogenous ATP to induce bladder overactivity but at much lower pH’s. The
authors concluded that an increased permeability of the urothelium is required
for exogenous ATP to induce detrusor activity via the P2X receptor (55).
ATP has been shown to play a role in inflammation where an increased
release has been described (56). Consistent with this observation, an
augmented release of ATP in response to stretch as well as an increased
urinary secretion of ATP has been demonstrated in patients with interstitial
cystitis in which bladder inflammation is described during cystoscopy (56).
Inflammation of the urothelium may play a part in the pathophysiology of OAB
by not only disrupting the integrity of the urothelial barrier but also by leading
to an increased release of ATP by the urothelium.
An aberrant ATP response induced by an inflammatory reaction may play a
role in the pathophysiology of OAB by increasing sensory nerve excitation.
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Figure 1.5 Photomicrograph showing the normal human urothelium (H&E staining) taken from a
bladder biopsy at the Whittington Hospital NHS Trust
1.3 The Diagnosis of OAB
Lower urinary tract symptoms (LUTS) described by OAB patients overlap with
those caused by other lower urinary tract syndromes such as interstitial
cystitis, painful bladder syndrome and acute urinary infection. The National
Institute of Clinical Excellence (NICE) states that the clinical history should be
sufficient to diagnose and differentiate between lower urinary tract syndromes.
There are many validated urgency scores in the literature which help to
diagnose OAB (57-60). It is important to understand that the exclusion of
infection is the cornerstone investigation in the diagnosis of OAB (1).
Lumen
Urothelium including Umbrella
cells, Intermediate cells, Basal
cells.
Basement membrane
Lamina propria with
myofibroblasts and Detrusor
smooth muscle.
The role of bacterial infection in the aetiology of the overactive bladder
34
In support of this, the International Consultation on Incontinence guidelines on
LUTS emphasise the need to exclude urinary tract infection (UTI) and
recommend dipstick testing as a screening method (61). NICE also
recommends the use of urinary dipstick for screening patients with lower
urinary tract symptoms (62). However, there is no published data to support
dipstick as a valid screening tool for patients with non- acute, non dysuric
symptoms. NICE further recommends a mid-stream urine (MSU) culture of
urine if the dipstick is positive for leukocyte esterase or nitrite. Similarly, there
is no evidential justification for this.
1.3.1 The exclusion of urinary tract infection (UTI) in patients
presenting with symptoms of the Overactive Bladder
As described, two techniques are commonly deployed to exclude UTI. An
MSU is submitted for culture, or urinalysis by dipstick is performed. The latter
seeks surrogate evidence of infection, either pyuria by detecting leukocyte
esterase activity; or bacterial splitting of urea by measuring nitrite.
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1.3.2 Urine Culture
The diagnosis of UTI from culture of an MSU has rested on criteria described
by Kass et al (1957) in his seminal paper (63). He reported that the MSUs of
25 patients with systemic symptoms (chills, fever, flank pain) and dysuria had
grown more than 106 bacterial colony forming unit’s ml-1 (cfu ml-1). After
studying the MSU in asymptomatic women, he established that 105 cfu ml-1 of
a known urinary pathogen should be the threshold between true bacturia and
contamination. Kass never claimed to define a threshold for use with
“cystitis”, i.e. localised symptoms of frequency/dysuria. Nevertheless, 105cfu
ml-1 has been widely adopted in clinical practise and the surrogate tests of a
dipstick have been validated against this standard.
In 1982, Stamm (64) published work on women presenting with acute dysuria.
He concluded that a culture result of 102 cfu ml-1 was a more appropriate
threshold for diagnosis of bacterial cystitis. There are no data on a threshold
applicable to patients with other lower urinary tract symptoms, notably
frequency, urgency and incontinence.
As a result of setting standard laboratory methods (64) for analysing MSUs
at a threshold of 105cfu ml-1 instead of 102cfu ml-1 , Hooton & Stamm have
demonstrated that laboratory MSU cultures miss over 50% of genuine
infections in women with frequency/dysuria (65).
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It must also be acknowledged that the culture methods assume dominant
pathogenicity from the Enterobacteriaceae species, notably Escherichia coli.
Because of this assumption, the MSU culture is performed on a selective
medium (chromogenic medium) for Enterobacteriaceae under aerobic
conditions. No anaerobic bacteria are sought and some aerobic bacteria can
be missed because of the choice of medium. Whilst this might be appropriate
for diagnosing acute infection, there is no evidence that the same bacteria are
implicated in chronic infections or patients presenting with non-dysuric lower
urinary tract symptoms such as in the overactive bladder. Thus, there are no
data to inform the selection of a suitable gold standard for diagnosing UTI in
this context.
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1.3.3 Urine Dipstick Test
There have been two meta-analyses of urinary dipsticks, used to assess
acute frequency/dysuria, in adults (66;67) and one in children (68). Hurlburt
and Littenberg (67) concluded that dipsticks cannot exclude infection reliably
in most clinical settings. Deville et al (66) reported leukocyte esterase
sensitivity of 76% (95% CI 60% to 98%) and specificity 46% (95% CI 32% to
68%) for the diagnosis of urinary infection and a nitrite sensitivity of 49% (95%
CI 38% to 62%) and specificity of 85% (95% CI 73% to 100%) in primary care.
Leukocyte esterase is used as evidence of pyuria, which in turn is considered
to be a surrogate for infection. Therefore, in validating the leukocyte esterase
test there are two potential gold standard references, the results of urine
culture and the urine microscopic white cell count.
The Nitrite test uses the Greiss reaction to detect nitrite as a marker for urea-
splitting urinary bacteria. The chemical basis of this reaction is that in an acid
environment nitrite reacts with an aromatic amine (sulfanilamide) to form a
coloured diazonium salt that in turn reacts with hydroxybenzoquinolone to
provide a pink colour (69). It requires the presence of bacteria that can
convert nitrate in the urine to nitrite. The published data on the nitrite dipstick
has used the 105 cfu ml-1 threshold as the gold standard for diagnosing
infection, and reported sensitivities ranging from 18% to 71% and specificities
from 82% to 100% (70).
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1.3.4 Urine microscopy and the quantification of pyuria
An alternative method of diagnosing urine infection is the identification of
significant pyuria. The determination of the excretion rate of white blood cells
in urine was first described by Hottinger in 1893 (71). However, the technique
used is usually attributed to Addis, who published his method in 1925,
referred to as the “Addis count” (72). Hamburger in 1950 (73), and Houghton
and Pears in 1957 (74) described modifications of the Addis count which
made it simpler but reliable, although a catheter was used to collect the urine.
The leukocytes were enumerated by examining the urinary sediment in a
haemocytometer.
Hamburger, Houghton and Pears obtained the sediment by centrifugation of
10 ml of urine at 1500 rpm (radius 12 cm) for three minutes. 9 ml of
supernatant was removed and the 1 ml of sediment re-suspended with a
Pasteur pipette before spreading on the haemocytometer chamber to count
the leukocytes. Having used this technique in volunteers, they concluded that
the normal rate of leukocyte excretion varied between 18,000 and 196,000
per hour.
The upper limit of the normal leukocyte excretion rate per hour was
established as 20,000 wbc h-1 to 200,000 wbc h-1 by Houghton and Pears in
1957 (74) . Hutt, Chambers and MacDonald in 1961 (75); Osborn and Smith
in 1963 (76), Little in 1962 (77) demonstrated excretion rates of >400,000 wbc
h-1 in patients with proven, symptomatic urinary infection. In 1968, Mabeck
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attempted to simplify evaluation by counting the white cells per high powered
field (x40 objective x10 optical = x400: wbc hpf-1) using the re-suspended,
stained, sediment. All patients showing three or more wbc per high powered
field (X400 , hfp) excreted more than 400,000 wbc h-1, but fewer wbc hpf-1 did
not exclude excretion rates of >=400,000 wbc h-1. The spun sediment
underestimated the leukocyte excretion (78;79).
Mond (1965) examined unspun fresh urine and counted the white cells using
a haemocytometer, finding that >=10 wbc mm-3 were noted in all patients with
symptomatic acute cystitis and bacteriuria (105 cfu ml-1) (80). In 1968
Gadeholt compared the examination of spun and unspun specimens and
showed that the calculated excretion rates on uncentrifuged specimens
showed higher values (81;82). This confirmed earlier suspicions that
centrifugation caused loss of cells. Gadeholt correlated unspun urine with
>=10 wbc mm-3 excreted >400,000 wbc h-1; This was confirmed by Mabeck in
1968 (79) and by Baerheim et al (1989) (83), all of whom implicated
centrifugation. Thus the finding of >=10 wbc mm-3, of unstained, unspun urine
examined on a haemocytometer, became established as the most effective
method for diagnosing urinary infection.
Latham and Stamm reported that the detection of pyuria (>=10 wbc mm-3)
was the most accurate and efficient method of identifying urinary tract
infections in ambulatory women with symptoms of acute cystitis (84). Whilst
Stamm has achieved much in clarifying the diagnostic criteria, useful with
classical symptoms, there remains a problem with the lower urinary tract
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symptoms not typical of acute cystitis, including those of OAB. It will be
argued that it is no longer reasonable to rely on the reassurances of
bacteriuria of >105 cfu ml-1 without due validation.
OAB could reflect genuine urinary infection, undetected by traditional analysis.
One study (85) has reported the results of a catheter specimen of urine
(CSU) taken from 864 women at the time of urodynamic investigation.
Laboratory reports of pyuria and bacturia were found to occur more often in
patients with OAB compared to those with stress incontinence.
1.4 Acute urine infection
The American Foundation for Urological Diseases reports that acute bacterial
cystitis affects 8–10 million Americans a year and most of these patients are
women. The National Institute of Diabetes and Digestive and Kidney Diseases
notes that acute cystitis prompts about 9.6 million doctor visits annually; $4.5
billion is spent on 11 million antibiotic prescriptions. Occurring in otherwise
healthy young women, acute, symptomatic, uncomplicated urinary tract
infection (UTI) is the most common infection (86) (87), next to the common
cold. 25 to 40% of females will experience an acute UTI in their lives, and up
to 6% of women will have one or more UTIs in a given year (87;88).
UTI is frequently caused by organisms which are normal commensals in the
distal urethra and adjacent sites. The most common route of infection is by
ascension. The gender difference in the prevalence of UTI is thought to be
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related to the short length of the female urethra and the uropathogens
involved are usually part of the normal faecal microbiota. These bacteria
colonise the perianal region and then ascend in women to the introitus
vaginae which is a reservoir for several uropathogens. Colonisation spreads
to the periurethral area, urethra, and bladder,this is also dependant on sexual
activity. The role of the normal vaginal microbiota in the defence against
genital colonisation with potentially pathogenic adhering E. coli has been
demonstrated in several studies. The reported vaginal colonization rate of E.
coli varies from 6 to 26% (89).
Defensive properties of the commensal microbiota against colonisation by
bowel organisms include production of inhibitory substances against
pathogens, colonisation of epithelial surfaces, and competition with potential
pathogens for sites of adhesion. The relationship of vaginal E. coli load with
phases of the menstrual cycle also indicates hormonal determinants of
vaginal colonisation with E. coli. Local trauma, such as sexual intercourse or
urethral massage, promotes invasion of the urinary tract. A vaginal pH of 5 or
less protects against vaginal colonisation and urogenital infections.
Lactobacillus spp usually colonise the vagina and generate an acidic vaginal
pH which interferes with the adhesion of E. coli, one of the most common
uropathogens in otherwise normal women. It is also likely that use of soaps to
clean the genital tract alters the pH and normal microbiota. In addition, the
use of diaphragms, cervical caps, or spermicides for contraception is
associated with a higher incidence of UTI (89). Spermicides have been shown
to increase colonisation of the vagina with uropathogens independently of
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sexual intercourse. Most spermicides contain Nonoxynol-9, which appears to
be active against hydrogen producing lactobacillus in the vagina, which may
be protective against colonisation of uropathogens (65;90).
In females with recurrent UTI, hormonal factors are thought to influence
bacterial attachment to epithelial cells. Genitourinary mucosal cells have
oestrogen receptors (91;92). Adherence changes during the menstrual cycle
and is maximal during peak oestrogen stimulation. Oestrogen deficiency in
postmenopausal women is associated with a higher risk of UTI. The mucosa
atrophies, lactobacilli disappear from the vaginal microbiota, vaginal pH
increases, and the vagina is then predominantly colonized by
Enterobacteriaceae, especially E. coli. The Cochrane review 2008, looked at
nine randomised control trials, in which postmenopausal women received any
kind of oestrogen therapy for recurrent UTI compared to placebo. They found
two studies (Eriksen 1999 and Raz 1993) (93;94) showing vaginal
oestrogens; a cream and a ring pessary to be superior to antibiotics for
treatment. Raz et al (94) reported both a lower vaginal pH in the oestrogen
treatment group and a higher proportion of vaginal Lactobacillus spp. as
compared to controls.
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1.4.1 Causative Organisms
Escherichia. coli
The predominant causative organism of acute UTI in women is reported to be
Escherichia. coli (E. coli) (88) (Figure 1.6). The prevalence of E. coli in
symptomatic patients with positive urine cultures is between 50-77% (95;96).
Other pathogens of importance are Staphylococcus. saprophyticus,
Streptococcus spp., Enterococcus. faecalis, Klebsiella. pneumoniae and
Proteus. mirabilis.
E. coli belongs to the large bacterial family, Enterobacteriaceae, the enteric
bacteria, which are facultative anaerobic Gram-negative rods. Physiologically,
E. coli is very well adapted to its habitat. E. coli colonizes the gastro intestinal
tract within hours or a few days after birth. There are over 700 antigenic types
(serotypes recognized based on O, H, and K antigens. Serotyping is still
important in distinguishing pathogenic strains (95).
Uropathogenic E. coli (UPEC) cause most of the UTIs in anatomically normal
urinary tracts. The bacteria colonize from the faeces or perineal region and
ascend the urinary tract to the bladder. Bladder infections are 14-times more
common in females than males by virtue of the shortened urethra (97). UPEC
differ from non-pathogenic E. coli and from other E. coli pathotypes by the
production of specific virulence factors, which enable the bacteria to adhere to
uroepithelial cells and to establish UTIs. In addition to cell adherence factors,
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toxins, ‘modulins’, capsules, iron uptake systems and other bacterial products
contribute to the mechanism of virulence.
Figure 1.6 E. coli with fimbriae (Transmission Electron Micrograph x17,250). Taken from
Dennis Kunkel Microscopy, Inc.
Staphylococcus. saprophyticus
Staphylococcus. saprophyticus is second to E. coli as the most frequent
causative organism of uncomplicated UTI in women (Figure 1.7). The vast
majority of infections with this organism occur in young sexually active
women. Wallmark et al (98) isolated S. saprophyticus from the urine of 22% of
consecutive female patients found to have bacturia. The highest rate of S.
saprophyticus infection was 42.3% among women aged between 16-25 years
in the study. Gupta et al. reported a prevalence of 8% among 665 women with
UTI (99).
The gastrointestinal tract is the major reservoir of S. saprophyticus. Rectal,
vaginal and urethral colonisation with S. saprophyticus is also associated with
UTI caused by other organisms (100).
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Figure 1.7 Electronmicrograph of S.saprophyticus. Taken from Dennis Kunkel Microscopy, Inc.
Group B Streptococcus
Group B Streptococcus (GBS) is a leading cause of UTI (Figure 1.8). There
are particular GBS capsular serotypes that are disproportionately associated
with colonization and disease; serotypes Ia, III, and V cause the majority of
invasive infections in the elderly (101). Multiple serotypes of GBS also cause
UTIs, asymptomatic bacturia, pyelonephritis, urethritis, and urosepsis
(102;103). GBS asymptomatic bacturia is particularly associated with
immunocompromise, such as the elderly, pregnant women, patients with
diabetes mellitus and chronic renal failure (104;105). However, the underlying
mechanisms of pathogenesis that lead to acute GBS UTI are unknown. A
recent study suggests that binding of uropathogenic GBS to the uroepithelium
and induction of the inflammatory cascade with interleukin 1α represents the
initial stages of GBS urinary tract infection (106).
The role of bacterial infection in the aetiology of the overactive bladder
46
Figure 1.8 Electronmicrograph of Group B Streptococcus. Taken from
Dennis Kunkel Microscopy, Inc.
Enterococcus. faecalis
Enterococcus. faecalis, while normally a gut commensal, is a frequent cause
of many serious infections, including urinary tract infections (Figure 1.9). E.
faecalis is responsible for approximately 110,000 cases of UTI each year. E.
faecalis is especially troublesome to treat because of its frequent resistance to
multiple antibiotics, including vancomycin (107).
Both rat and mouse model systems have been used to study factors involved
in the pathogenesis of E. faecalis in the urinary tract. Studies by Guze (108)
showed that E. faecalis has a growth advantage over other Enterococcal
species in rat kidneys and that pyelonephritis caused by Pseudomonas
aeruginosa was aggravated by coinfection with E. faecalis, determined by
histological changes in the kidney. In a bladder catheterization model of
urinary tract infection, the Esp (enterococcal surface protein) adhesin was
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found to increase persistence in the bladder of mice, although no histological
changes were observed (109).
Figure 1.9. Pseudocolor low-voltage field emission scanning electron micrograph of
Enterococcus faecalis biofilm microcolony cultured on a submerged cellulose membrane (40,000×
magnification). Taken from “Development and Use of an Efficient System for Random mariner
Transposon Mutagenesis to Identify Novel Genetic Determinants of Biofilm Formation in the Core
Enterococcus faecalis Genome.” Kristich et al 2008
1.4.2 Defence against infection
The first defences against bacterial infection and adhesion to the urothelium
are the physical and chemical properties of the urine. Invading bacteria
stimulate micturition. Voiding washes out bacteria from the bladder and
urethra and urine dilutes the bacterial load. Bacterial growth is impeded by
low pH and the high urea and organic acid concentrations and the extremes
of high and low osmolality deter some less adapted bacteria (110;111).
Nevertheless, aggressive bacterial species have evolved mechanisms to
overcome these obstacles.
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There are a number of interrelated anatomical/ physiological factors which
influence the maintenance of bacterial numbers in urine once infection is
established. The flow rate of ureteric urine into the bladder; the volume of
residual urine remaining in the bladder after micturition and the frequency with
which micturition occurs.
The flow rate of ureteric urine into the bladder is inevitably variable, but
averages at about 1 ml/min during the day and at about 0.25 ml/min during
the night (112). The flow rate is increased by high fluid intake and diuretics so
the urine produced may be dilute and less suitable for supporting bacterial
growth. Providing the ureteric urine is not carrying bacteria from a focus of
infection in the kidney, the influence of urine flow on bacterial numbers in
bladder urine is a dilution effect. However, this dilutional effect also influences
the immune response, by diluting immune cells at the site of infection.
Furthermore, post micturition residual urine can vary enormously in the
infected bladder. Studies by Shand have suggested that a normal residual of
1ml may increase enormously and even modest increases (> 1 to 10 ml) may
by association render UTIs more difficult to treat (Shand et al 1970) (113).
Mackintosh et al. (1975) (114) have constructed a mathematical model to
explain this phenomenon. Their calculations predict that, in conditions in
which the mean generation time of bacteria is 40 min, the ureteric urine flow is
1 ml per minute and the bladder is emptied hourly, a residual bladder volume
of 8.5 ml would prevent bacterial numbers from falling, even in the unlikely
event that all the bacteria are evenly distributed in the urine and fully affected
by washout forces. The interval between episodes of micturition will fluctuate
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during the day and vary with fluid intake. Most people micturate only once, or
not at all, during the night, but urinary infection may alter this habit. In acute
cystitis frequency of micturition is a common presenting system. This may be
invoked as a natural defence mechanism until the resolution of infection. In
addition, higher residual volumes are also associated with urinary tract
infection, particularly in the post-menopausal group.
As a result of normal kidney function, the variability in the chemical
characteristics of urine such as pH and osmolality can facilitate or suppress
bacterial growth. Any reduction in the bacterial growth rate will, of course, be
to the patient's advantage, but this does not necessarily equate to elimination
of infection. The situation may be complicated by the fact that the bacteria
may fix themselves to the surface of the bladder mucosa or reside in foci
within the urinary system where they are unaffected by hydrokinetic forces (fig
1.10).
Figure 1.10 Scanning electron micrograph of an infected bladder superficial facet cell with
E.coli. Taken from “A murine model of urinary tract infection.” Scott J Hultgren et al 2009
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The importance of 'bound' organisms in the persistence of infection has been
investigated, through mathematical modelling, by Mackintosh et al. (1975)
(114). They calculated that if 10 'bound' bacteria continuously seed the urine
with fresh organisms, infection would be maintained at around the 10 bacteria
per ml level, even in the most favourable washout conditions in which a
patient with a normal residual bladder volume micturates every hour.
This synthetic data is supported by clinical studies which have shown that,
infection will persist in a proportion of women despite adequate diuresis and
any impairment of the efficiency of the washout mechanism will exacerbate
the situation (115).
1.4.3 The Inflammatory Response
Urothelial damage by infection leads to the release of inflammatory mediators
including platelet derived growth factor (PDGF), tumour necrosis factor-
(TNF-), interleukin 6 (IL-6) and interleukin 8 (IL-8). E. coli infection has been
well studied (116) (117) (118), in which a rapid cytokine response is
observed, particularly with adhering, P- or type 1-fimbriated E. coli.
Fimbria-mediated adherence is one of the virulence factors needed to
stimulate the mucosal barrier (fig 1.11). Recent studies with human urinary
epithelium have confirmed this concept (119). Adherence is an important first
step to establish tissue contact, in addition, the molecular interactions
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between bacteria and host trigger a host response (120) (118). In urinary tract
cell lines, epithelial cell activation by fimbriated E. coli requires primary
recognition receptors for fimbrial adhesins and Toll-like receptor 4 (TLR4) for
transmembrane signalling (121). Human urinary tract epithelial cells express
both glycosphingolipid and mannosylated surface glycoprotein receptors,
which recognize the P fimbrial adhesins (122) and the type1 fimbriae,
respectively (123).
Figure 1.11 Transmission electron micrographs of UPEC expressing different fimbriae. Taken
from “Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic
Escherichia coli (UPEC) in the mammalian kidney.” Mobley et al. 2007
1.4.3.1 The role of cytokines and other inflammatory markers
Cytokines play a key role in the innate defence (123). Almost all cells produce
cytokines when appropriately stimulated, especially lymphocytes. Cytokines
perform an almost hormonal role by allowing communication of epithelial cells
with local and distant host cells. Recently, there has been much interest in
other inflammatory markers in OAB, particularly for use as biomarkers for the
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disease. Neurotrophins such as Nerve growth factor (NGF) and Brain derived
growth factor (BDGF) and prostaglandins have been studied in OAB.
1.4.3.2 The role of cytokines in the overactive bladder
Urinary cytokines are elevated in patients with UTI (124)(125). Murine UTI
studies have identified epithelial cells as early producers of cytokines (123)
but the epithelial cytokine response of the human mucosa in vivo has not
been investigated. IL-6 is known to cause fever and trigger the acute-phase
response in response to bacterial infections and in addition, it has been
demonstrated that IL-6 plays a critical role in the formation of chronic
inflammation, including in the bladder (126), while chemokines such as IL-8
recruit inflammatory cells to the site of infection. Uroepithelial cell lines
constitutively make IL-6 and respond with elevated IL-6 production to
exogenous stimuli like bacteria or cytokines (120;124). Studies of patients
with UTI have shown rapid increases in urine IL-6 levels after the onset of
infection or instillation of bacteria into the urinary tract (124;127) but serum IL-
6 levels are only elevated in those with acute pyelonephritis (128).
There is very little and conflicting data on the expression of inflammatory
mediators in OAB. Other lower urinary tract syndromes such as Interstitial
Cystitis and painful bladder syndrome have been linked to an inflammatory
aetiology. Interstitial cystitis and the painful bladder syndrome are associated
with increased mast cells on bladder biopsy and raised inflammatory markers
in the urine including histamine, methylhistamine and IL-6, thought to result
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from the degranulation of granules from the mast cells(129;130). Erickson et
al. found elevated levels of IL-6 and Epidermal growth factor (EGF) in patients
with interstitial cystitis (131). Transforming growth factor β1 (TGFβ1) is
upregulated in interstitial cystitis and a three-fold increase in IL-10 has been
demonstrated in patients with OAB (132). Bouchelouche et al. showed that IL-
1β and and TNFα stimulate the secretion of IL-6 in cultured human detrusor
smooth muscle cells (133). The regulatory effect of cytokines in inflammation
has been shown in animal models, particularly the stimulation with bacterial
endotoxin lipopolysaccharide leading to the secretion of IL-6 (134). Heinrich et
al (135) showed an upregulation in the gap junction proteins connexin 43 and
45, secondary to stimulation by IL-6. They suggested that this modification of
cell-cell communication by IL-6 could be pivotal in the pathophysiology of the
overactve bladder and interstitial cystitis. Conversely, Ghoniem et al. (136)
have shown a down regulation of IL-6 in the urine of patients with OAB,
however, they do not describe the minimum level of detection of the cytokine
in their micro-array.
Tyagi et al. (137) studied IL-5, IL-6, IL-10, IL-12p70/p40, IL-1 receptor
antagonist (IL-1Ra), Epidermal growth factor (EGF) and soluble IL-2 receptor
a (sIL-2Ra) in the urine of patients diagnosed with OAB compared to control
volunteers. They found a significant increase in IL-10, IL-12, EGF and IL-
12p70/p40. They suggested a relationship with inflammation in OAB, possibly
secondary to irritation or stress. An increased IL-8 has been shown in
Interstitial Cystitis but not in the overactive bladder (121;125;127).
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1.4.3.3 The role of neurotrophins in the overactive bladder
NGF and BDGF are both increasingly studied in OAB. In animal models, NGF
is released in high amounts from smooth muscle cells and the urothelium in
OAB models (138) and has been shown to reduce bladder capacity and
increase bladder reflex contractions (139). In human studies, increased levels
of NGF have been found in the urine of patients with OAB and IC (140;141).
Interestingly, it has been suggested that urinary NGF concentration in OAB
patients correlates with urgency intensity (142).
Little is known about the role of Brain derived neurotrophic factor (BDNF) in
bladder function. After chronic bladder inflammation or spinal cord injury, the
synthesis of BDNF in the urinary bladder is increased (143). Antunes-Lopes et
al. (144) assessed urinary levels of BDNF in healthy volunteers to investigate
if there was a physiological pattern of secretion and to discern any gender
differences. In healthy volunteers, BDNF/creatinine ratio was low, irrespective
of gender or time of urine sampling. In contrast, urinary BDNF/creatinine ratio
was significantly higher in OAB patients compared to controls.
1.4.3.4 The role of prostaglandins in the overactive bladder
The role of prostaglandins in OAB is very controversial. They are locally
synthesised in the bladder muscle and urothelium, triggered by detrusor
muscle stretch, bladder nerve stimulation, bladder mucosa damage, and
inflammation (145) . They are involved in the micturition reflex by decreasing
the thresholds of the stimuli necessary to trigger bladder contraction through
activation of the capsaicin-sensitive afferent nerves (145) Activation of
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prostaglandin EP3 receptors exerts an excitatory effect on urinary bladder
function through modulation of bladder afferent pathways (146). Kim et al.
found urinary levels of PGE2 and PGF2α in patients with OAB were
significantly increased compared to a control group (145). In addition, an
inverse correlation was found between urinary PGE2 and the volume to first
desire to void and the maximum cystometric capacity. However, in contrast
Liu et al. measured urinary levels of PGE2 in patients with OAB wet, OAB dry,
IC, and controls and did not find significant differences (147).
The literature certainly supports a role for inflammation in the pathophysiology
of the overactive bladder with the presence of many inflammatory markers
described in OAB as above. However, there is little suggestion as to the
cause of the inflammation, and more a move to investigate a novel biomarker
for the disease.
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1.4.4 A mouse model of urine infection
Hultgren et al. have mapped out the probable sequence of events involved in
UTI by means of a series of experiments conducted on mice as described
below, (Fig1.12). Hultgren et al. used the mouse model due to the similarities
in the bladder epithelium between mouse and human. The urothelium in both
species is comprised of small, relatively undifferentiated basal and
intermediate epithelial cells underlying a single layer of highly differentiated,
large and often-binucleate superficial facet cells. These cells are coated on
the apical side with semi-crystalline arrays of four integral membrane proteins
known as uroplakins. The primary sequence and biochemical properties of
the uroplakins as well as the ultrastructures of the asymmetric unit membrane
they form are highly conserved among many mammalian species, including
human and mouse (148).
(1) UPEC possess adhesive, fibrous organelles on their surface, which are
called pili. The type-1 pilus adhesin FimH binds to mannosylated uroplakins
on the surface of urothelial umbrella cells (149).
(2) The UPEC then invade the umbrella cells and can be detected in the
cytoplasm.
(3) Following invasion the bacteria enter replication phase (150) that begins
with the rapid growth of rod-shaped bacteria in an amorphous colony.
Hultgren et al. have called these “Bacterial factories” (151). The bacteria
exhibit a 30-minute doubling time during this period.
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(4) After 6 to 8 hours the bacteria form organised collections of coccoid
bacteria. Growth is slowed to a doubling time in excess of 45 minutes.
Eventually these colonies come to occupy most of the cytoplasm (151).
(5) At the periphery of the colonies, some of the E. coli regain their rod shape,
detach and swim in the cytoplasm. If the umbrella cell becomes perforated,
these bacteria will swim out into the urine and attach to other uninfected
umbrella cells. Hultgren et al. referred to this as “Bacterial fluxing” (151).
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Figure 1.12. A murine model of UTI taken from Hultgren et al 2009.
In response, the urothelium attempts to eliminate the pathogens with a,
bipartite, innate immune response (152). The first is mediated through Toll-
like receptor 4 (TLR4) a transmembrane lipopolysaccharide receptor.
Activation causes the release of antimicrobial peptides, inflammatory
cytokines and chemokines, and co-stimulatory molecules that initiate the
innate immune response to common Gram-negative bacteria. The signalling
cascade is activated by UPEC lipopolysaccharides binding to TLR4 on the
urothelium, which eventually recruits Polymorphonuclear Neutrophils (PMN).
However, as a great deal of the bacterial load is intracellular,
multiplication/growth can continue while evading the action of PMNs as well
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as antibiotics and other defence mechanisms. The filamentous bacteria also
appear to be resistant to phagocytosis by PMNs although the mechanism is
unknown (150;153). Even if the umbrella cells exfoliate with their bacterial
load, mobile, flagellated rods are released into the urine. These can then bind
to and migrate into exposed transitional epithelial cells. Through this
manoeuvre, a chronic infection can establish. It appears that the bacteria that
are able to invade these transitional cells are biologically quiescent, as a
superficial umbrella cell layer is able to re-establish itself (150;152).
In the murine model, chronic infection can serve as a nidus for recurrent
infections that are resistant to short-term (10-day) treatment with
trimethoprim-sulfamethoxazole (154). This recapitulates a common pattern
seen in human infection, where very protracted courses of urinary antibiotic
are required to clear pyuria and the associated symptoms.
Hultgren et al. have discovered that in their murine model, populations of E.
coli can persist in the bladder for months on end, during which time they exist
as a quiescent reservoir (151).
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1.4.5 Evidence for bladder pathogens in Patients with LUTS
without acute frequency and dysuria.
The diagnosis of OAB relies on the exclusion of infection using conventional
methods; however, there are a few early publications which have sought
bacterial pathogens using enhanced culture techniques, in patients with
LUTS.
In 1988, Payne et al. studied 88 patients attending for urodynamic studies. 37
of 42 women with detrusor instability and 14 of 17 women with stress urinary
incontinence showed evidence of infection with aerobic or fastidious bacteria
before investigation (155). They suggested that urinary symptoms may be
caused by infection, the urodynamic findings being secondary to this.
Maskell et al., in 1983, (156) conducted a two-year study of 51 women with
chronic urinary symptoms. They showed a highly significant relation between
high counts of fastidious organisms in the urine and the presence of
symptoms.
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1.4.6 Fastidious bacteria in the bladder
In the context of UTI, fastidious bacteria can be defined as those which
require culture conditions other than overnight incubation in air on a primary
isolation medium. Culture on additional media, or prolonged incubation in an
atmosphere containing carbon dioxide or anaerobic conditions, may be
necessary for their detection (156).
Before the practice of examining MSU samples and the application of the
Kass threshold of greater than 105cfu ml-1 of a known urinary pathogen, as
diagnostic of UTI, such organisms were found in catheter specimens of urine
from patients with clinical evidence of UTI (157). The importance was then
placed on aerobic incubation and high bacterial counts and techniques for
detecting other organisms were no longer applied. Since that time, published
studies of UTI refer only to the isolation of aerobes. Some suggest we
reconsider the possible role of fastidious organisms in the pathogenesis of
UTI (156).
Another reason for reconsidering the role of fastidious bacteria is the growing
body of published evidence that such organisms can be isolated from the
urine of many patients with LUTS and from patients with indicative symptoms
but seemingly sterile pyuria. Such organisms require a reduced oxygen
tension and are usually present, as natural commensals, occupying the sites
where the aerobes that cause ascending UTI are also found. There is
increasing acknowledgment that organisms, otherwise lacking pathogenicity,
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may become secondary pathogens as a result of selection by antibacterial
treatment or by other changes in the natural environment such as hormonal
involution.
It has been shown that certain fastidious bacteria, such as Streptococcus
spp., (158) Gardnerella vaginalis, (159) Haemophilus influenzae (160) some
Corynebacterium sp (161) and Lactobacillus spp. (162) may be associated
with infections of the bladder and upper urinary tract. These organisms have
been isolated from urine collected by bladder catheterisation, by suprapubic
aspiration or by ureteric catheterisation, and by culture of bladder biopsy
tissue (159), from patients with objective evidence of bladder or kidney
infection. They have also been isolated from bladder urine of symptom-free
pregnant women who, however, later developed symptoms more often than
those with sterile bladder urine (163;164). Maskell et al.(156) describe culture
of Lactobacillus spp. in many of their study group. They assume pathogenicity
of the organisms they have cultured, despite other literature that suggests
Lactobacillus spp to be protective against colonisation of the urogenital tract
with known urinary pathogens, particularly E.coli (89;165).
1.4.7 The role of Chlamydia and other sexually transmitted
infections.
In men, the role of these organisms in the aetiology of urinary symptoms is
well understood. They are implicated in urethritis and epididymitis. Evidence
for chlamydial infection as a cause of urinary symptoms in women is
conflicting. Stamm et al. (166) reported that chlamydial infection may be
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associated with dysuria and frequency in young women. They did not,
however, seek the presence of fastidious bacteria in the urine of these
patients and they did not explain the presence of bladder pyuria. Others have
failed to prove chlamydial infection in women with urinary symptoms (167).
Maskell et al. (168), considering the question from the reverse direction,
questioned women with proven chlamydial infection for the presence of
urinary symptoms. 70% of them denied any such symptoms. Of the 30% who
admitted to them, all had positive MSU cultures, two with E. coli and one with
G. vaginalis. This supports the hypothesis that women with chlamydial
infection and urinary symptoms may have more than one infection.
1.4.8 Evidence for an Inflammatory Response in the Overactive
bladder
There are several clinical conditions, affecting patients, which are
characterised by objective evidence of inflammatory disease, including pyuria,
for which no aerobic causal organism is found. Furthermore, comprehensive
explorations for causes of inflammation other than UTI are typically
unsuccessful. These include interstitial cystitis, urethral syndrome and acute
abacterial cystitis. Many patients with these conditions have pyuria; others
have clinical evidence of inflammation, for example a tender prostate or
paraurethral glands, as well as symptoms which are clinically identical to
those of patients with aerobic pathogens and acute UTI. As we have seen,
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several studies have shown an inflammatory cytokine response in patients
with Interstitial Cystitis.
Malone-Lee et al. (169) identified evidence of pyuria in 58% to 74% of
patients presenting with overactive bladder symptoms, despite a negative
routine urine culture. They suggested that an occult bacterial cystitis may be
responsible for this inflammatory marker in the urine. They also showed that
patients with pyuria had worse 24 hour frequency and incontinence in
comparison to patients without pyuria.
Taking into account the studies described above, it is entirely plausible that
OAB could in part be due to an occult chronic urine infection that has evaded
detection. This may be due to inadequate microbiological techniques and
intracellular colonisation of bacteria not detected because of the low
sensitivity of current clinical tests.
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1.5 Hypotheses to be tested
1. The presence of pyuria ≥ 10 wbc µl-1 in patients with OAB is associated
with other evidence of an inflammatory response.
2. The traditional diagnostic methods deployed to exclude urinary
infection in OAB patients are missing genuine infection.
3. OAB is associated with intracellular bacterial colonisation of
uroepithelial cells by pathogenic bacteria
1.5.1 Aims of the project
1. To revalidate the routine clinical methods used to exclude infection in
patients with OAB.
2. To discover whether patients with overactive bladder with pyuria harbour
bacteria which are undetected in current clinical practice.
3. To discover whether any bacteria isolated from patients with OAB are
intracellular bacteria parasitizing uroepithelial cells.
4. If such bacteria are present, to identify and quantify them.
5. To determine whether bacteria isolated from patients are able to invade
uroepithelial cells.
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Chapter 2
Patient recruitment and routine methods
for analysis
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2.1 Ethical Review
The study was approved by the Moorefield’s and Whittington Hospitals
Research Ethical Committees. (REC reference number 07/H0704/74).
2.2 Patient recruitment
Women and men newly presenting to the Incontinence Clinic at The
Whittington Hospital were approached. They were characterised as having
OAB by the use of a validated questionnaire (see appendix 1) (170). There
are many validated questionnaires that can be used to characterise patients
with OAB and express symptom severity such as the OAB-ss (171) , OAB-q
(172),OAB-SCS (173) and the UPS (174). However, most of these scores
were developed to look at symptom improvement during drug trials and some
look at symptom bother and quality of life. These aspects of the disease were
not relevant to my studies and for this reason I used a simple 10 point scale
showing symptom severity.
A medical history was taken. Previous negative urine culture results, reported
by the referrer, were used for purposes of diagnosis. Pregnant women were
excluded from the study as were those with a known anatomical or functional
abnormality of the urinary tract.
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2.3 Patient data
Patient details and symptom questionnaires were recorded onto the hospital
database “Artemis”, which is a secure database that is backed-up by the
hospital IM&T department each day. It is defended by the NHS and Hospital
Firewall.
The patient demographics and symptom scores are shown in table 2.1 for
each study conducted.
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Table 2.1 Patient demographics and symptom profile for patients used in the studies
throughout this thesis.
Study Chapter Patient
number
Male:
Female
ratio
Mean
age
patients
(Sd)
Mean
age
controls
(Sd)
Median
frequency
24hrs patients
(interquartile
range)
Median
urgency score
patients
(interquartile
range)
Median
Incontinence
episodes
24hrs patients
(interquartile
range)
Comment
MSU vs
CSU
2 40 0:40 60 (18) N/A 9.5 (7-12) 2.5 (1-6.5) 1 (0-2)
Dipstick
analysis
experiment 1
4 615 89:526 51 (19) 34 (11) 8 (6-11) 2 (0-5) 1(0-3)
Dipstick
analysis
experiment 2
4 607 0:607 57 (18) 34 (11) 8 (5-11) 2 (0-5) 1 (0-2)
Cytokine
study
5 104 0:104 56 (17) N/A 9 (6-11) 1 (1-1) 2 (0-5)
Enhanced
culture study
3 194 0:194 57 (18) N/A 7.5 (5-12) 2.5 (1-5.5) 1 (0-5)
Sediment
culture study
3 89 0:89 56 (17) 29 (12) 10 (8-12) 3 (0-6) 0.5 (0-5)
Bladder
biopsy study
3 11 0:11 56 (19) N/A 8 (5-11) 2.5 (0-5) 1.5 (0-6) All patients
used in this
study were
also part of
the sediment
culture study
Urothelial
intracellular
invasion
study
6 23 0:23 56 (17) 29 (12) 7.8 (5-8) 2 (0-5) 2.5(0-5) All patients
in this study
were also
part of the
sediment
culture study
Urothelial
intracellular
invasion
study-
microscopy
6 24 0:24 56(17) 29 (12) 8.75 (5-9) 2 (1-6) 0.9(0-3) All patients
in this study
were also
part of the
sediment
culture study
and
urothelial
intracellular
invasion
study
The methods outlined in this chapter were used throughout the project.
Methods used for a specific chapter are outlined at the beginning of the
relevant chapter.
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2.4 Diagnosing Urine infection in clinical Practice
2.4.1 Urine microscopy
A disposable pipette was used to load a clean haemocytometer chamber with
a sample (fig 2.1). This preparation was examined using an x20 objective with
an x10 optical (magnification x200). The leukocyte count (wbc mm-3) was
enumerated by counting cells in five large squares and doubling the result. If a
cell overlapped a ruled line engraving, it was counted "in" if it overlapped the
top or right ruling; ignored as "out", if it overlapped the bottom or left ruling (fig
2.2).
Fig 2.1.A haemocytometer grid
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Figure 2.2 A haemocytometer grid. The numbers indicate the sequential order in which the large
squares were viewed under the microscope (Adapted from Caprette 2000).
2.4.2 Urine Dipstick examination
Nitrite Test: The urine was dipped by a Multistix® 8 SG and read by a Clinitek
Status colorimeter (Bayer Healthcare). The nitrite test pad sensitivity of the
dipstick was stated to be 13-22 µmol/L (0.06-0.1 mg/dL) nitrite ions. Therefore
if the urine sample contained nitrite ion in the range specified, the pad would
turn pink indicating a positive result.
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Leukocyte Esterase Test: The urine was dipped by a Multistix® 8 SG. The
leukocyte esterase pad sensitivity of the dipstick was stated to be 15 wbc μL-1
when “trace positive” and this level was considered to be positive.
2.4.3 Urine Sampling
2.4.3.1 Mid-stream urine collection
Written or verbal instructions were given to the patient. Samples were
obtained by the midstream clean-catch method. The patients began urinating
into the toilet or urinal. After the urine had flowed for a few seconds, a sterile
container was placed into the stream and approximately 60 ml was collected
without interruption of flow (see appendix 2).
2.4.3.2 Obtaining a catheter specimen of urine
The procedure was explained to the patient and verbal consent was obtained.
Hands were washed using soap and water. Disposable gloves were worn to
minimise the risk of cross-infection. The perineum was wiped with sterile
normal saline solution. A Lofric (in and out) size 12 Fr catheter was inserted
into the urinary bladder under aseptic conditions with a “no touch technique”.
The urine was collected into a sterile container. The urine was transferred into
a sterile 20ml container which was labelled with the patients details. Hands
were washed using soap and water.
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2.5 What is the best method of sampling urine from female
patients?
2.5.1 Hypothesis
Clean-catch MSU samples are unacceptably contaminated by extrinsic white
cells when compared to samples collected by the catheter specimen of urine
(CSU) method.
2.5.2 Background
The diagnosis of UTI is based on urine sampling, which requires a high quality
specimen, free of vaginal, perineal or faecal contamination with organisms or
inflammatory cells.
Urine specimens from women are particularly at risk of contamination due to
anatomical factors; proximity of urethral meatus to the vulva and labia and
due to compliance factors in collecting the sample.
Urine can be sampled by suprapubic aspiration, catheter insertion or mid-
stream urine collection. Contamination by vaginal, perineal and faecal flora is
inherent in MSU sampling. Contamination rates as high as 30% have been
reported (175) (176) (177).
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Most sample collections are unsupervised and although instructions on
collection can be given to patients to reduce contamination, this is difficult to
achieve in a busy, unfamiliar clinical environment. In addition, physical
constraints such as old age or urinary pathology such as overactive bladder
can make compliance difficult (175;176). It has also been found that
conventional sampling of the MSU with additional cleansing procedures of the
perineum does not significantly alter culture outcomes or levels of
contamination (178) (179).
The presence of true infection can be confirmed by urethral catheterisation or
suprapubic aspiration. Although suprapubic aspiration is free of contaminating
organisms, it is an invasive procedure and not suitable for routine diagnosis. A
novel device, which collects a MSU sample by excluding the initial low-flow
portion of the urinary stream and with no interruption of flow, has been studied
and shown to reduce contamination rates in urine samples. However, this
device is not yet commercially available (180).
In order to collect a sample that is of sufficient quality to be studied with
confidence, particularly without contamination by vaginal cells, a catheter
specimen of urine is the preferred option. This delivers a specimen
approaching the quality of a suprapubic aspiration (181). The method is
remarkably well tolerated in women and proves painless.
As I was to investigate patients with OAB symptoms and pyuria, the aim was
to obtain a urine specimen which was uncontaminated by skin and vaginal
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white cells and pathogens. One method of investigating any potential
contamination was to compare a MSU specimen with a catheter specimen
(CSU) in the same patient for white cells.
2.5.3 Methods
40 newly presenting, female patients with symptoms of OAB were recruited
and gave consent. The patient demographics are described in table 2.1. They
provided an MSU sample and up to three days later, during which time they
went untreated, they provided a CSU. The sequence was used to avoid CSU
introduction of new infection. The sample was analysed immediately on
collection. The leucocyte count (wbc μL-1) was enumerated by microscopy
(2.4.1) The investigators were blinded to the previous results.
2.5.4 Statistics
Two statistical tests were used. In the first, the null hypothesis was that the
proportion of pyuria positive samples was identical whether collection was by
MSU or CSU. A clinically significant difference in proportions was estimated
as 0.33 (specifically, 0.66 versus 0.33). A sample size of 40 pairs of data was
calculated to have power of 85.3% to yield a statistically significant result. The
data were collated and analysed. The between method differences in
proportions of positive (pyuria) and negative (no pyuria) samples were
assessed by the Chi squared test. The between method differences in white
cell counts were compared by the paired t-test. In the second, in agreement
with the current literature, it was assumed that the CSU is a superior method
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of sampling and so the sensitivity and specificity of the MSU was calculated
using the CSU as the gold standard test.
2.5.5 Results
40 women were recruited. Their mean age was 60 (sd=18). The patient
demographics are described in table 2.1. The results from the different
sampling methods are illustrated in table 2.2
Table 2.2 The comparison of pyuria detection between sampling by midstream urine
collection (MSU) and catheter specimen (CSU) collection in the same patient
Method of sampling No pyuria detected Pyuria detected
MSU 3 37
CSU 24 16
37 (93%) of the MSU samples showed pyuria but only 16 (40%) of CSU
samples (Χ2 =25, df=1, p<0.001). The differences in absolute white blood cell 
count between sampling methods is illustrated in Figure 2.3.
If the CSU should be treated as the gold standard reference for the analysis of
pyuria, then the sensitivity of the MSU is 1 (95% CI = 0.7 to 1.0) but the
specificity is 0.1 (95% CI = 0.04 to 0.4). See Table 2.3.
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Table 2.3 The comparison of pyuria detection between sampling by midstream urine
collection (MSU) and catheter specimen (CSU) collection in the same patient,
showing the sensitivity and specificity of MSU when compared to CSU
These data imply substantial contamination in the MSU.
CSU Neg CSU Pos Totals
MSU Pos 21 16 37
MSU Neg 3 0 3
Totals 24 16 40
Sensitivity 1 (95% CI 0.75-1), Specificity 0.081(95% CI 0.037-0.37)
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Figure 2.3 Comparison of absolute pyuria counts obtained from midstream urine (MSU) and
Catheter urine (CSU) samples obtained from the same patients.
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There was a significant difference in mean pyuria count between the two
groups with higher counts evident from MSU samples (95% CI of difference =
18 to 144, p=0.013, t=2.6).
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2.5.6 Discussion
These data support the hypothesis that MSU samples may be contaminated
by extraneous white blood cells, possibly from the vagina. This could lead to
over-diagnosis of urinary infection and studies that involve the analysis of
pyuria in association with symptoms must take this into account. This was a
blinded study but the method did not randomise the sampling because of
concerns that a catheterisation of the bladder might introduce infection or
perturb the bladder in some way. It may be that the difference in counts could
be explained by spontaneous resolution during the time between sampling.
Given the numbers, it is not probable but nevertheless, despite the risk of
catheter contamination, these data will require verification in a trial using a
randomised order for sampling. These data suggest that in the case of
women, a CSU is a much more reliable sampling method for enumerating
pyuria and potentially avoiding contamination from bacteria and cells also
from the vagina.
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2.6 Routine Laboratory Urine Culture
An aliquot of all CSU specimens collected was sent to the Whittington
Hospital NHS Trust microbiology laboratory, as is routinely done, for urine
microscopy, culture and sensitivity. The sampled urine was treated fresh, or
after overnight storage at 4° C at the hospital laboratory. 1μl of unspun urine
was transferred by loop to a chromogenic media, CPS ID2 (bioMerieux). The
plate was incubated aerobically for 24 hours at 37°C. Bacterial colonies were
identified by colour change and size as below. The result was taken as
positive if greater than 105 colonies were generated per ml after 18-24 hours
culture.
2.6.1 Chromogenic Agar
Some of the organisms found in UTI produce enzymes either for the
metabolism of lactose or glucosides or both. Other organisms produce none
of these enzymes. For example, E.coli contains enzymes for lactose
metabolism but is -glucosidase negative. These enzymes can be used to
identify microorganism phenotype in culture.
The principle of this medium is the use of chromogenic substrates revealing
metabolic enzymes. The medium is composed of peptone, yeast extracts and
agar and a special chromogenic mixture. It enables the presumptive
identification of E. coli, Enterococci, Klebsiella-Enterobacter group, and
Proteus group.
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Table 2.3 Bacterial identification using chromogenic agar according to colour
change
SPECIES COLONY COLOUR SENSITIVITY
E.coli Red
Klebsiella spp, Citrobacter spp Metallic blue
Enterococcus spp Turquoise blue
Proteus mirabilis Clear with brown halo
Staphyloccus saprophyticus Pink opaque
Staphylococcus aureus Colourless opaque
Candida spp Creamy
2.7 Bladder biopsy
Well characterised, suitable patients with refractory OAB symptoms were
provided with an information leaflet summarising the cystoscopy procedure
and bladder biopsy (see appendix 3). Patients were consented for the
procedure on a follow up visit. All cystoscopies were performed under sterile
conditions in the main theatre complex at the Whittington Hospital NHS trust.
The perineum of patients was cleaned with Iodine solution and all patients
were draped with sterile drapes. A flexible cystoscope or size18 rigid
cystoscope was used. Two biopsies were taken from the dome of the bladder
and immediately placed in sterile normal saline or gluteraldehyde solution for
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routine pathology. The biopsy placed in the normal saline was transported to
the Eastman Dental Institute.
2.8 Control urine catheter specimens
Female patients attending The Whittington Hospital for day surgery
procedures under the care of the Gynaecology department were approached.
Any patient requiring the routine emptying of the bladder during surgery was
asked to fill out a bladder symptom questionnaire (appendix 1). Patients with
any lower urinary tract symptoms were excluded. Patients without symptoms
were asked to donate urine removed during the procedure. Typically, patients
attending for a laparoscopy gave permission for the use of their urine
specimen. The specimen was collected as above (2.4.3.2) prior to their
surgery. The urine was collected into a sterile container and patient details
were entered into the Artemis database (2.3). An aliquot of urine was subject
to microscopy, dipstick, and routine culture and enhanced culture as above
(2.4.1, 2.4.2, 2.6, 2.9.1). An aliquot of urine was transported to the Eastman
Dental Institute and subject to sediment culture (2.9.2)
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2.9 Laboratory Methods- Culture Techniques
2.9.1 Enhanced Culture Technique
The urine sample was mixed by gentle inversion and the top of the container
was removed aseptically. With a calibrated sterile 200µL pipette, urine was
dropped onto the edge of the ChromID plate (CPS Biomerieux).The inoculum
was spread over the entire surface of the plate with a spreading spatula taking
care to avoid the edges of the plate. In a similar way, a second aliquot of
specimen was inoculated onto a blood agar plate (Oxoid). The blood agar
plates were placed into anaerobic jars (AnaeroGen, Oxoid) and the
manufacturer’s instructions were followed to generate the anaerobic
environment using a gas pack. The ChromID plates were transferred to racks
and transported to together with the “gassed out” anaerobic jars to the
microbiology laboratory at the Whittington Hospital. The chrome plates were
incubated aerobically at 35-37°C for 18 hours. The blood agar plates were
incubated anaerobically for 5 days at 35-37°C. The colonies were counted
and identified visually.
2.9.2 Sediment Culture
The samples were transported to the Eastman Dental Institute from The
Whittington. The volume of the urine was recorded. The entire volume of the
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urine was centrifuged at 8000rcf for 5 minutes at room temperature using an
Eppendorf 5804R centrifuge. The supernatant was removed gently and the
sediment was kept. The sediment was re-suspended in 400µL of normal
saline. Serial dilutions were performed to 10-3 and 100µL of each solution
(50µL on each half) was placed on a Columbia Blood Agar (CBA) plate (E&O
laboratories) and Fastidious Anaerobic Agar (FAA) plate (E&O laboratories).
10µL of the neat solution was placed on a double frosted slide for Gram stain.
The CBA plates were placed in a CO2 incubator at 37°C for 48hrs. The FAA
plates were placed in an anaerobic incubator at 37°C for 7 days.
2.9.3 Colony counts and sub-culturing
After the respective incubation periods, colony descriptions were recorded
following the colony description guide as below. The colonies were counted
and recorded. A single colony of each micro-organism was streaked onto a
fresh CBA plate or FAA plate and incubated as above. The plates were
examined after the incubation periods. If the culture appeared to be a pure
growth, biochemical identification tests were carried out as below (3.2).
Subcultures were repeated until a pure culture was obtained.
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2.9.4 Colony Description
Taken from “Western Michigan University Microbiology Lab Procedures”
http://homepages.wmich.edu/~rossbach/bios312/LabProcedures.html
Size: A ruler was held under a plate and used to measure the diameter of
several representative colonies; these measurements were then averaged
and recorded.
General Shape: The shape of a colony was described as round, irregular and
spreading, filamentous, rhizoid or curled when viewed from above
Margin: The margin was observed from above and represented the outside
edge of the general shape. The margin was described as entire, undulate
lobate or filamentous
Elevation: The elevation of a colony was observed from the side of the plate
and was characterized in the following ways; effuse (like water on a flat
surface), flat (discrete colony with a flat top), convex (water on wax paper),
umbonate (with a nipple in the centre), or umbilicate (sunken centre)
Surface: The surface of the colony was observed from the top and was
described as smooth, filamentous, powdery, wrinkled or ringed.
Density: If the colony was opaque or translucent
Pigment: (1) Non pigmented colonies were described as colourless, white, or
off-white, (2) Non-diffusible pigment described the colony as pigmented,
while (3) Diffusible soluble pigment coloured the agar around the colony
The role of bacterial infection in the aetiology of the overactive bladder
86
Figure 2.4 Colony Morphology
http://www.northern.wvnet.edu/~tdanford/cmorph1.jpg
The role of bacterial infection in the aetiology of the overactive bladder
87
2.10 Methods- Biochemical Identification Tests
2.10.1 Catalase Test
Using a sterile disposable loop, growth from the centre of a colony was
transferred to a clean glass slide. 20µL of 3% hydrogen peroxide (Sigma) was
added to the colony. The sample was observed for the production of bubbles.
A sustained appearance of effervescence was reported as positive.
2.10.2 Oxidase Test
A solution of tetramethyl-p-phenylenediamine (Sigma) was prepared in 1ml of
sterile distilled water. A sterile swab was placed into the solution and soaked.
The cotton bud was then touched onto the surface of the test colony. A
positive reaction was taken as the development of a purple colour within 20
seconds. Pseudomonas. aerogenosa (NCTC 10662) was used as a positive
control.
2.10.3 Carbohydrate Oxidation- Fermentation Tests
To determine the products of sugar fermentation, a carbohydrate fermentation
medium was prepared at pH 6.6-7.0. This medium contained three essential
ingredients: glucose, nutrient medium, and the pH indicator bromothymol
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blue. The test organisms were inoculated into 20ml sterile tubes containing
10ml of the medium by stabbing the centre of the medium to greater than half
the depth with a sterile loop. The medium was incubated at 37°C for 48 hours.
A duplicate tube was inoculated with the same organism and covered with
3ml of paraffin oil to create an anaerobic environment. A bright yellow colour
indicated the production of enough acid products from oxidation/ fermentation
of the sugar to drop the pH (182). E. coli (NCTC 10418) was used as a
positive control strain.
2.10.4 Bacterial Motility
A motility medium was prepared containing brain heart infusion broth,
gelatine, potassium nitrate and agar. 20ml sterile tubes containing 10ml of the
agar were inoculated with a pure culture by stabbing the centre of the column
of the medium to greater than half the depth. The tubes were incubated for
24-48 hours at 37°C in an aerobic atmosphere. After incubation, the tubes
were observed for growth in relation to the stab line. Non-motile organisms
grew only along the line of inoculation, while motile organisms spread out
from the line of inoculation. Pseudomonas. aeroginosa (NCTC 10662) was
used as a positive control.
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2.10.5 Gram stain
20µl of the neat sediment solution was placed on a glass slide. In addition, a
single pure colony was picked with a sterile loop and mixed on a glass slide
with 20µl of PBS. The solutions were allowed to dry in air. Crystal violet stain
(Sigma) was added over the slide. This was allowed to stand for 30 seconds.
The slide was then gently rinsed with a stream of water. Iodine solution
(Sigma) was added on the smear, enough to cover the slide. This was
allowed to stand for 30 seconds. The iodine solution was rinsed off the slide
with running water. A few drops of acetone (Sigma) were added so the
solution trickled down the slide and rinsed off with water after 5 seconds. A
counter stain of 1% neutral red solution (Sigma) was added for 30 seconds.
The solution was washed off with water. The slide was air-dried after blotting
off excess water.
2.10.6 Identification based on biochemical Tests
Identification was carried out using standard tables from Cowan and Steel's
Manual for the Identification of Medical Bacteria, third edition (183).
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2.11 Laboratory methods-16s rRNA gene typing
After biochemical microbiological identification techniques had been carried
out, DNA was extracted from the bacterial isolates, which was used as a
template to amplify the 16S rRNA gene using global primers (27f and 1492r,
Genosys, Sigma, UK) via the polymerase chain reaction. Sequences were
analysed using the Basic Local Alignment Search Tool (BLAST). DNA was
submitted for sequencing at the Cambridge University DNA sequencing
facility. They carry out sequencing on an Applied Biosystems 3730xl DNA
Analyser.
2.11.1 Extraction of genomic DNA
The DNA extraction kit was obtained from Invitrogen. A single bacterial
colony from a fresh culture was suspended in 200µL of phosphate buffered
saline (PBS). The sample was centrifuged at 3000rcf for 5 minutes. The
supernatant was expelled and the pellet obtained re-suspended in 200µl PBS.
5µl of Lysozyme was added and mixed using a vortex. The specimen was
incubated at 37°C for 15 minutes to digest the cell walls. 200µl of binding
buffer (guanidinium hydrochloride) was added to increase DNA binding. 40µl
of proteinase K was added and the sample was then incubated at 70°C for 15
minutes to digest protein. In addition, proteinase K rapidly inactivates
nucleases that might degrade the DNA. 100µl of propan-2-ol was added to the
sample and mixed by vortexing to precipitate the DNA. The whole mixture
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was then applied to a filter tube provided by Invitrogen. Nucleic acids bind
selectively to glass fibres pre-packed in the filter tube. After centrifuging the
sample at 8000rcf for 1 min, the supernatant was discarded and 500µl of
inhibitor removal buffer was added. The sample was centrifuged again at
8000rcf for one minute and the supernatant discarded. 500µl wash buffer was
then added and the sample centrifuged again at 8000rcf for one minute. The
supernatant was discarded and this step was repeated. The filter tube was
then applied to a 1.5ml Eppendorf tube and 200µl of elution buffer was added
to the filter tube. This releases the DNA from the glass fibres. The sample was
then centrifuged at 8000rcf for 1 minute and the supernatant containing the
eluted DNA was stored at 4°C until used.
2.11.2 Polymerase Chain Reaction (PCR) protocol
The total reaction volume was determined as 50µl. This provided the basis for
the calculations concerning buffer solution (1X concentration), MgCl2
(2.5mmol), deoxynucleoside triphosphates (dNTP’s) (200µM) and DNA
polymerase enzyme used; Taq polymerase (1.5µl per reaction). The 16S
gene primers used for the PCR reactions were 27f (5’
AGAGTTTGATCMTGGCTCAG 3’ and 1492r 5’
TACGGYTACCTTGTTACGACTT 3’ ) (184). The PCR programme, using the
Biometra T3000 Thermocycler, was as follows: 94ºC for five minutes to
ensure denaturing of the template DNA. This was followed by 29 cycles of 94
ºC for 1 minute, 54 ºC for 1 minute and 72ºC for 1minute 30 seconds. After
cycling, an extension of 72 ºC for 5 minutes was followed by cooling to 4ºC
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until the samples were analysed. Standard techniques were used for agarose
gel electrophoresis and PCR purification(184). The supernatant containing the
purified DNA was stored at 4°C until used. 10µL of the purified DNA was sent
for sequence analysis.
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2.11.3 Storage of bacterial isolates
Bacterial isolates were inoculated into Brain Heart Infusion (BHI, Oxoid Ltd.)
broth. Sterile glycerol (BDH Chemicals, Poole, UK) was added to the broth to
give a final concentration of 10% glycerol. One ml aliquots were then stored at
-70°C as frozen glycerol 10% v/v) stocks.
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Chapter 3
Using an enhanced culture method to
detect urinary infection in patients with
overactive bladder and the use of urine
sediment culture and bladder biopsy
culture to enhance the detection of bacteria
in patients with OAB
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3.1 Hypotheses
This study tested two hypotheses and this chapter is therefore split into two
parts.
1. The first hypothesis tested was that a more inclusive culture method
and a diagnostic threshold of 102 cfu ml-1 would demonstrate more
infections than routine clinical laboratory methods applying the 105 cfu
ml-1 criterion.
2. The second hypothesis tested was that OAB is associated with
intracellular bacterial colonisation of uroepithelial cells by pathogenic
bacteria.
3.2 First hypothesis
3.2.1 Methods
Female patients with symptoms of OAB gave their consent to participate.
Their symptoms were recorded using a validated questionnaire (appendix 1)
and their antibiotic consumption noted. A CSU was obtained by inserting a
Lofric 12 Fr catheter into the urinary bladder under aseptic conditions
(2.4.3.2). The urine was collected into a sterile container and processed
immediately as per 2.9.1. An aliquot of each CSU also underwent routine
analysis at the threshold of 105 cfu ml-1 (2.6). An aliquot of urine was also
taken for enumeration of white blood cells using a light microscope and
haemocytometer (2.4.1).
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3.2.2 Statistics
Because I wished to include patients taking antibiotics, it was estimated that a
clinically significant effect would be the observation of a positive diagnostic
bacterial culture in 10% of routinely processed samples and 20% of those
using the study method. It was calculated that a sample size giving 400 pairs
would have a power of 97.8% to yield a statistically significant result.
3.2.3 Results
194 women with OAB symptoms were recruited with a mean age of 57
(sd=18). They yielded 378 urine samples collected by CSU. Some women
were sampled twice according to their attendance at clinic during the study
period. The patient demographics are described in table 2.1.
The routine laboratory cultures reported positive results in 46 (12%) samples
whereas the study culture methods isolated bacteria in 114 (30%) samples
(Χ2=100, df=1, p<0.001, 95% CI of difference 17% to 26%). Figure 3.1
describes the pyuria counts according to culture result for the two methods.
The study method identified bacteria in 43 (94%) samples positive on routine
culture. More Significantly, 71 (21%) of those positive with enhanced culture
did not grow bacteria with the established laboratory method. The
concomitant consumption of antibiotics had no effect on these differences.
The different bacteria cultured are shown in figure 3.2. Four per cent of
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patients grew anaerobic bacteria. The prominent bacteria in the OAB patients
were E.coli, Enterococcus sp., Pseudomonas sp and Streptococcus sp.
Figure 3.1 The mean white cell count and 95% CI comparing the routine culture results and
study culture results
F
Figure 3.2 The Prominent bacteria found in CSU cultures
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3.2.4 Discussion
These data demonstrate a more than doubling of the bacterial isolation rate
when a more meticulous culture method is deployed. By using CSU sample, I
could be confident that the isolates originate from the bladder. Figure 3.1
illustrates the fact that the differences between the methods occurred over the
whole spectrum of the inflammatory response and was not limited to the most
symptomatic. These data imply that the misgivings about the validity of routine
culture methods apply to patients with symptoms of OAB. The routine
methods for culturing urine to detect ≥105 cfu ml-1, when applied to patients
with symptoms of OAB, may be failing to identify a significant proportion of
patients with genuine urine infection. These data are supported by the study
described in chapter 4 in which, in a similar cohort of patients, a positive
culture result using the MSU (105cfu/ml-1) method was 15%, using a CSU
specimen (105cfu/ml-1) the positive result was 20% and using a CSU
(102cfu/ml-1) the positive result was 29%. Thus, by using a MSU, we are
potentially missing 5% of UTI’s and a further 9% of patients by using a
threshold of 105cfu/ml-1. These data suggest that the laboratory diagnosis of
UTI should be reviewed especially in the context of patients with chronic lower
urinary tract symptoms such as OAB.
The findings of this study prompted me to develop a method of culturing urine
to maximise the growth of any pathogenic bacteria and the second hypothesis
was studied.
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3.3 Second Hypothesis
3.3.1 Background
This study examined the association between OAB and intracellular bacterial
colonisation of uroepithelial cells by pathogenic bacteria.
If the hypothesis is correct then culture of the urinary sediment, containing the
shed uroepithelium, and bladder biopsies taken from OAB patients and
normal controls would yield a greater number and, possibly, species, of
bacteria than the routine urine culture currently conducted in the NHS which
seeks a single dominant species of bacteria at 1 x105 cfu/ml-1 as a positive
result.
Currently, there are no human studies in the literature to suggest methods of
culturing the urinary sediment and so the study described below uses two pilot
methods, the purpose of which was to allow the detection of bacteria in a
urine sample and bladder biopsy by collecting the uroepithelial cells, hence
culturing bacteria attached to and invading these cells. Gatoria et al. (185)
describe a method of culturing the urinary sediment and bladder wall biopsies
in samples taken from dogs. They centrifuged 5mls of collected urine and
discarded the supernatant. They then used a loopful of the sediment collected
for culture. Bladder biopsy tissue was first macerated and then cultured. The
methods below are adapted from this study. In addition to the culture
methods, a duplicate bladder biopsy taken from patients was sent for
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histological examination by pathologists at the Whittington Hospital NHS
Trust. This was only to confirm the presence of inflammation in the bladder
and to exclude any malignancy as a cause of any of the changes seen in the
bladder tissue.
3.3.2 Methods
89 women were recruited. The urine sediment was collected and plated on
Columbia blood agar (CBA) and Fastidious anaerobic agar (FAA) and
incubated both aerobically and anaerobically (2.9.2). A duplicate aliquot of
urine was sent for routine culture at the Whittington Hospital microbiology
laboratory, with an infection threshold of 105 cfu/ml (2.6). Bacteria were
identified using biochemical tests and 16S rRNA gene typing (2.10-2.11).
An aliquot of unspun urine was examined immediately by microscopy using a
haemocytometer and the urinary white cells evaluated (2.4.1.)
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3.3.2.1 Bladder biopsy
Patients with Overactive bladder symptoms were provided with an information
leaflet summarising the cystoscopy procedure and bladder biopsy (See
appendix 3). The biopsy was taken as per section 2.7.
3.3.2.2 Bacterial Retrieval from bladder biopsies
Patients with OAB symptoms undergoing cystoscopy for investigation of their
condition or for treatment of their condition with intravesical Botulinum toxin A
(Botox A) consented to take part. The patients were characterised by using a
validated questionnaire (appendix 1). The biopsies were obtained as
described in section 2.7.
Each biopsy measured up to 1mm in length. The biopsy was placed in 400µl
of normal saline (neat solution) and gently macerated with a sterile plastic
pestle to break up the biopsy tissue. Serial dilutions tenfold, one hundred fold
and one thousand fold were then prepared and 100µL of each dilution (50µL
on each half) spread onto a CBA plate (E&O laboratories) and FAA plate
(E&O laboratories). 10µL of the neat suspension was placed on a double
frosted slide for Gram stain. The CBA plates were incubated at 37°C in 5%
CO2 for 48hrs. The FAA plates were placed in an anaerobic incubator at 37°C
for 7 days. Colony counts and sub-culturing was carried out as per 2.9.3-
2.9.4). A second identical biopsy was taken from the same site for histological
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analysis at the Whittington hospital NHS Trust histopathology department.
There were no biopsies taken from control volunteers.
3.3.3 Statistics
There were no data from previous studies to assist in a sample size
calculation. The experiment was therefore conducted to capacity. The
analysis performed explored the difference in total bacterial count (cfu/ml-1)
and largest bacterial count (cfu/ml-1) of the most abundant bacteria between
patients and volunteers.
The power to test the null hypothesis that the population means were equal
was calculated. The criterion for statistical significance (alpha) was set at
0.050. The test was 2-tailed, meaning that an effect in either direction would
be interpreted.
The statistical analysis of the data was conducted using one-way analyses of
variance (ANOVA). The statistical program SPSS was used for analysing data
and calculating (ANOVA) and 95% confidence intervals. Where the data were
the average of means the standard errors of the means were used to
construct distribution bars. In all other cases the distribution bars were the
95% CI.
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3.3.4 Results
89 women provided specimens, 63 had OAB symptoms and provided a CSU
mean age 56 (sd=17); 26 asymptomatic female controls, average age 29
(sd=12), of which 11 provided a MSU and 15 a CSU. The symptom profiles
are described in table 2.1 Both MSU and CSU was used in this study despite
previous reports of higher contamination rates to compare and validate the
new culture method.
3.3.4.1 Urine culture results
The routine cultures at 105cfu ml-1 were positive in 7 of the 63 patients (11%);
all of these (100%) had pyuria (>10 white blood cells per ml). The enhanced
culture at 102cfu ml-1 was positive in 12 of the 63 patients (19%); 11 of these
(92%) had pyuria. 7 patients proved positive on both cultures and all of these
had pyuria.
2 out of 26 controls (8%) grew E. coli in both cultures, the others were found
to be negative. These were both MSU specimens. One of the control
volunteers had pyuria. Again, this was in an MSU specimen. In contrast, the
spun sediment culture grew bacteria in all samples, with differences in colony
counts related to OAB and to pyuria (F= 9.4, P=0.003): (fig 3.3 -3.5). Figure
3.3 compares the mean total colony counts cfu/ ml -1 between the patient
groups and normal volunteer groups, showing the SEM. This graph shows a
significant difference between the two groups in mean total bacterial count.
Figure 3.4 below shows the total bacterial counts in cfu/ml -1 in the different
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patient and normal volunteer groups. It shows a higher total bacterial count in
both the patient groups (OAB patients with and without pyuria) when
compared to the normal volunteer groups in samples taken by both CSU and
MSU methods. OAB patients also grew a significantly higher count of the
single most abundant colony type compared to the control volunteers (F=
4.664, df= 2, P= 0.012), (fig 3.5). The single most abundant colony type was
also different in the different groups.
465 bacterial isolates were sub-cultured and purified from the sediment
culture and subjected to biochemical tests and sequence analysis as
described in section 2.10-2.11. 12 isolates were not identified by sequence
analysis because of no growth on sub-culture.
The normal volunteers (N=26) grew between 1-4 x103 cfu ml-1; there was no
significant difference between MSU and CSU collected samples. OAB
patients without pyuria (N= 40) grew 1x106 cfu ml-1. OAB patients with pyuria
(N=23) grew 8x106 cfu ml-1.
In the OAB patients the dominant bacterial isolates were Streptococcus spp
(18% of bacteria found), Lactobacillus spp (15% of bacteria found) and
Enterococcus spp (10% of bacteria found) (fig.3.4).
The dominant bacteria found in the catheter control group (30% of bacteria
found) were Lactobacillus spp. (fig 3.7) and the dominant isolates in the MSU
volunteers were Staphylococcus spp (30% of bacteria found) (fig 3.8). Other
prominent control isolates were Enterococcus spp. (13% of bacteria found)
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and Streptococcus spp (11% of bacteria found) and Corynebacterium spp.
(8% of bacteria found) in catheter control volunteers and Corynebacterium
spp. (20% of bacteria found), Streptococcus spp (16% of bacteria found) and
E.coli (11% of bacteria found) in MSU volunteers.
Figure 3.3 Log mean total bacterial colony count and SEM comparing OAB patients (N=63)
with asymptomatic controls (N=26)culturing the urinary sediment.
The role of bacterial infection in the aetiology of the overactive bladder
106
Figure 3.4 Log mean total bacterial colony count and SEM comparing OAB patients with and
without pyuria and asymptomatic controls providing catheter specimens of urine and Mid-
Stream specimens of urine subjected to culture of the urinary sediment.
Figure 3.5 Log mean largest bacterial colony count and SE mean comparing OAB patients
with asymptomatic controls providing catheter specimens and mid- stream urines subjected to
culture of the urinary sediment .(Cont=control volunteers, OAB=Overactive bladder patient
group)
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Figure 3.6 Bacterial species isolated in patients with overactive bladder
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Figure 3.7 Bacterial species isolated from asymptomatic volunteers providing a catheter
specimen of urine as a percentage of the total number of bacteria identified.
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Figure 3.8 Bacterial species isolated in asymptomatic volunteers providing a mid-stream
specimen of urine.
Bacterial species
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3.3.4.2 Biopsy culture
11 women, mean age 56 (sd=19) years with overactive bladder symptoms,
provided bladder biopsy specimens for culture. The symptom profile is
described in table 2.1
One woman had pyuria (>10 white blood cells per µL) at the time of the
biopsy. 10/11 patients were on long-term antibiotic treatment (median time on
antibiotics being 12 weeks) in preparation for the investigative procedure or to
avoid infection during and after the procedure. 8/11 patients were taking
Nitrofurantoin, 1/11 patient was taking Doxycycline and 1/11 patient was
taking ciprofloxacin. 5/11 patients had negative sediment cultures with no
bacterial growth. 6/11 patients grew bacteria from the biopsy culture despite
taking antibiotics at the time. The average total bacterial count was
3.75x103cfu ml-1 (sd=8.1x102cfu ml-1). 2/5 culture positive patients grew
anaerobes only. Table 3.1 illustrates the histology results of the bladder
biopsy samples and the routine and sediment culture results. The table
demonstrates an inflammatory reaction in all but two of the bladder biopsy
samples according to the histology of the bladder biopsy. This confirms an
inflammatory reaction in the bladders of these patients with OAB symptoms.
However, the routine urine culture sent to the Whittington Hospital NHS Trust
microbiology department (2.6) was negative in all but one patient.
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Table 3.1 Routine culture results and histology results of bladder biopsies
Patient number
Routine urine
culture result
(>105cfu ml-1)
Sediment culture
dominant
bacteria
Pyuria count
(Wbc mm-3) Antibiotic status Histology result
GW1 no growth
Massilia.timonae
0
Taking at time
of biopsy
Normal
urothelium
57 no growth
Veillonella spp
0
Taking at time
of biopsy
Urothelium
showing
inflammation
58 no growth
Veillonella spp
0
Taking at time
of biopsy
Urothelium
showing
inflammation
59 no growth
No growth
0
Taking at time
of biopsy
Urothelium
showing
inflammation
67 no growth
Streptococcus
agalactiae
0
Taking at time
of biopsy
Urothelium
showing
inflammation
71 no growth
No growth
0
Taking at time
of biopsy
Urothelium
showing
inflammation
74 no growth
Neisseria sp
0
Taking at time
of biopsy
Urothelium
showing
inflammation
106
Pseudomonas
aeroginosa
Pseudomonas/
Bifidobacterium
100
Taking at time
of biopsy
Urothelium
showing
inflammation
108 no growth
No growth
0 Not taking
Urothelium
showing
inflammation
109 no growth
Bifidobacterium
0
Taking at time
of biopsy
Urothelium
showing
inflammation
110 no growth
No growth
0
Taking at time
of biopsy
Normal
urothelium
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3.3.5 Discussion
The symptom-free control group in the urine study provided some CSU
samples as well as MSU’s but these did not differ significantly in pyuria or
total bacterial counts. They did differ in the prominent bacteria found however,
fig 3.7 & 3.8. The CSU specimens contained fewer bacterial species and a
larger number of samples grew Lactobacillus spp. This difference between
MSU samples and CSU samples may be because of contamination of the
MSU sample from the perineum. This confirms the findings of the study in
chapter 2.5, suggesting that MSU specimens taken from women are
contaminated from the perineum. However, the species that were isolated
provide some discriminant power in judging the significance of the bacterium
cultured. It is unclear as to why the CSU samples in the control group grew
more Lactobacillus spp as compared to the MSU samples from the control
group. Higher numbers are required to identify a meaningful difference.
Lactobacillus spp are vaginal commensals in women and are found in higher
numbers in pre-menopausal menstruating women. The volunteers in the
control group used in this study were significantly younger than the patient
group (average age 29 years Vs 56 years) and this may account for the
higher proportion of Lactobacillus spp in the control group. The Lactobacillus
species identified are all commonly found in the vagina, including
Lactobacillus. crispatus, Lactobacillus. gasseri, Lactobacillus. johnsonni, and
Lactobacillus. vaginalis. It is also possible that the bacterial community is
different between the patient group and control group, again, due to difference
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in age and hormonal status. However, this does not account for the larger
bacterial load found in the patient group, particularly of organisms such as
Streptococcus spp. and Enterococcus spp. Although vaginal commensals,
these are also found in high counts in disease states.
The largest Streptococcus groups amongst patients were Strep. agalactiae
and Strep. anginosus. Strep. agalactiae is a Group B Streptococcus (GBS)
and colonization of the urinary tract in women probably occurs by an
ascending route from the vagina, where GBS can persist without causing
symptoms. The literature is dominated by reference to Group B Streptococcus
and its role in neonatal sepsis intrapartum, due to vaginal colonisation in the
mother, however, several studies have also reported high rates of GBS UTI in
non-pregnant adults (186) (187;188). One study by Trivalle et al. (189)
reported GBS cultured from 39% of all cases of symptomatic UTI among
nursing home residents >70 years of age. Several studies have reported the
recovery of GBS from between 1 and 2% of all UTI cases (104;190).
Interestingly, relatively high rates of treatment failure and poor clinical
outcomes have been associated with GBS UTI and attributed to macrolide
resistance (104).
Ulett et al. (191) investigated the early pathogenic mechanisms underlying
GBS UTIs. Particularly, whether Uropathogenic GBS can bind to human
bladder urothelium and trigger host responses as a means to colonize and
cause inflammation in the bladder. They used an in vitro binding assay with 2
cell lines and a murine model of cystitis. They demonstrated that GBS binds
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directly to human bladder urothelial cells, which facilitates colonization of the
bladder in vivo. They also observed that the GBS isolate used in the study
triggered a more potent induction of IL-1α than a virulent uropathogenic E.coli
strain. These studies are very interesting in the context of this study as they
give a possible explanation for the existence and persistence of these
potential pathogens causing UTI in my patient group. Strep. anginosus
bacteria are found as members of both the normal and pathogenic microbiota.
They are most often found as part of the normal flora of the oral cavity and
gastrointestinal tract of humans but these organisms have also been isolated
from the normal microbiota of the respiratory and female genital tracts. The S.
anginosus group has been associated with multiple types of infections. The
first reported infections caused by these bacteria were oral infections;
however, S. anginosus group bacteria are now known to be involved in
infections in multiple body sites. S. anginosus is more commonly isolated from
blood, urine, and soft tissue infections (192). There is very little in the
literature in relation to this organism as a pathogen in UTIs and the
mechanism of infection. Strep. anginosus is commonly associated with
abscess formation and particularly with gastrointestinal infections. Several
studies have found an association between Strep. anginosus and other
pathogens in disease, particularly, the association with E.coli and
Pseudomonas spp. in abscess formation (193).
Enterococcus.faecalis, again, although a vaginal commensal and found in the
gastrointestinal tract, is not usually associated with UTI. The interaction
between Enterococcus spp and urothelial tissue has been examined (194). In
a study of E. faecalis isolates from patients with UTI and endocarditis,
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Guzman et al showed that UTI isolates adhered efficiently to urothelial cells
(195). The nature of the interaction of Enterococcus spp with urothelial tissue
appears to be quite complex, with a role for bacterial cell surface carbohydrate
and protein (196).
There were two obligate anaerobes isolated in the patient group: a
Peptostreptococcus sp. and a Veillonella sp. commonly found in the vagina
and implicated in bacterial vaginosis. Other commensal organisms were also
found in smaller counts such as Propionibacterium sp, Actinobaculum sp,
Bifidobacterium sp, Enterobacterium sp, Finegoldia sp, Fusobacterium sp,
Gardnerella sp, Mobiluncus sp, Neiserria sp, Paenibacillus sp, Prevotella sp,
Rothia sp.
This study compared the bacterial retrieval from uroepithelial cells compared
to the standard culture used in the NHS which uses a loop of urine (both
sediment and supernatant). This pilot study used a small number of patients
and a control group which was not matched to the study group by age. This
arose because of the difficulty in recruiting age matched control volunteers
without any bladder symptoms such as nocturia, which can occur normally in
later life for a variety of reasons. Despite this, the data demonstrate a very
marked enhancement in the isolation of bacteria when the spun urinary
cellular sediment is cultured. The data support the view that ordinary
laboratory cultures, which focus on isolating E. coli at a threshold of 105 cfu
ml-1, are insensitive and inappropriate for screening out infection in patients
with OAB. However, a much larger study would be required to confirm these
findings and to implement any clinical change. Additionally, they support the
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hypothesis that patients with OAB have a high probability of suffering from a
bacterial UTI. The probability of bacterial growth, and the number of colonies,
is increased if pyuria is detected. This is a coherent property because pyuria
is a reflection of activation of the innate immune response. Pyuria has been
found to affect about 35% of OAB patients when sampled by CSU, compared
to 0% of asymptomatic controls (197).
A critical interaction between uropathogenic bacteria and the bladder
epithelium appears to be adherence by bacteria through expression of surface
adhesive organelles such as type 1 pili (152). It is possible that if the bacteria
are attached to the urinary urothelial cells they may evade detection because
current methods sample uncentrifuged urine. The sediment culture is directed
at a concentrated suspension of the shed urothelial cells and may enhance
detection because of selection of colonised cells. The literature supports this
interaction in association with the most commonly found bacteria in the patient
group (119;152;191;196;198;199).
It is an inevitable consequence of these data that we must implicate UTI in
the aetiology of overactive bladder symptoms to a far greater extent than has
previously been assumed. According to the accepted definition, most of the
patients in this study, based on MSU culture data, would have received the
diagnosis of OAB and not been offered treatment for urinary infection. This
must be a cause for concern because of the considerable differences in
bacterial colonisation between these patients and controls.
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The sediment culture is evidently sensitive since bacteria were isolated from
controls but in fewer orders of magnitude and the organisms were
predominantly Lactobacillus spp.
Despite antibiotic treatment, bacteria were isolated from the urothelium taken
at the time of bladder biopsy. In addition, the histology results of biopsies
taken at the same time, confirm, that despite antibiotic treatment, an
inflammatory process was present in the urothelium in most of the patient
group. There are numerous causes for inflammation but the high bacterial
counts and the species isolated are very supportive, but not proof, of infection
being the cause of this inflammatory response. Again, only a small number of
patients were recruited to the study and a biopsy at initial presentation, when
the patient is not taking antibiotics, would be ideal. However, taking a biopsy
without antibiotic prophylactic treatment may increase the risks to the patient
and so this was not done.
These findings certainly cast doubt on current assumptions about the
aetiology and the definition of OAB.
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Chapter 4
Sensitivity and Specificity of Urinary
Dipstick Test in the Detection of Urinary
Tract Infections in Patients with Overactive
Bladder
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4.1. Hypothesis
The sensitivity and specificity of the popular leucocyte esterase and nitrite
dipstick tests to exclude infection in patients with OAB are too low to be used
to exclude infection in these patients.
4.2 Background
This study addressed the absence of validation data on the use of the
leucocyte esterase and nitrite tests when applied to patients with non-dysuric,
chronic lower urinary tract symptoms such as in OAB. This was approached
by measuring the sensitivity and specificity of urinary dipsticks for UTI in
patients with OAB, taking a 105 cfu ml-1 culture on MSU and both 102 cfu ml-1
and 105 cfu ml-1 on CSU as well as the results of microscopy of a fresh,
unspun specimen of urine for pyuria using the same samples.
4.3 Methods
Researchers were blind to microbiological outcomes. Patients recorded their
symptoms using a validated questionnaire and their reported urinary
frequency and incontinence episodes were noted. From these data an
urgency score (0 to 10) was calculated using a validated method as per
section 2.2 (appendix 1) (170).
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Data were also collected from a sample of asymptomatic controls.
Experiment 1 – A study, of MSU samples using the Gold standard 105
cfu ml-1
MSU samples were obtained, an aliquot was tested by dipstick for leucocyte
esterase (positive = trace and above) and nitrite; an aliquot was sent for
routine laboratory culture; a fresh aliquot was examined immediately by
microscopy.
Experiment 2 – A study of CSU samples using enhanced reference
standard 102 cfu ml-1
A sample of corresponding female patients with OAB was seen in order to
obtain a CSU. The specimens were examined similarly but in addition aliquots
were submitted to an enhanced culture (vide infra)
MSU Collection: Samples were obtained by the midstream clean-catch
method. (2.4.3.1)
CSU Collection: The procedure was performed on female patients only and by
a doctor or specialist nurse (2.4.3.2)
Leukocyte Esterase and Nitrite Tests: The urine was dipped by a Multistix™
8 SG. The leukocyte esterase pad sensitivity of the dipstick was stated to be
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15 wbc μl-1 when “trace positive” and this level was considered to be positive
for the study. The nitrite test pad sensitivity of the dipstick was stated to be
13-22 µmol L-1 (0.06-0.1 mg dL-1) nitrite ions. These data were collected by
clinic doctors and nurses (2.4.2).
Routine culture method (gold standard): The sampled urine was treated fresh,
or after overnight storage at 4°C at the hospital laboratory. The samples were
processed as in 2.4.6.
Enhanced culture method (enhanced reference standard): The sample
obtained by CSU was processed immediately as described in 2.9.1. An
aliquot of each CSU also underwent routine analysis at the threshold of 105
cfu ml-1 (2.6)
Microscopic white cell count: A fresh, unspun aliquot of urine was examined
by microscopy as described in 2.4.1.
4.4 Statistics
The study followed the Standards for Reporting Diagnostic Accuracy (STARD)
(200). The experiments were powered to detect a 75% sensitivity and 45%
specificity so that 100 patients in each group culture positive / culture negative
gave 85% power, alpha=0.05. The challenge was to obtain the 100 with
positive cultures. The data were analysed by 2x2 contingency tables using
Pearson Chi-Square (SPSS). Empty data points were excluded from analysis.
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Patients with missing data were compared with those analysed using the
variables of age, median 24-hour frequency, median 24-hour incontinence
and urgency score by ANOVA. Differences in sex distribution were compared
by Pearson Chi-Square.
4.5 Results
The STARD recruitment analysis is shown at the bottom of this section
Experiment 1 – A study, of MSU samples using the Gold standard 105 cfu ml-1
This experiment analysed data from 508 patients (432 women and 76 men).
These were newly presenting with OAB without acute frequency/dysuria
between 2nd August 2004 and 6th January 2009. Their mean age was 51
(sd=19). No patients were taking antibiotics.
The median daily frequency was 8(IQ range 6-11), daily incontinence
episodes 1 (IQ range 0-2) and the median urgency score was 2. (IQ range 0-
5) reflecting the widespread overactive bladder symptoms. Of these 132
(35%) had pyuria on microscopy, 90 (24%) with sterile pyuria, and 79 (21%)
had positive MSU cultures. Only 209 (55%) of patients with OAB symptoms
had normal urine.
The data for this experiment are shown in table 4.1. The key findings were
that the sensitivity for the gold standard, of leukocyte esterase was 56%,
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Nitrite 10% and microscopic pyuria 56%; with specificities of 66%, 99% and
72% respectively. The sensitivity of leukocyte esterase for microscopic pyuria
was 81% (specificity 83%)
Experiment 2 – A study of CSU samples using the Gold standard 105 cfu ml-1
and an enhanced reference standard 102 cfu ml-1
470 women with OAB without acute frequency/dysuria agreed to provide a
CSU between 1st October 2007 and 27th January 2009. Their mean age was
57 (sd=18). The median daily frequency was 8(IQ range 5-10), median daily
incontinence episodes 1 (IQ range 0-2) and the median urgency score was 2
(IQ range 0-5).
The data for this experiment are shown in tables 4.2 and 4.3. The key finding
was that on using CSU the gold standard culture method (105 cfu ml-1 ) proved
positive in 71 (15%) samples, in contrast to the MSU samples which were
positive in 106 samples (21%).
In CSU samples the sensitivity for the gold standard, of leukocyte esterase
was 59%, Nitrite 20% and microscopic pyuria 66%; with specificities of 84%,
97% and 73% respectively. The sensitivity of leukocyte esterase for
microscopic pyuria was 64% (specificity 97%).
The enhanced method of CSU culture (102 cfu ml-1) proved positive in 137
(29%); inevitably more than the gold standard 71 (15%). Commensurately,
the surrogate markers were less sensitive for 102 cfu ml-1 (table 4.3).
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Table 4.4 contains the data that compare the leukocyte esterase test results
with the microscopic pyuria data.
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Control subjects
42 volunteers with no lower urinary tract symptoms provided meticulously
collected MSU specimens. There were 16 men and 26 women (mean age 34,
sd-11). The volunteers recruited were hospital staff and students. Only two
subjects (4.8%), both women, were leukocyte esterase positive and only one
of these proved positive on urine culture, routine and enhanced. This woman
provided the only nitrite positive specimen. Three controls (7%) showed
pyuria on microscopy, one of these being leukocyte esterase positive.
Patients with positive cultures at different thresholds
There were no symptom differences in average daily frequency, incontinence
or urge score between patients showing a positive culture only at the
threshold of 105 cfu ml-1, MSU or CSU, and those with a positive CSU at the
102 cfu ml-1. The more sensitive culture did not identify a different
symptomatic group (See table 4.5).
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STARD participant recruitment analysis
Experiment 1
615 (526 female, 89 male) OAB without acute dysuria were identified: 20 (3%)
patients could not provide a sample. Thus MSUs from 595 patients were
provided. Of these 87 (15%) had missing data for one or all of the following:
Leukocyte esterase 84 (14%); nitrite 80 (13%) microscopy 52 (9%). Thus the
total analysed was 508 samples. Missing data occurred from equipment
failures, equipment availability and omission of database entry during a busy
clinic. The patients with missing data did not differ from those analysed in
respect of age, sex, urinary frequency, urgency and incontinence (table 4.5).
Experiment 2
607 women with OAB without acute frequency/dysuria attending outpatient
clinic provided a CSU: 137 (23%) of these had incomplete data for one or all
of the following: Leukocyte esterase 103 (17%); nitrite 101 (17%) microscopy
83 (14%); culture results 48 (8%). This arose from equipment failures but
more commonly oversight in data entry and culture plate transport failures.
The patients with missing data did not differ from those analysed in respect of
age, sex, urinary frequency, urgency and incontinence (table 4.5).
Sensitivity and specificity applied to ordinary clinical practice
The receiver operator characteristic (ROC) curves for the leukocyte esterase
and the nitrite tests as predictors of a routine MSU analysis with a threshold of
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105 cfu ml-1, reflecting normal clinical practice are shown in figures 4.1 and
4.2.
5.6 Discussion
This large study, examined of the reliability of the urinary dipstick test, as a
surrogate for urinary infection, in patients without the classic symptoms of
acute frequency /dysuria. Thus the experiment scrutinised a particular group
for whom the accuracy of the test has greatest clinical relevance. These data
show that the dipstick test in this context is insensitive, at best 59% sensitive
(95% CI 47% to 70%) which is not appropriate for the exclusion of urinary
tract infection when the symptoms are so noxious. It is remarkable that the
Nitrite test which is commonly advocated had a sensitivity of 13% (95% CI 8%
to 21%) at best. Nitrite stood out for its specificity of 99% (95% CI 98%
to100%) but the data distribution would suggest that in such circumstances
infection is likely to have been clinically overt. Recent NICE guidelines on
female incontinence contain the statement “A urine dipstick test should be
undertaken in all women presenting with urinary incontinence to detect the
presence of blood, glucose, protein, leukocytes and nitrites in the urine” (201).
The data reported here challenge the veracity of this. The International
Consultation on Incontinence guidelines on lower urinary tract symptoms
similarly recommends dipstick testing as a screening method (61). If this
advice be followed it could be argued that significant number of patients with
urinary infection become misdiagnosed with OAB. This is no small matter
given the prevalence of lower urinary tract symptoms.
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The inclusion of controls, albeit younger, permits comparisons that imply that
the prevalence of pyuria (56% with MSU and 30% with CSU) and bacturia
(20% with MSU at 105 cfu ml-1 and 30% with CSU at 102 cfu ml-1) must be
related to the disease process. This merits further scrutiny. The symptom
analysis show that the patients, on average, had marked and disruptive
symptoms of OAB. The youth of the controls arises from very exacting
insistence on absent symptoms, particularly nocturia.
This study was conducted amidst normal clinical practice, giving it wide
applicability. Nevertheless it resulted in more missing data than would be
expected in non-pragmatic trials. A key quandary was the adoption of
computer data entry to generate the hard copy in the notes. In pressure of the
clinics it is very easy to overlook data entry cells. It was however reassuring
that the demographic and symptomatic comparisons imply that a selection
bias was not implicated.
The difference in sensitivities between MSU and CSU samples raises an
additional concern. The tests proved less sensitive when CSU specimens
were analysed whatever the method adopted. This implies a significant
contamination of MSU samples. The differences in pyuria would indicate that
the most plausible explanation would be vaginal contamination. The numbers
were small but men did not show such dissociation. Again, the suitability of a
MSU for screening out UTI in women must be questioned.
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The use of a CSU submitted to enhanced culture with a diagnostic threshold
of 102 cfu ml-1 did not reflect normal practice. It was affected in response to
the doubts expressed by Stamm et al in 1982 (86) about the veracity of
standard MSU culture for acute frequency/dysuria. This method did result in a
higher yield with consequently reduced sensitivities for the tests. It would
seem that it would be wise to scrutinise the gold standards that we use for
identifying urinary infection in patients with OAB. It must also be
acknowledged that the culture methods assume dominant pathogenicity from
the Enterobacteriaceae. Whilst this might apply to acute infection there is no
evidence that is appropriate to patients with non-dysuric OAB. Thus, there are
no data to inform a selection of a suitable gold standard for diagnosing UTI in
this context.
The performance of leukocyte esterase dipstick analysis for diagnosing acute
UTI has been well studied but the literature is contradictory. The sensitivity
and specificity vary considerably. The samples studied manifest differing
prevalence’s and that alone will affect PPV and NPV (202-205). Studies of
populations with low prevalence of acute UTI show high NPV for leukocyte
esterase, similar to our study (84% to 93%) (205;206) (205;207). However,
these trials describe low sensitivity resulting in an objectionable under-
treatment of genuine acute UTI.
In contrast to the findings of this study, some of the literature is confident
about the efficacy of the nitrite test. The very high specificity may contribute to
this since it means that the test is likely to be positive the more impressive the
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urinary tract infection. Thus vivid recall may cause a cognitive bias perversely
in favour of the test. In contrast, the test must excel where symptoms are
unclear for it to be useful. This is transparently not the case.
The common nitrite producing organisms are Proteus, E. coli, Klebsiella,
Pseudomonas, Staphylococcus, but there are other bacteria pathogenic to the
bladder that do not reduce nitrate. Thus the nitrite test is inevitably going to
miss a proportion of infections.
These data highlight a need to clarify the criteria for the exclusion of urinary
tract infection in this group of patients. The limitations of the dipstick test have
to be acknowledged when managing patients with non-dysuric OAB. It must
be accepted that UTI may be erroneously excluded in the assessment of such
symptoms, particularly OAB symptoms, and our understanding of this
important condition may be very much at fault.
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Table 4.1 Experiment 1: A study of MSU samples using the Gold standard 105cfu ml-1.
MSU samples: Comparison of surrogate markers to gold standard 105 cfu ml-1
(1) Leukocyte esterase (2) Nitrite (3) Microscopic pyuria
Culture
positive
Culture
negative
Culture
positive
Culture
negative
Culture
positive
Culture
negative
Leukocyte positive 59
(12%)
138
(27%)
Nitrite
Positive
11 (2%) 2 (0.4%) Pyuria
positive
59
(12%)
113 (22%)
Leukocyte
negative
47 (9%) 264
(52%)
Nitrite
Negative
95
(19%)
400 (79%) Pyuria
negative
46 (9%) 290 (57%)
Sensitivity = 56% (95% CI 46% to
66%)
Sensitivity = 10% (95% CI 6%
to 18%)
Sensitivity = 56% (95% CI 46% to
66%)
Specificity = 66% (95% CI 61% to
70%)
Specificity = 99% (95% CI 98%
to 100%)
Specificity= 72% (95% CI 67% to
76%)
Table 4.2 Experiment 2: A study of CSU samples using the Gold standard 105cfu ml-1.
CSU samples: Comparison of surrogate markers to gold standard 105 cfu ml-1
(1) Leukocyte esterase (2) Nitrite (3) Microscopic pyuria
Culture
positive
Culture
negative
Culture
positive
Culture
negative
Culture
positive
Culture
negative
Leukocyte positive 42 (9%) 64
(14%)
Nitrite
Positive
14 (3%) 10 (2%) Pyuria
positive
47
(10%)
106 (23%)
Leukocyte
negative
29 (6%) 335
(71%)
Nitrite
Negative
57
(12%)
389 (83%) Pyuria
negative
24 (5%) 293 (62%)
Sensitivity = 59% (95% CI 47% to 70%
)
Sensitivity= 20% (95% CI 12%
to 31% )
Sensitivity = 66% (95% CI 54% to
77% )
Specificity = 84% (95% CI 80% to
87%)
Specificity=97% (95% CI 95%
to 99% )
Specificity = 73% (95% CI 69% to
78% )
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Table 4.3 Experiment 2: A study of CSU samples using the Enhanced reference
standard 105cfu ml-1.
CSU samples: Comparison of surrogate markers to enhanced standard 102 cfu ml-1
(1) Leukocyte
esterase
(2)
Nitrite (3) Microscopic pyuria
Culture
positive
Culture
negative
Culture
positive
Culture
negative
Culture
positive
Culture
negative
Leukocyte positive 61
(13%)
45
(10%)
Nitrite
Positive
18 (4%) 6 (1%) Pyuria
positive
73
(16%)
80 (17%)
Leukocyte
negative
76
(16%)
288
(61%)
Nitrite
Negative
119
(25%)
327 (70%) Pyuria
negative
64
(14%)
253 (54%)
Sensitivity = 45% (95% CI 36% to 53%
)
Sensitivity = 13% (95% CI 8%
to 20% )
Sensitivity = 53% (95% CI 45% to
62% )
Specificity = 86% (95% CI 82% to 90%
)
Specificity = 98% (95% CI 96%
to 99% )
Specificity = 76% (95% CI 71% to
80%)
Table 4.4 Sensitivities and specificities of leukocyte esterase for detecting pyuria
MSU Samples - Leukocyte esterase
compared with microscopic pyuria
CSU Samples - Leukocyte esterase
compared to microscopic pyuria
Pyuria
positive
Pyuria
negative
Pyuria
positive
Pyuria
negative
Leukocyte
esterase positive
140
(28%)
57
(11%)
Leukocyte
esterase
positive
98
(21%)
8 (2%)
Leukocyte
esterase positive
32 (6%) 279
(55%)
Leukocyte
esterase
positive
55
(12%)
309
(66%)
Sensitivity = 81% (95% CI 75% to
87%)
Sensitivity = 64% (95% CI 56% to
71% )
Specificity = 83% (95% CI 78% to
87%)
Specificity = 97% (95% CI 95% to
99% )
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Figure 4.1 ROC curve for urinary leukocyte esterase as a predictor of a positive routine MSU
culture of 105 cfu ml-1
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Figure 4.2 ROC curve for urinary nitrite as a predictor of a positive routine MSU culture of 105
cfu ml-1
ROC Curve for the nitrite test
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Table 4.5. The symptom profiles according to key patient groups. These comparative data
demonstrate similar symptom profiles from patients with 105 cfu/ml and 102 cfu/ml. The 102 cfu/ml did
not select a sub-set. Similarly the symptom profiles of patients with missing data imply that there was no
selection bias.
Patient group Mean Age Median total
Frequency
episodes 24hrs
Median Urge
Score
Median Total
Incontinence
episodes in
24hrs
MSU positive
105cfu/ml
50.84
(Sd=18.8)
8
(IQ range 6-
11)
2
(IQ range 0-5))
1
(IQ range 0-2)
CSU positive
105cfu/ml
56.38
(Sd= 18.5)
8
(IQ range 5.5-
11))
2
(IQ range 0-5)
1.5
(IQ range 0-2)
CSU positive
102cfu/ml
56.38
(Sd=18.5)
8.5
(IQ range 4-
9.5)
2
(IQ range 0-5)
1
(IQ range 0-
2.5)
Missing Data 50.81
(Sd=18.7)
8
(IQ range 5-
12))
3
(IQ range 0-4)
1. (IQ range 0-
2.5)
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Chapter 5
A chemical Cytokine Response in the urine
of Patients with Overactive Bladder
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5.1 Hypothesis
The study tested the hypothesis that urinary IL-6 expression in the urine of
patients with OAB would be increased in association with pyuria.
5.2 Background
There is ever increasing support in the literature for an inflammatory aetiology
of many lower urinary tract syndromes, however, the inflammatory mediators
that are involved in the pathophysiology of OAB are unclear. There are many
studies describing the inflammatory signals in the urine in acute UTI and so
these studies were used as a starting point to try and identify an additional
inflammatory signal in the urine in patients with OAB which is also associated
with urinary infection. The literature leans towards IL-6 in this respect, IL-6
being the most frequently identified cytokine in the urine in acute UTI
(149;208-210);(126;150). Urothelial production of IL-6 occurs in response to
bacterial challenge of the human urinary tract and at deliberate colonisation.
Importantly, at disease recovery, IL-6 levels are normalised. Asymptomatic
controls secrete very low, levels of IL-6 in urine and it has been proposed that
IL-6 levels in urine could be used as a marker of UTI severity. This makes IL-6
an ideal cytokine to study between patients and normal control volunteers
(211;211). Mouawad et al. (212) found the mean circulating IL-6 concentration
in 40 healthy controls in blood serum to be 2.65 pg/ml. Healthy individuals
also secrete IL-6 in their urine. Lamale et al. (130) reported the mean urinary
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IL-6 level in 29 healthy individuals to be 0.63 pg/ml whilst Erickson et al. (131)
reported healthy female IL-6 levels to be around 1.5 pg/ml. There seems to be
no difference in urinary IL-6 between healthy males and females (213).
5.3 Methods
This was a blinded, observational cohort study. Women with symptoms of the
OAB were asked to give consent to participate and provide catheter
specimens of urine (CSU) for the study. Their symptoms were recorded using
a validated questionnaire as per section 2.2. A CSU was obtained by inserting
a Lofric (in and out) size 12 Fr catheter into the urinary bladder under aseptic
conditions (2.4.3.2). Urine specimens were collected into a sterile container
and a 4ml aliquot was taken immediately. A sample of 0.9μl was taken in
order to affect a white blood cell count (2.4.1).
The samples were thawed and analysed in batches, blinded, once weekly.
Human urinary IL-6 concentrations were determined using a commercial very
high sensitivity sandwich ELISA with a limit of detection of 0.09pg/ml with a
inter and intra assay coefficient of variation of less than 10% (R&D Systems,
Oxon, UK).
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5.3.1 ELISA Assay
4ml of urine from each sample was transferred to a sterile 10ml centrifuge
tube. Tubes were placed in a Denley BR 401 centrifuge machine and
centrifuged at 8000rcf for 5min. Subsequently, the supernatant was removed
and placed in cryogenic tubes. Care was taken to ensure that the sediment
pellet was not agitated at this stage. The tubes were frozen at -80 ºC in a
Forma Scientific freezer. Freezing the samples was deemed more practical
than immediate analysis, and it has been shown that IL-6 remains fairly stable
even with up to 6 freeze-thaw cycles (214).
Urine IL-6 concentrations were measured by transferring the frozen samples
to the Rayne Institute, UCL, and conducting an enzyme linked immunosorbent
assay (ELISA). Samples were analysed in batches by defrosting a set number
on the day of the ELISA and then refreezing them immediately afterwards, in
case of a repeat being necessary. Repeated freeze-thaw cycles were avoided
to ensure good conditions of urine were maintained. The samples were
analysed blind with regard to the white cell content of the urine samples. The
Quantakine high sensitivity IL-6 ELISA was used (© 2008 R and D Systems,
MN, USA) and is based on a sandwich enzyme immunoassay system. IL-6 in
samples added to the microplates, became bound to IL-6 immobilised
monoclonal capture antibody coating the plates. After that, enzyme-linked
polyclonal antibody was added to the plates, followed by substrate solution
and amplifier solution. To end the colour producing reaction, stop acid solution
was added to each well. Plates were washed with wash buffer in between
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additions, to ensure removal of unbound material. In addition to the samples,
standard IL-6 concentrations were added to the microplates in order to
produce a calibration curve. In between additions and washes the microplate
was incubated either on an orbital microplate shaker or in line with the
protocol, on the benchtop. Finally, microplate colour optical densities were
read with a microplate reader to determine IL- concentration. The reader
produced standard curves and printed the results of each well automatically.
The minimum detectable dose (MDD) of the ELISA kit according to the
manufacturers ranges from 0.016-0.110 pg/ml, with an average MDD of 0.039
pg/ml. 40 of the samples were analysed twice to test the inter-assay precision
and the mean value was taken, the other 64 samples were analysed only
once. The intra-assay precision for urine assays suggested by the company is
5.5-9.8% and the inter-assay precision is suggested to 5.5-11.2%.
5.4 Statistics
The study was powered at 87% to detect a significant difference in IL-6 of 1
pg/ml with a standard deviation of 1.5. 1 pg/ml was chosen as the clinically
significant difference to seek because low levels of IL-6 are detected in
healthy individuals and there is a lack of data in the literature to define a cut-
off level for chronic bladder conditions. The study was powered at 79%, with
35 patients in each group. In order to accommodate dropouts and missing
data the target recruitment number of patients was rounded up to 40 in each
group. In the event this goal was achieved without lost data so the ultimate
power was 87%.
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The between group differences in IL-6 were tested by use of the Mann–
Whitney U test (Wilcoxon rank-sum test) for independent samples.
Correlations between IL-6 and log pyuria were examined by means of
Spearman’s R.
5.5 Results
104 women with symptoms of the Overactive Bladder gave their consent to
participate and provided catheter specimens of urine for the study. The patient
demographics are described in table 2.1
Because of the exponential nature of increasing pyuria the log of the urinary
white cell count was calculated. The median IL-6 level in the pyuria group was
2.36 pg/ml (IQ range 0.56-7.59) and the median IL-6 level in the non-pyuria
group was 0.52 pg/ml (IQ range 0.16-1.91) see figure 5.1. The mean and 95%
confidence interval has also been calculated because 95% CI plots are often
better at illustrating the distributions to the human eye in figure 5.2. This would
not be appropriate if non-parametic analysis had failed to identify a difference.
There was a significant difference in IL-6 levels between those with pyuria and
those without (95% CI of difference -2.9 to -0.11, p=0.34, t=-2.1) Figure 5.2.
It was found that there was a correlation between the log white cell count and
IL-6 Spearman’s R = 0.5, p=0.001 (Figure 5.3). There was no relationship
between IL-6 and symptoms of urgency, frequency and incontinence.
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Figure 5.1 Box plot showing IL-6 levels in pg/ml comparing patient samples with pyuria
against no pyuria
Figure 5.2 Mean Il-6 and 95% CI comparing pyuria against no pyuria
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Figure 5.3 Scatter plot of Il-6 and log urinary white cell count showing correlation
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5.6 Discussion
Several studies have identified various bladder epithelial cell derived
mediators which are thought to be responsible for the vigorous neutrophil
response in the bladder after acute bacterial infection (208;215). IL-6 is by far
the most prominent cytokine detected in the urine of patients with acute UTI
(198). There is also some evidence of multiple pathways in bladder epithelial
cells for triggering the IL-6 response as an adaptation to avoid inactivation by
uropathogenic bacteria (216). Identifying a cytokine response in patients with
OAB supports the premise that some patients with OAB have an inflammatory
aetiology to their condition.
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The pyuria found in these patients with OAB was associated with a marker of
inflammation, namely IL-6. This provides some additional independent
verification of the significance of pyuria detected by microscopy of fresh
unspun specimens of urine. Whilst there was a correlation between the pyuria
and IL-6 this was not sufficiently strong to encourage the view that IL-6 might
prove to be a useful surrogate marker of pyuria.
The association between IL-6 and urine infection in the literature also leads us
to hypothesise on an infective aetiology in these patients. In addition, there is
growing evidence in the literature that the magnitude of the cytokine response
and the type of cytokine found in the urine is influenced by the virulence of the
pathogen. IL-6 has been particularly associated with fimbriae (208;217). One
study by Wullt et al(218) showed a larger IL-6 response to bladder infection in
mice due to P-fimbriated E.coli as compared to non-fimbriated E.coli The
findings in this study support the view that OAB symptoms in some patients
are associated with a urothelial inflammatory reaction which may be caused
by urine infection.
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Chapter 6
The presence of Intracellular bacteria in
bladder epithelium of patients with OAB
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6.1 Hypothesis
Uropathogenic bacteria invade bladder urothelial cells.
6.2 Background
The invasion assay used to determine intracellular invasion in this study was
adapted and developed from Hultgren et al. 2001 (151), who used a method
of determining intracellular invasion and growth of uropathogenic E.coli using
a human bladder epithelial cell line. They infected the preparation with 100
E.coli per epithelial cell. After two hours they applied the antibiotic Gentamicin
to kill the extant extracellular E.coli.
Urine specimens are likely to contain multiple bacterial species and not a pure
culture of E.coli. Therefore, it was necessary to extend the Hultgren et al.
2001(151) method to address a wider bacterial community. The data in
chapter 3 has also shown a dominance of Group B Streptococcus,
Enterococcus. sp and Lactobacillus spp. in the patient group.
A recent study conducted by Bean et al (219) examined the antibiotic
resistance of common uropathogens, particularly E.Coli from community and
hospital based patients in East London. They published a table of resistance
frequencies as below (Table 6.1). The table demonstrates low resistance in
the community to Amoxicillin (12.4% resistance), Cefalexin (8.8% resistance),
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Gentamicin (5.2% resistance), Nitrofurantoin (5.4% resistance) and
Cefpodoxime (6.2% resistance).
Table 6.1Frequency of antibiotic susceptibility in relation to sex
Antibiotic Female (n = 10157) Male (n = 1656)
n n (%) Resistant n n (%) Resistant
Ampicillin 10153 5460 (53.8) 1652 1051 (63.6)
Amoxicillin/clavulanate 9178 1139 (12.4) 1491 310 (20.8)
Cefalexin 10139 892 (8.8) 1643 321 (19.5)
Ciprofloxacin 10137 1038 (10.2) 1649 374 (22.7)
Gentamicin 10149 525 (5.2) 1655 214 (12.9)
Nitrofurantoin 10134 551 (5.4) 1647 142 (8.6)
Trimethoprim 10138 3989 (39.3) 1652 748 (45.3)
Cefpodoxime 8512 525 (6.2) 1418 215 (15.2)
Ann Clin Microbiol Antimicrob. 2008; 7: 13. Published online 2008 June 18. doi: 10.1186/1476-0711-7-
13.Copyright © 2008 Bean et al; licensee BioMed Central Ltd.
In deciding upon an appropriate antibiotic to use for selective destruction of
extracellular microbes, it is important to consider the intracellular
concentration of the antibiotics, which must be kept to a minimum so as to
avoid elimination of intracellular bacteria. In 2006, Barcia-Macay et al (220)
analyzed the pharmacodynamic factors influencing the activities of various
antibiotics against intracellular forms of S. aureus. They measured the
intracellular concentrations in relation to the time-lengths of exposure. Table
6.2 describes the intracellular and extracellular concentration of these
antibiotics. The table demonstrates low intracellular to extracellular
concentration for the antibiotics Gentamicin, Linezolid, Peniciliin V, Nafcillin,
Amoxicillin and Ciprofloxacin.
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Table 6.2. Cellular accumulation factor of antibiotics in THP-1 cells after 24 h of
incubation at a fixed extracellular concentration
Antibiotica Cellular accumulationb Extracellular concn (mg/liter)
Azithromycin 37.8 ± 1.3 5c
Telithromycin 27.9 ± 1.3 2d
Gentamicin 4.4 ± 0.1 250c
Linezolid 0.5 ± 0.0 250c
Penicillin V 1.2 ± 0.1 150c
Nafcillin 2.6 ± 0.1 400c
Amoxicillin 1.0 ± 0.1 150c
Oxacillin 4.0 ± 0.1 250c
Teicoplanin 7.4 ± 0.2 150c
Vancomycin 6.3 ± 0.1 100c
Oritavancin 148.0 ± 12.0 25d
Rifampin 17.6 ± 0.9 50c
Ciprofloxacin 5.1 ± 0.1 4.3d
Levofloxacin 7.0 ± 0.6 4d
Garenoxacin 9.1 ± 0.3 4d
Moxifloxacin 7.6 ± 0.3 4d
a The molecules are ranked by pharmacological classes, with each class appearing by order of its mean
level of intracellular accumulation, b Apparent cellular concentration-to-extracellular concentration ratio,
based on a cell volume of 5 µl per mg of cell protein. c A concentration larger than the Cmax was used
because of a lack of sensitivity of the microbiological assay.
d Concentration corresponding to the Cmax
Taken from Pharmacodynamic Evaluation of the Intracellular Activities of Antibiotics against
Staphylococcus aureus in a Model of THP-1 Macrophages
Maritza Barcia-Macay, Cristina Seral, Marie-Paule Mingeot-Leclercq, Paul M. Tulkens, and Françoise
Van Bambeke* Antimicrobial Agents and Chemotherapy, March 2006, p. 841-851, Vol. 50
These data therefore support the use of gentamicin and amoxicillin for
invasion assays, as resistance to them in the community is infrequent and
they achieve low intracellular concentrations. Gentamicin is an
aminoglycoside antibiotic which works by binding to the bacterial 30S
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ribosomal subunit, preventing the translocation of the peptidyl-tRNA from the
A-site to the P-site and also causing misreading of mRNA, this leaves the
bacteria unable to synthesize vital proteins. It is particularly useful against
Gram negative rods (221). Amoxicillin is a β-Lactam antibiotic, which is
bactericidal, and acts by inhibiting the synthesis of the peptidoglycan layer of
bacterial cell walls. It is used against Gram positive bacteria (222).
Whilst this project focused heavily on microbiological scrutiny of the
phenomenon of interest I felt it was important to explore a complementary line
of evidence so as not to rely wholly on one set of techniques. Therefore,
microscopic evidence of uropathogenic bacterial invasion of the urothelium
was sought.
A variety of methods have been used to visualise and discriminate
intracellular and surface-adherent bacteria in cells. There are many direct
microscopy methods with specific and non-specific staining techniques,
including electron microscopy and immuno-fluorescent bacterium-specific
antibodies and fluorescence techniques. Intracellular invasion assays such as
described in Chapter 7 rely on the recovery of viable bacteria after their
internalisation by urothelium cells, however, they do not discriminate between
efficient bacterial invasion in combination with low intracellular survival or low
invasiveness coupled to effective intracellular survival. Such assays can be
complemented with microscopic evaluation of infected samples.
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There are a number of fluorescent dyes that have been used to visualise
intracellular bacteria.
Acridine orange is a nucleic acid selective fluorescent cationic dye. It is cell-
permeable, and interacts with DNA and RNA by intercalation or electrostatic
attractions respectively. When bound to DNA, it has an excitation maximum at
502 nm and an emission maximum at 525 nm (green). When it associates
with RNA, the excitation maximum shifts to 460 nm (blue) and the emission
maximum shifts to 650 nm (red). Acridine orange has been used to
enumerate intracellular organisms in bronchoalveolar lavage cells and HeLa
cells, using crystal violet as a counter-stain as it is not cell permeable (223).
6.3 Method development and results
6.3.1 Microbiology methods
Patients with overactive bladder symptoms, attending the Incontinence clinic
for the first time provided CSU specimens as described (2.4.3.2). An aliquot of
urine was sent for routine culture and enhanced culture as described (2.6 and
2.9.1). Another aliquot underwent routine microscopy (2.4.1). The patients
were not taking any antibiotics.
Urine was centrifuged at 8000rcf and the supernatant discarded. The
sediment obtained was re-suspended in 400µL of sterile PBS and split into
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two aliquots of 200µL. To re-concentrate these two halves each aliquot was
centrifuged again as above and the sediment was collected. One aliquot was
re-suspended in 1ml of Eagles minimum Growth medium supplemented with
Non-Essential Amino Acids (NEAA) - 1% (Sigma), foetal bovine serum-5%
(Sigma) and glutamine (Sigma) to 2mmol. This was to ensure a viable and
supportive environment for the survival of the urothelial cells. To the medium,
200µg per ml of Gentamicin (Amdipharm plc) and 200µg per ml of Amoxicillin
(Sigma) were added. This was to inhibit the growth and kill any extracellular
bacteria attached to the urothelial cells. A viable epithelial cell count was
conducted using 10µL of the suspension and 10µL of 1% Trypan blue
(Sigma). 100µL of the suspension was plated on CBA and FAA in dilutions to
1x107 (time zero count). This was in order to get an initial bacterial count from
the urothelial cells which would represent both intracellular and extracellular
bacteria. The rest of the suspension was seeded onto one well of a 12 well
culture dish and incubated at 37C, 5% CO2 for 24 hrs. The second aliquot
was plated as per 2.9.2. After 24 hours, the cells were viewed for adherence
to the culture dish and for the presence of bacteria using a light microscope
(Leica) at X 400 magnification. The supernatant was removed and the cells
were washed three times with 400µL PBS. This was done to remove any
remaining attached extracellular bacteria. The supernatant and every wash
were plated in dilutions to 1x 103 on CBA and FAA and incubated for 48hrs at
37C, 5% Co2 and 7 days in an anaerobic incubator at 37C respectively.
These bacterial counts allowed me to determine the effectiveness of the
antibiotics and of washing the cells. Triton X 0.1% (Sigma) 200µl was added
to the cells in the well to break down the cell membranes and release any
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intracellular bacteria which could then be cultured. The cell suspension was
cultured to 1x 103 dilutions on CBA and FAA as above.
All bacteria cultured were counted and sub-cultured as per section 2.9.3,
biochemical identification tests were carried out as per section 2.10, 16srRNA
gene typing was carried out as per section 2.11 and the samples were stored
as per section 2.11.3.
6.3.2 Results of 1st Assay
First Sample (Study number 787). The patient was symptomatic and aged
54 years. Routine microscopy showed no pyuria. 195mls of urine was
collected by CSU. Both the routine culture (105cfu/ml) and enhanced culture
(102cfu/ ml) were negative. The reported frequency was 10 episodes per 24
hours, the urge score was 5 and the incontinence episodes reported were 1
per 24 hours. The total bacterial counts in both the aerobic and anaerobic
cultures are described below in fig 6.1. There was a rise in total bacterial
count after 24hrs of incubation in the culture media of 2.66x103cfu/ml (starting
count 8.6x10-1 cfu/ml and count after 24 hours incubation 2.66x103 cfu/ml).
This is labelled as ‘supernatant 24hrs’ on the graph. There was an increase of
total bacterial count after the addition of Triton X of 6.18x101cfu/ml. This is
labelled as ‘Triton X’ on the graph. The viable urothelial cell count was 1x105
cells per ml. Table 6.3 shows the morphologically different bacterial species
identified by culture at each stage of the assay. It demonstrates the efficacy of
the antibiotics and washes, since the colony count gradient is negative over
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this phase. For the anaerobic culture it also demonstrates the presence of
intracellular bacteria in the sample as the number of morphologically different
bacteria increases after the addition of Triton X. Table 6.4 describes the
identity of the bacterial species found in the assay. It is interesting to note that
in the aerobic culture, a Corynebacterium. sp was identified after the addition
of Triton X only, implying that it was growing intracellularly and in the
anaerobic culture Streptococcus sp and Lactobacillus spp were found
intracellularly.
Figure 6.1Total bacterial counts at different stages of the Intracellular bacterial isolation assay
for sample 787 aerobic and anaerobic cultures. (Time zero=initial bacterial count at the start
of the assay (cfu ml-1), Supernatant 24hrs= the bacterial count after 24hrs incubation of the
urothelium with Gentamicin and Amoxicillin (cfu ml-1), Wash1= the bacterial count after
washing the incubated cells in PBS for the first time (cfu ml-1), wash 2= the bacterial count
after washing the incubated cells in PBS for the second time (cfu ml-1), wash 3= the bacterial
count after washing the incubated cells in PBS for the third time(cfu ml-1), Triton x= the
bacterial count after the addition of triton X. This corresponds to the intracellular bacterial
count (cfu ml-1).
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Table 6.3. The number of morphologically different colonies identified at each stage
of the Intracellular bacterial isolation assay for sample 787 aerobic and anaerobic
culture (Time zero=initial bacterial count at the start of the assay (cfu ml-1), Supernatant 24hrs= the
bacterial count after 24hrs incubation of the urothelium with gentamicin (cfu ml-1), Wash1= the bacterial
count after washing the incubated cells in PBS (cfu ml-1), wash 2= the bacterial count after washing the
incubated cells in PBS for the second time (cfu ml-1), wash 3= the bacterial count after washing the
incubated cells in PBS for the third time(cfu ml-1), Triton x= the bacterial count after the addition of triton
X. This corresponds to the intracellular bacterial count (cfu ml-1)
Wash No. of different colonies
aerobic
No of different colonies
anaerobic
Time zero 3 3
Supernatant 24hrs 3 4
1st wash 1 1
2nd wash 1 0
3rd wash 1 0
Triton x 1 2
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Table 6.4. The identity of the different colonies at each stage of the Intracellular
bacterial isolation assay for sample 787 aerobic and anaerobic culture.
Bacterial isolate
(CO2= identified in aerobic culture; 5%
CO2, Anaerobic = identified in anaerobic
culture, Triton X =identified in culture
after the addition of Triton X)
Bacterial identification using 16srRNA
gene typing
787 A CO2 Strep.anginosus
787 B CO2 Lactobacillus. sp
787 C CO2 Actinomyces sp
787 A Anaerobic Lactobacillus sp
787 B Anaerobic Lactobacillus sp
787 C Anaerobic Strep.anginosus
787 D Anaerobic Strep. agalactiae
787 A Triton X CO2 Corynebacterium sp
787 A Triton X Anaerobic Lactobacillus sp
787 B Triton X Anaerobic Strep. agalactiae
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6.3.3 Conclusion from 1st Assay
The experiment showed that despite addition of antibiotic to the growth
medium, the supernatant after 24hrs. of incubation, sustained growth of
bacteria. This implied resistance to the antibiotics. However, the three washes
of the sediment reduced the total bacterial count, which increased after the
addition of triton X. In addition, bacteria not cultured in the washes were
present after the addition of Triton X. I concluded that the bacteria cultured
after this step were therefore a combination of cell adherent bacteria and
intracellular bacteria. Consequently, in order to identify the intracellular
bacteria adequately, it was concluded that it was necessary to eliminate all
extracellular bacteria and so the assay would have to be modified to achieve
this.
6.3.4 Method development- washing urinary sediment cells before
incubating them in growth media
Two specimens from new patients, not on antibiotic treatment were used. The
assay was modified in an attempt to reduce the bacterial load in the urine
sediment by washing the cells before incubation in growth medium. In
addition, after incubation, all of the sediment was collected after gentle
washing with PBS and centrifuge at 3000rcf. The centrifugation was reduced
to 300rcf to protect the urothelial cells from damage. This process was
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followed by washing as described above in 6.3.1. Bacteria cultured were
treated as described above in section 6.3.1.
6.3.5 Results of method development- washing urinary sediment
cells before incubating them in growth media
Two symptomatic patients provided CSU specimens as described previously.
Patient 837 reported frequency of 9 episodes per 24 hours, an urgency score
of 4 and 2 incontinence episodes per 24 hours. Patient 841 reported
frequency of 11 episodes, an urgency score of 4 and 1 incontinence episode.
One patient showed pyuria on microscopy. This patient grew a Streptococcus
sp. on both routine (105cfu ml-1) and enhanced cultures (102cfu ml-1). The
second patient, without pyuria, had a negative routine culture (105cfu ml-1) and
grew a Streptococcus sp. on the enhanced culture (102cfu ml-1). The average
viable epithelial cell count in the two specimens was 1x105 cells ml-1. The total
bacterial counts at each step of the assay are illustrated below in figures 6.2
and 6.3. In each assay, the total bacterial count was reduced from the initial
count through to the third washing step by an average of 1.09x103cfu ml-1
(sd=1.64x103cfu ml-1), there was an average rise in the total bacterial count by
5.37x102cfu ml-1 (sd=5.93x103cfu ml-1) after incubation in the culture medium
for 24hrs, there was an average rise of total bacterial count after the addition
of triton X of 3.02x102cfu ml-1 (sd=3.56x102cfu ml-1). Tables 6.5 and 6.7 show
the number of morphologically different bacterial species identified by culture
at each stage of the assay. There was no reduction in the number of different
isolates seen after washing but a reduction in the total bacterial load. Table
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6.6 shows the identity of the different bacterial species isolated. One of the
colonies went unidentified because of failure to grow it in a pure culture. The
table shows the presence of Strep.pasterunis and Enterococcus. faecalis
intracellularly. Sample 841 initially cultured Staphylococcus. aureus and yet
after the addition of Triton X only Streptococcus. agalactiae. Again, this
suggests that the Streptococcus. agalactiae was an intracellular organism.
These organisms were not grown as extracellular organisms in the initial
culture. This could be explained by low extracellular numbers.
Figure 6.2 Sample 837: Total bacterial counts at different stages of the Intracellular bacterial
isolation assay for sample 837 aerobic and anaerobic cultures with the addition of an extra
washing stage. Viable cell count 2x 105 ml-1. (Initial count=initial bacterial count at the start of the
assay (cfu ml-1), Wash1= the bacterial count after washing the cells in PBS (cfu ml-1), wash 2= the
bacterial count after washing the cells in PBS for the second time (cfu ml-1), wash 3= the bacterial count
after washing the cells in PBS for the third time(cfu ml-1)Time zero = bacterial count after addition of the
urothelial cells to the growth media, Supernatant 24hrs= the bacterial count after 24hrs incubation of the
urothelium with antibiotics (cfu ml-1), , 1a= bacterial count after one wash of the cultured cells with PBS
(cfu ml-1), 2a= bacterial count after two washes of the cultured cells with PBS (cfu ml-1), 3a= bacterial
count after three washes of the cultured cells with PBS (cfu ml-1), Triton x= the bacterial count after the
addition of triton X. This corresponds to the intracellular bacterial count (cfu ml-1).
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Table 6.5: The number of morphologically different colonies identified at each stage
of the Intracellular bacterial isolation assay for sample 837 aerobic and anaerobic
culture with the addition of an extra washing stage. (Initial count=bacterial count at the
start of the assay (cfu ml-1), Wash1= the bacterial count after washing the cells in PBS (cfu ml-
1), wash 2= the bacterial count after washing the cells in PBS for the second time (cfu ml-1),
wash 3= the bacterial count after washing the cells in PBS for the third time(cfu ml-1)Time
zero = bacterial count after addition of the urothelial cells to the growth media, Supernatant
24hrs= the bacterial count after 24hrs incubation of the urothelium with antibiotics (cfu ml-1),
1a= bacterial count after one wash of the cultured cells with PBS (cfu ml-1), 2a= bacterial
count after two washes of the cultured cells with PBS (cfu ml-1), 3a= bacterial count after three
washes of the cultured cells with PBS (cfu ml-1), Triton x= the bacterial count after the addition
of triton X. This corresponds to the intracellular bacterial count (cfu ml-1).
Wash No. of different colonies
aerobic culture
No. of different colonies
anaerobic culture
Initial Count 4 3
1st wash 4 4
2nd wash 4 4
3rd wash 4 4
Time zero 4 4
Supernatant 24hrs 1 3
1st wash 1 2
2nd wash 1 2
3rd wash 1 1
Triton x 1 1
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Table 6.6. The identity of the colonies identified at each stage of the intracellular
bacterial isolation assay for sample 837 aerobic and anaerobic culture.
Bacterial isolate
(CO2= identified in aerobic culture; 5%
CO2, Anaerobic = identified in anaerobic
culture, Triton X =identified in culture
after the addition of Triton X)
Bacterial identification using 16srRNA
gene typing
837 A CO2 Unknown (unable to grown in pure
culture)
837 B CO2 Strep.pasterunis
837 C CO2 Eschericia. coli
837 D CO2 Enterococcus. faecalis
837 A Anaerobic Enterococcus. faecalis
837 B Anaerobic Alloscardovia. omnicolens
837 C Anaerobic Strep.pasterunis
837 D Anaerobic Strep. pasterunis
837 A Triton X CO2 Strep.pasterunis
837 A Triton X Anaerobic Enterococcus. faecalis
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Figure 6.3 Total bacterial counts at different stages of the Intracellular bacterial isolation
assay for sample 841 aerobic and anaerobic culture with the addition of an extra washing
stage. Viable cell count 1x103 ml-1
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Table 6.7: The number of morphologically different colonies identified at each stage
of the Intracellular bacterial isolation assay for sample 841 aerobic culture with the
addition of an extra washing stage. (Initial count= bacterial count at the start of the assay (cfu
ml-1), Wash1= the bacterial count after washing the cells in PBS (cfu ml-1), wash 2= the bacterial count
after washing the cells in PBS for the second time (cfu ml-1), wash 3= the bacterial count after washing
the cells in PBS for the third time(cfu ml-1)Time zero = bacterial count after addition of the urothelial
cells to the growth media, Supernatant 24hrs= the bacterial count after 24hrs incubation of the
urothelium with antibiotics (cfu ml-1), , 1a= bacterial count after one wash of the cultured cells with PBS
(cfu ml-1), 2a= bacterial count after two washes of the cultured cells with PBS (cfu ml-1), 3a= bacterial
count after three washes of the cultured cells with PBS (cfu ml-1), Triton x= the bacterial count after the
addition of triton X. This corresponds to the intracellular bacterial count (cfu ml-1).
Wash No. of different colonies
aerobic cultures
No. of different colonies
anaerobic cultures
Initial Count 1 1
1st wash 1 1
2nd wash 1 1
3rd wash 1 1
Time zero 1 1
Supernatant 24hrs 1 1
1st wash 1 1
2nd wash 1 1
3rd wash 1 1
Triton x 1 1
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6.3.6 Conclusions from method development- washing urinary
sediment cells before incubating them in growth media
The extra washing steps reduced the bacterial count, but there was still a rise
of total bacterial count after incubation in the culture media, although this was
not great (<101). There remained a possibility that resistant bacteria were
propagating. The possible paths for development of this assay were to: 1.
Change the antibiotics used, 2. Add another antibiotic, 3. Use another method
of killing extracellular bacteria such as enzyme lysis.
6.3.7 Further development of the invasion assay-adding a further
antibiotic or enzymes
The most common bacterial species isolated from the patients were
Enterococcus spp, Streptococcus spp and Lactobacillus spp. Enterococcus
antimicrobial susceptibility patterns vary among species of Enterococci, they
are commonly resistant to high-level aminoglycosides and can also acquire
resistance to vancomycin or the penicillins (224). Streptococcus strains
display variable antibiotic resistance to azithromycin, clindamycin,
erythromycin and tetracycline (225). Lactobacillus spp show antibiotic
susceptibility patterns to β-lactam antibiotics (penicillin and ampicillin).
Several strains are sensitive to tetracyline, however, most strains are resistant
to erythromycin and the aminoglycoside group (226).
Linezolid has a very poor intracellular penetration and would be a good
additional antibiotic. It is not commonly used, particularly for the treatment of
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UTI and resistance would be expected to be low in the bacterial population.
Linezolid is a synthetic antibiotic of the oxazolidinone class used for the
treatment of infections caused by multi-resistant strains. Linezolid is effective
against Gram-positive pathogens, notably Enterococcus faecium,
Staphylococcus aureus, Streptococcus agalactiae, Streptococcus
pneumoniae, and Streptococcus pyogenes. It has almost no effect on Gram-
negative bacteria and is only bacteriostatic against most Enterococcus
species. Linezolid is also active against some anaerobic strains (227).
6.3.8 Methods of elimination of bacteria without the use of
antibiotics; the use of enzymes.
Lysozyme, Lysostaphin and mutanalysin are three enzymes, which are active
against bacteria. There are others but these are commonly used to eliminate
bacteria from microbial assay experiments (228;229).
Lysozyme is found in high concentrations (>500 µg/ml) in mucosal surface
fluids such as those lining the upper respiratory tract (230). Lysozyme is
expressed by the epithelia and is also a major component of the granules of
neutrophils, which may be recruited when the mucosa is acutely inflamed
(231). Lysozyme has two distinct antibacterial activities (231). Its enzymatic
muramidase activity hydrolyzes the conserved ß-1,4 glycosidic bond between
N-acetyl glucosamine and N-acetyl muramic acid, the disaccharide residues
of the bacterial peptidoglycan backbone. Hydrolysis of the glycan strands
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leads to degradation of the cell wall and bacterial lysis. In addition, an
antibacterial activity is observed with catalytically inactive lysozyme. This
activity has been attributed to the disruption of bacterial membrane function
by an inherent nine amino acid cationic antimicrobial peptide (CAMP). It has
been used in invasion assays against Gram negative rods (232) (233);(234).
Lysostaphin is a zinc-containing metalloenzyme which has a specific lytic
action against Staphylococcus spp by hydrolyzing glycylglycine bonds in the
polyglycine bridges which form cross links between glycopeptide chains in the
cell wall peptidoglycan of S. aureus cells. Its lytic activity was shown in tests
with over 50 strains of Staphylococcus.aureus, and shown to be independent
of phage type, resistance to other antibiotics, and the condition of the cell wall
or degree of capsulation of the bacterium (235). It is widely used in cellular
invasion assays (236) (237).
Mutanolysin is a N-Acetyl Muramidase. It is a muralytic enzyme that cleaves
the N-acetylmuramyl-β(1-4)-N-acetylglucosamine linkage of the bacterial cell
wall polymer peptidoglycan-polysaccharide. Mutanolysin provides cell lysis
and is used for the isolation of biomolecules and RNA from the bacterial cell.
Mutanolysin is particularly used for lysis of Listeria. spp and other Gram
positive bacteria such as Lactobacillus. spp and Lactococcus. Spp (238)
(239).
The addition of these enzymes would potentially enhance the assay by
achieving a greater extracellular kill.
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6.3.9. Methods-Testing bacteria for sensitivity to proposed
antibiotics and enzymes for the invasion assays
The six most commonly found bacteria in the patient population were selected
for this study. Streptococcus. anginosus, Enterococcus. faecalis,
Escherichia.coli, Lactobacillus.gasseri, Corynebacteria.sp and
Proteus.mirabilus. Pseudomonas sp. was found in higher numbers as
compared to Proteus sp but it is very difficult to work with, forming a film of
slime like colony, difficult to enumerate and so Proteus.mirabilis was used
instead. Colonies were obtained from the stored pure cultures isolated from
patient samples. The strains were inoculated into a Columbia blood agar plate
and incubated overnight at 37°C at 5% CO2. The following day, a single
colony of each bacterium was inoculated into 15mls of Brain Heart Infusion
broth (Sigma) and incubated overnight at 37°C at 5% CO2 in a shaking
incubator (Progen scientific). As described by Hultgren et al. (151), Eagles
Minimal Essential Medium (Sigma) was made up with 10% fetal bovine serum
(Sigma), glutamine (Sigma) to 2mmol in 500mls and 1% non-essential amino
acids (Sigma). The following additives were then added so that 14 different
combinations of antibiotics and enzymes could be tested for their activity
against the selected bacteria (Total volume 10mls):
1. 50µL Gentamicin from a stock solution of 40mg/ml (final concentration
of 200µg/ml)
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2. 1ml of Linezolid from a stock solution of 2mg/ml (final concentration of
200µg/ml)
3. 10 µL Amoxicillin from a stock solution of 200mg/ml (final concentration
of 200µg/ml)
4. Gentamicin, Linezolid and Amoxicillin in the concentrations as above
5. Gentamicin and Linezolid in the concentrations as above
6. Gentamicin and Amoxicillin in the concentrations as above
7. Amoxicillin and Linezolid in the concentrations as above
8. Gentamicin in the concentration as above and Enzymes (Lysostaphin
50µg/ml, Mutanolysin 50µg/ml and Lysozyme 50µg/ml)
9. Linezolid and Enzymes in the concentrations as above
10.Amoxicilin and Enzymes in the concentrations as above
11.Gentamicin, Linezolid, Amoxicillin and Enzymes in the concentrations
as above
12.Gentamicin, Linezolid and Enzymes in the concentrations as above
13.Gentamicin and Amoxicillin and Enzymes in the concentrations as
above
14.Amoxicillin and Linezolid and Enzymes in the concentrations as above
The overnight bacterial cultures were centrifuged at 8000rcf for 5 minutes at
room temperature using an Eppendorf 5804R centrifuge. The supernatant
was gently removed and the bacterial pellet was re-suspended in 10ml of cell
culture media as described above. The bacterial suspension was adjusted to
an optical density at 600nm (OD600) of 0.5 corresponding to 1x108cfu/ml of
bacteria. 250µL of this suspension was added to 10mls of Growth media as
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above and the optical density of this bacterial suspension was adjusted to an
optical density of 600nm (OD600) of 0.05 corresponding to 1x106cfu/ml of
bacteria. This was further diluted to a final bacterial concentration of
1x103cfu/ml. Three final concentrations of bacterial suspension were thus
used. These concentrations were confirmed by plating to a dilution of 1X108
with 200µL of each solution (100µL on each half) placed on a Columbia Blood
Agar (CBA) plate (E&O laboratories).
To a 96 well plate (Sigma), 1ml of the Growth media was added to each well.
For each bacterial isolate, 48 wells were inoculated with each bacterial
concentration (1X108 shown in red, 1x106 shown in green and 1x103 shown in
blue in table 6.8) and the antibiotic / enzyme mixtures described above were
added as described in the following table (6.8), in triplicate, to test for bacterial
resistance:
The role of bacterial infection in the aetiology of the overactive bladder
169
1 2 3 4 5 6 7 8 9 10 11 12
A Mediaonly
Media
only
Media
only
Bacteria
+media
only
Bacteria
+media
only
Bacteria
+media
only
G G G L L L
B A A A GLA GLA GLA GL GL GL GA GA GA
C AL AL AL GE GE GE LE LE LE AE AE AE
D GLAE GLAE GLAE GLE GLE GLE GAE GAE GAE ALE ALE ALE
E Mediaonly
Media
only
Media
only
Bacteria
+media
only
Bacteria
+media
only
Bacteria
+media
only
G G G L L L
F A A A GLA GLA GLA GL GL GL GA GA GA
G AL AL AL GE GE GE LE LE LE AE AE AE
H GLAE GLAE GLAE GLE GLE GLE GAE GAE GAE ALE ALE ALE
1 2 3 4 5 6 7 8 9 10 11 12
A Mediaonly
Media
only
Media
only
Bacteria
+media
only
Bacteria
+media
only
Bacteria
+media
only
G G G L L L
B A A A GLA GLA GLA GL GL GL GA GA GA
C AL AL AL GE GE GE LE LE LE AE AE AE
D GLAE GLAE GLAE GLE GLE GLE GAE GAE GAE ALE ALE ALE
1x108CFU/mL
1x106CFU/mL
1x103CFU/mL
Table 6.8. 96 Well plate showing sequence of antibiotics and enzymes added to test bacterial
strains for resistance. G= Gentamicin, L= Linezolid, A= Amoxicillin, E= Enzymes (Lysostaphin, Lysozyme,
mutanalysin)
1x108CFU/mL
1x108CFU/mL
1x106CFU/mL
1x106CFU/mL
1x106CFU/mL
1x103CFU/mL
1x103CFU/mL
1x108CFU/mL
1x103CFU/mL
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As can be seen in Table 6.8, triplicate wells were also inoculated with cell
growth media alone and others with a bacterial suspension without any
antibiotics or enzymes, these acting as controls. An absorbance reading was
taken from each plate using a spectrophotometer and the plates were
incubated overnight at 37°C in 5% CO2. The following day, another
absorbance reading was taken to confirm bacterial growth and the wells were
inoculated onto Columbia blood agar using multipoint inoculators (Denley)
delivering approximately 10uL from each well onto the plate. The plates were
then incubated overnight at 37°C in 5% CO2. Positive growth was noted the
following day. In all wells that showed negative growth, the entire well volume
(1ml) was inoculated onto a Columbia blood agar plate and incubated at 37°C
in 5% CO2 for 24 hours to confirm negative growth in that well.
All bacterial isolates were tested twice in the same manner to re-evaluate
resistance.
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6.3.10 Results of sensitivity tests
Tables 6.9, 6.10 and 6.11 show the sensitivity of the bacterial isolates to each
combination of antibiotic and enzymes. There was no growth in the culture
medium alone but there was growth in every well which contained growth
medium with bacterial isolates alone. Culture confirmed the optical densities
OD600 of 0.5 to correspond to a bacterial count of 1x108cfu/ml, OD600 of 0.05
corresponding to 1x106cfu/ml and the bacterial suspension diluted fourfold to
1x103cfu/ml in each case.
The tables show that all bacterial isolates were sensitive to Gentamicin at a
concentration of 200µg/ml except Enterococcus.faecalis at 1x108cfu/ml,
which was sensitive to Linezolid. E coli was resistant to Amoxicillin 200µg/ml
at all bacterial concentrations. Streptococcus.anginosus and Proteus. mirabilis
were resistant to Amoxicillin 200µg/ml at bacterial concentrations of
1x108cfu/ml and 1x106cfu/ml. Lactobacillus. gasseri, Corynebacterium.Sp
were sensitive to all antibiotics. The addition of enzymes did not improve the
sensitivity of the bacterial isolates to the antibiotics at any concentration of
bacteria.
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Bacteria
1x108cfu/ml
E.coli E.faecalis Strep.anginosus Corynebacteriu
m. Sp.
Lactobacillus.
gasseri
Proteus.
mirabilus
Consistency
of media
Media+bacteria Growth Growth Growth Growth Growth Growth
G No
growth
Growth No growth No growth No growth No growth
L Growth faint
growth
No growth No growth No growth Growth
A Growth Growth Growth No growth No growth Growth
GLA No
growth
No growth No growth No growth No growth No growth
GL No
growth
No growth No growth No growth No growth No growth
GA No
growth
Growth No growth No growth No growth No growth
AL Growth faint
Growth
No growth No growth No growth Growth
GE No
growth
Growth No growth No growth No growth No growth
LE Growth faint
growth
No growth No growth No growth Growth
AE Growth Growth Growth No growth No growth Growth
GLAE No
growth
No growth No growth No growth No growth No growth
GLE No
growth
No growth No growth No growth No growth No growth
GAE No
growth
Growth No growth No growth No growth No growth
ALE Growth Growth No growth No growth No growth Growth
Table 6.9. Bacterial sensitivity at bacterial count of 1x108cfu/ml to combinations of gentamicin 200µg/ml,
Linezolid 200µg/ml, amoxicillin 200µg/ml and mutanalysin 50µg/ml, Lysostaphin 50µg/ml and Lysozyme
50µg/ml. G= Gentamicin, L= Linezolid, A= Amoxicillin, E= Enzymes (Lysostaphin, Lysozyme, mutanalysin)
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Bacteria
1x106cfu/ml
E.coli E.faecalis Strep.anginosus Corynebacteriu
m. Sp
Lactobacillus.
gasseri
Proteus.mirabilus
Consistency
of media
Media+bacteria Growth Growth Growth Growth Growth Growth
G No
growth
No growth No growth No growth No growth No growth
L Growth No growth No growth No growth No growth Growth
A Growth No growth Growth No growth No growth Growth
GLA No
growth
No growth No growth No growth No growth No growth
GL No
growth
No growth No growth No growth No growth No growth
GA No
growth
No growth No growth No growth No growth No growth
AL Growth No growth No growth No growth No growth Growth
GE No
growth
No growth No growth No growth No growth No growth
LE Growth No growth No growth No growth No growth Growth
AE Growth No growth Growth No growth No growth Growth
GLAE No
growth
No growth No growth No growth No growth No growth
GLE No
growth
No growth No growth No growth No growth No growth
GAE No
growth
No growth No growth No growth No growth No growth
ALE Growth No growth No growth No growth No growth Growth
Table 6.10. Bacterial sensitivity at bacterial count of 1x106cfu/ml to combinations of gentamicin 200µg/ml,
Linezolid 200µg/ml, amoxicillin 200µg/ml and mutanalysin 50µg/ml, Lysostaphin 50µg/ml and Lysozyme
50µg/ml. G= Gentamicin, L= Linezolid, A= Amoxicillin, E= Enzymes (Lysostaphin, Lysozyme, mutanalysin)
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Bacteria
1x103cfu/ml
E.coli E.faecalis Strep.anginosus Corynebacteriu
m. Sp
Lactobacillus.
gasseri
Proteus.mirabilus
Consistency
of media
Media+bacteria Growth Growth Growth Growth Growth Growth
G No
growth
No growth No growth No growth No growth No growth
L faint
Growth
No growth No growth No growth No growth No growth
A Growth No growth No growth No growth No growth No growth
GLA No
growth
No growth No growth No growth No growth No growth
GL No
growth
No growth No growth No growth No growth No growth
GA No
growth
No growth No growth No growth No growth No growth
AL Growth No growth No growth No growth No growth No growth
GE No
growth
No growth No growth No growth No growth No growth
LE Growth No growth No growth No growth No growth No growth
AE Growth No growth No growth No growth No growth No growth
GLAE No
growth
No growth No growth No growth No growth No growth
GLE No
growth
No growth No growth No growth No growth No growth
GAE No No growth No growth No growth No growth No growth
Table 6.11. Bacterial sensitivity at bacterial count of 1x103cfu/ml to combinations of gentamicin 200µg/ml,
Linezolid 200µg/ml, amoxicillin 200µg/ml and mutanalysin 50µg/ml, Lysostaphin 50µg/ml and Lysozyme
50µg/ml. G= Gentamicin, L= Linezolid, A= Amoxicillin, E= Enzymes (Lysostaphin, Lysozyme, mutanalysin)
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6.3.11 Conclusion from sensitivity testing
All of the isolates were sensitive to Gentamicin except Enterococcus faecalis
at 1x108cfu/ml, which was sensitive to Linezolid. For this reason, Gentamicin,
Amoxicillin and Linezolid 200µg/ml were used in the following experiment. The
addition of enzymes did not seem to make a difference to the susceptibility of
the bacteria to the antibiotics. It was therefore concluded that the addition of
Linezoid alone to the existing assay would improve the elimination of
extracellular bacteria and therefore enhance the retrieval of intracellular
bacteria.
6.3.12 Methods- Addition of Linezolid for the elimination of
extracellular bacteria
The assays were conducted as described in 6.3 with the addition of Linezolid
200µg/ml into the antibiotic Growth medium. This method was adapted from
(232-234) Herbert, Kristian and Ellison.
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6.3.13 Results of assay development- Addition of Linezolid for
elimination of extracellular bacteria
23 women were studied, mean age 56 (sd=17); 16 had OAB symptoms and
provided a CSU; 7 asymptomatic female controls, average age 29 (sd=12),
provided a CSU. The patient demographics are described in table 2.1 The
routine culture at 105cfu/ml were reported as positive in 3 OAB patients, none
of whom had pyuria. 15/16 of the OAB samples showed evidence of
intracellular bacterial colonisation of the bladder epithelium and only 2/7 of the
control specimens showed the same. The intracellular bacteria retrieved from
the last stage of the assay were subjected to biochemical tests and sequence
analysis (section 2.10 and 2.11) and are shown in table 6.12. The average
total intracellular bacterial count retrieved in the patient group was 1.5x106
cfu/ml. By contrast, the average total intracellular bacterial count in the control
group was 3.63x101 cfu/ml so that the difference was 5 orders of magnitude,
ie ≈105 (F=5.668, df=1, P=0.027) (Fig 6.6). The bacterial cell counts at
different stages of the assay in both patient and control groups are shown in
figures 6.4 and 6.5. By the 3rd wash, after the addition of Gentamicin,
Amoxicillin and Linezolid, counts approaching zero were obtained and so
cultures obtained after the addition of Triton X are presumed to have
intracellular origins.
The role of bacterial infection in the aetiology of the overactive bladder
177
Table 6.12. Bacterial isolates retrieved from patient and control samples using the
intracellular protection assay.
Identity Patient/Control Bacteria Retrieved Intracellularily
Intracellular bacterial
count cfu/ml-1
1 Patient Corynebacterium/ Lactobacillus sp. 1.22 x102
2 Patient Enterococus faecalis 1.43 x103
3 Patient Streptococcus agalactiae 5.73
4 Patient Enterococus faecalis/ E.coli 2.00 x107
5 Patient Enterococus faecalis/ Pseudomonas sp 2.5 x102
6 Patient Streptococcus anginosus 5.19x10
7 Patient Proteus sp 3.51x10
8 Patient Proteus sp 7.43 x102
9 Patient Enterococus faecalis 1.39 x10
10 Patient Streptococcus anginosus 1x106
11 Patient No growth 0.00
12 Patient Streptococcus agalactiae 1.00 x106
13 Patient No growth 0
14 Patient No growth 0
15 Patient Streptococcus agalactiae 0.1
16 Patient E.coli 2.00 x102
1 Control No growth 0.00
2 Control Enterococus faecalis 2.43x102
3 Control No growth 0.00
4 Control Streptococcus agalactiae 1.08x10
5 Control No growth 0.00
6 Control No growth 0.00
7 Control No growth 0.00
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Figure 6.4 Total bacterial counts (cfu/ml-1) at different stages of the Intracellular bacterial
isolation assay for patients with Overactive bladder, using the antibiotics Gentamicin,
Amoxicillin and Linezolid at concentrations of 200µg/ml. 1=Initial bacterial count before incubation
with the antibiotics, 2= Bacterial count after 24hrs incubation with the antibiotics, 3=Bacterial count after
3rd wash with PBS, 4=Bacterial count after addition of Triton X. Average epithelial cell count 1x105cells
per ml.
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Figure 6.5 Total bacterial counts (cfu/ml-1) at different stages of the Intracellular bacterial
isolation assay for control volunteers, using the antibiotics Gentamicin, Amoxicillin and
Linezolid at concentrations of 200µg/ml. 1=Initial bacterial count before incubation with the
antibiotics, 2= Bacterial count after 24hrs incubation with the antibiotics, 3=Bacterial count after 3rd wash
with PBS, 4=Bacterial count after addition of Triton X.. Average epithelial cell count 2.3x104cells per ml.
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Figure 6.6 Log total intracellular bacterial counts cfu/ml-1 after the addition of Triton X and SE
of the mean comparing the Overactive bladder patient group and the control volunteers.
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6.3.14 Methods of microscopic examination of intracellular
invasion
This method was adapted and developed from Miliotis et al. (223).
Thirty four patients attending the incontinence clinic provided urine specimens
by the CSU method (2.4.3.2). Eight asymptomatic controls, attending the Day
Surgery unit for an unrelated condition, agreed to provide a catheter specimen
of urine. An aliquot of urine was used for routine microscopy (2.4) and another
aliquot was used for routine culture and enhanced culture (2.6 and 2.9.1). A
further aliquot was used for sediment culture (2.9.2).
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An aliquot of urine was centrifuged at 800rcf for 5 minutes at room
temperature using an Eppendorf 5804R centrifuge. The supernatant was
removed gently and the sediment was kept. The sediment was washed in
200µl of Hank’s balanced salt solution (SIGMA). Hank’s balanced solution
contains glucose and it provides an energy source for cell metabolism. It also
provides cells with water and certain bulk inorganic ions and it provides a
buffering system in order to maintain the solution within the physiological pH
range of 7.2 to 7.6 (from the product information sheet by SIGMA).The cells
were then stained with 100µl of 0.01% acridine orange( PARIS ANTICORPS)
in Gey's solution (SIGMA) for 45 seconds. The sediment was then rinsed with
200µl of Hanks balanced salt solution, and counterstained with 100µl of
0.05% crystal violet (Fluka Biochemika) in for 45 seconds. The sediment was
then washed again with Hanks balanced salt solution. The sediment was
placed onto a double frosted glass slide and a cover slip was added which
was sealed with clear nail-varnish. Slides were then viewed immediately
under a Olympus BX-40 fluorescence microscope by using incident light at
x200 magnification for screening and x400 magnification - for quantification.
The number of green (viable) fluorescent bacteria in the first 30 cells was
counted, and the mean number of bacteria per cell was determined.
The initial protocol was taken from experiments conducted by Miliotis et al.
(223). However, when viewing the samples under the fluorescent light
microscope, there was no fluorescence detected from the sample. The
protocol was therefore modified by increasing the exposure time of both the
acridine orange solution and the crystal violet counterstain. The time the
acridine orange solution was left on the cells was increased to 30 minutes
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while the crystal violet counter staining was left on for 5 minutes. The green
fluorescence from the acridine orange solution showed that the stain was
binding to viable cells. Nevertheless, all of the extracellular bacteria were not
being quenched by the crystal violet solution. Further experiments focused on
increasing the exposure time of the crystal violet solution to the cells. The
exposure time was increased from 5 minutes to 10, 15, 20 and 25 minutes.
Investigations were carried out using the Olympus BX-40 fluorescent light
microscope. It was found out that leaving the crystal violet counter stain for 20
minutes was sufficient time for the extracellular bacteria to be quenched. The
intensity of the fluorescence from intracellular bacteria was discernible from
the fluorescence from extracellular bacteria.
6.3.15 Statistics-Acridine Orange staining to visualise intracellular
bacteria
A non-parametric test for Independent samples, the Mann Whitney U test was
used to compare the median number of bacteria visualised per cell between
the patient and control groups.
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6.3.16 Results-Acridine Orange staining to visualise intracellular
bacteria
Of the thirty four patient samples, after modifications to the assay, twenty four
samples were used for the final experiment and all eight of the control
samples. The assay was disappointing; the fluorescence emitted under the
BX-40 microscope was poor. This meant that some cells fluoresced well and
a neighbouring cell would fluoresce poorly. This may have occurred because
of the variability of urine pH and the variability of urea and various ions in the
urine. However, Hanks balanced salt solution should have corrected for this
irregularity.
No patients were taking antibiotics. 16 had pyuria on microscopy. The
sediment culture in the patient group showed a mean total bacterial count of
7.28x104cfu/ml. The asymptomatic control group had a mean total bacterial
count of 8.67x103cfu/ml. The mean number of bacteria counted per cell for the
patient group was 2.94 bacteria per cell and for the control group 0.22
bacteria per cell. This was significantly different (p= .01). The mean number of
bacteria counted per sample for the patient group was 49.9 and 6.6 for the
control group. This was significantly different (p= .01). Figure 6.7 shows the
mean number of bacteria per cell between patients and controls. Although
significant, the graph demonstrates the wide variance in the mean in the
patient group. This may have occurred because of the larger number of shed
cells in the patient group seen on microscopy. Figures 6.8-6.9 are
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photographs taken of the fluorescent microscopy showing intracellular
bacteria in patient samples.
Figure 6.7 Log mean number of bacteria counted in the first 30 cells and the 95% confidence
interval of the mean using acridine orange staining comparing the Overactive bladder patient
group and the control volunteers.
Figure 6.8 Fluorescent microscopy x400 magnification using the Olympus BX-40 showing
intracellular rods in a bladder epithelial cell.
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Figure 6.9 Fluorescent microscopy x 400 magnification using the Olympus BX-40 showing
intracellular organisms in a bladder epithelial cell.
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6.4 Discussion
These experiments resulted in a very marked discrimination between patients
with OAB and normal controls. Whilst imaging through confocal microscopy
would be the most direct means of locating intracellular bacteria, the data
presented here constitute a microbiological test of this hypothesis which
stands in the face of the results.
The dominant bacteria in this sample of patients was Enterococcus faecalis,
Streptococcus agalactiae, Streptococcus anginosus, Escherichia coli and
Proteus mirabilis. The findings affirm the results reported in chapter 3, where
similar species dominated isolates obtained from other OAB patients.
Additionally, A. omnicolens was isolated from one of the patients. A.
omnicolens has been rarely isolated from human clinical specimens. This
organisms is a member of the normal microbiota of the human gastrointestinal
tract and oral cavity, and some strains have been used as probiotics to protect
against gut pathogens (240), (241).
Mahlen et al. (242), found A. omnicolens and Bifidobacterium isolates as
causative agents of UTI in symptomatic patients with pyuria. They concluded
that these organisms should not be ignored when isolated from clinical
specimens. Clinical laboratories may consider these organisms to be normal
microbiota or not recover these organisms since they are slow growing and
are difficult to identify (243).
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This is the first time that this evidence for intracellular bacterial invasion of
bladder epithelium in patients with OAB has been shown. Intracellular
invasion is a known mechanism of bacterial evasion of the host immune
response leading to persistence and treatment failure.
The failure of the enzymes to influence the demise of the extracellular
bacteria was disappointing and, at the time, perplexing. On reflection there
may well be good reason for this observation. A finding from these studies
and those of other groups such as Hultgren et al. is that the bacteria of
interest seem to be very well adapted to life inside a host cell. The implication
is that there may be an extensive evolutionary story leading to these
behaviours. Recent attention, albeit limited, to innate immune function of
epithelia, particularly of the intestine, provide some signposts.
In response to the pathogens, the urothelium mounts a, bipartite, innate
immune response (149). Recognition of pathogen lipopolysaccharides by
TLR4 on the urothelial cells initiates an intracellular cascade which leads to
the transcription and release of antimicrobial peptides, inflammatory cytokines
and chemokines, and co-stimulatory molecules that promote the many
elements of the innate immune response to common bacteria, including the
recruitment of polymorphonuclear neutrophils (PMN). Because the bacteria
are located inside the cells they can increase in number while evading the
action of PMNs as well as antibiotics and other defence mechanisms. There
are intracellular innate immune mechanisms, notably the fusion of the bacteria
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containing endosomes with lysososmes. It has come to light that some
microbes have evolved methods of escaping such attacks. Others seem to
depend on the fusion of the endosome with the lysosome because the
bacteria concerned have evolved mechanisms that permit them to thrive in an
environment that contains lysosome enzymes which the microbes seem to be
controlling (244) (245) (246). These findings certainly imply lysosyme
resistance in the bacteria that were cultured from the patients, both from the
intracellular and extracellular spaces.
The use of the acridine orange stain was disappointing as it was a difficult
stain to use with variance in its staining from cell to cell. Confocal microscopy
techniques have been used by Hultgren et al. (149), allowing visualisation of
the cell membrane and the bacteria inside the cell. However, that group were
using a known bacterium, E.coli and so they were able to use immunological
staining specific for E.coli bacterial components. In this study the problem was
that staining was that a variety of bacteria was present in the urine and so no
specific stains could be used.
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Chapter 7
Intracellular Invasion of a Bladder
Epithelial Cell Line
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7.1 Hypothesis
Bacteria isolated from patients with the overactive bladder syndrome will
invade a human bladder epithelial cell line in contrast to similar bacteria
isolated from the urine of asymptomatic controls.
7.2 Background
This study examined four of the isolates retrieved from OAB patients to
investigate whether they would invade a human bladder epithelial cell line.
This was to test the hypothesis that bacteria from patients would exhibit the
capability of cell invasion in contrast to microbes isolated from controls. This
provided a different path to scrutinising the veracity of the results reported in
chapter 6.
The method was adapted from Martinez et al., 2000 (247), who used E.coli to
infect a human bladder cell line, Marouni et al., 2004 (248), who used a Group
A Streptococcus to infect Hep-2 epithelial cells and Fabretti et al., 2009 who
used Enterococcus faecalis to infect Hep-2 epithelial cells (249).
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7.3 Methods
Four bacterial isolates were studied, previously isolated from patients
presenting with symptoms of OAB. These were Eschericia. coli,
Enterococcus. faecalis, Streptococcus. anginosus and Proteus. mirabilis. One
isolate from a control volunteer Lactobacillus. gaseri was also used. These
isolates had been previously cultured during the intracellular growth assays
described in chapter 6. The isolates were identified as per section 2.10-2.11
A bladder epithelial cell line from a transitional cell carcinoma (EJ138) was
grown to confluency in Eagles Minimal Essential Medium supplemented with
Glutamine to 2mmol (Sigma), fetal bovine serum 10% (Sigma) and Non-
essential amino acids 1% (Sigma) in a 5% Co2 atmosphere. Cells were
passaged at a ratio of 1:5 twice weekly. All experiments were performed on
the cells between the 3rd and 15th passage. All experiments were conducted in
triplicate. The experiments were conducted as follows:
Day 1
The bacteria required (Eschericia. coli, Enterococcus. faecalis, Streptococcus.
anginosus, Proteus. mirabilis and Lactobacillus.gaseri ) were retrieved from
frozen storage (2.11.3) and a loop of the isolate was streaked onto a CBA
plate and cultured overnight in 5% CO2 at 37ºC.
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Day 2
A single colony of the bacterium was added to 15ml of Brain Heart infusion
broth (Oxoid Ltd) and incubated overnight at 37ºC in 5% CO2. This was in
order to get a bacterial suspension in which the bacterial count could be
adjusted for the experiment.
The human bladder cell line EJ138, was split and seeded into 5 wells of a 24
well plate (Sigma) at 1x105 cells per well and grown to confluency overnight at
37ºC in 5% CO2.
Day 3
The bacterial suspension was centrifuged at 600g for 5 minutes. The
supernatant was removed and the sediment was re-suspend in 10mls of
Eagles Minimal Essential Medium and adjusted to an optical density at 600nm
(OD600) of 0.5, so that a final multiplicity of infection (M.O.I) of 100 bacteria per
bladder cell could be achieved. CBA plates were inoculated with the bacterial
suspension at dilutions to x1000. This was in order to check the adjusted
bacterial suspension and confirm the colony count.
The 24 well plate was removed from the incubator and microscopy was
performed at x400 magnification with an inverted microscope (Olympus) to
check for confluency. The cell media were removed from the wells and each
well was washed with 1ml PBS. The PBS was plated onto CBA and incubated
overnight at 37ºC, 5% CO2 to check for bacterial growth prior to inoculation of
the bladder cells with bacteria.
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The bacterial suspension was added at the correct volume to give a final MOI
of 100 bacteria per cell and additional Eagles Minimal Essential Medium
supplemented with Glutamine to 2mmol (Sigma), fetal bovine serum 10%
(Sigma) and Non-essential amino acids 1% (Sigma) for a final volume of 1ml.
The triplicates were as follows:
1. Media only, no cells, no bacteria, (control)
2. Bacteria, no cells (control)
3. Cells only (control)
4. Cells and bacteria (To give the total bacterial counts, both intracellular
and extracellular)
5. Cells and bacteria (To give the counts of the adhesive and invasive
bacteria)
6. Cells and bacteria ( To give the counts of the intracellular bacteria only)
7. Cells and bacteria (for viable epithelial cell line counts at the end of the
assay)
The wells were incubated at 37° C, 5% CO2 for 2 hours.
After incubation, the media were removed and replaced with media containing
gentamicin at 100µg/mL to triplicates 3, 6, 7 only (to kill any extracellular
bacteria) and wells 1,2,3,6,7 were incubated for 2 hours.
To triplicate 4, triton X was added for a final concentration of 0.1% for 5
minutes. The solution in triplicate 4 was plated on CBA at dilutions to x1000
and incubated at 37° C, 5% CO2. This gave the total bacterial count both
intracellular and extracellular.
To triplicate 5, the media were removed and the wells were washed with 1ml
PBS 5 times. The total volume of the last wash was kept and plated onto CBA
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and incubated overnight at 37° C, 5% CO2. The cells in the well were then
lysed with Triton X at a final concentration of 0.1% for 5 minutes. The solution
in triplicate 5 was plated on CBA at dilutions to x1000 and incubated at 37° C,
5% CO2. This gave the bacterial counts for the adherent and invasive
bacteria.
After a further 2 hour incubation period for triplicates 1, 3, 6, 7 the media were
removed and the total volumes were plated on CBA and incubated at 37° C,
5% CO2 overnight for the initial bacterial counts after incubation with
gentamicin.
Triplicates 1,3,6,7 were then washed with PBS 1ml 10 times and the last
wash was plated on CBA and incubated at 37° C, 5% CO2 overnight. This
step was to remove any cell adherent bacteria after incubation. Triton X was
then added for a final concentration of 0.1% for 5 minutes to lyse the epithelial
cells and release any intracellular bacteria.
Triplicates 1,2,3,6,7 were then treated as follows:
Triplicate 1: The entire volume was plated on CBA and incubated at 37° C,
5% CO2 overnight. This well was to insure that the culture media were not
contaminated.
Triplicate 2: The total volume of the wells was plated on CBA and incubated at
37° C, 5% CO2 overnight and then the wells were washed with 1ml PBS 5
times and every wash was plated on CBA and incubated at 37° C, 5% CO2
overnight . Triton X was then added for a final concentration of 0.1% for 5
minutes and the entire well volume was plated on CBA and incubated at 37°
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C, 5% CO2 overnight. This was to make sure the bacteria grew in the media
and was not altered by the addition of Triton X.
Triplicate 3: The entire volume of the wells was plated on CBA and incubated
at 37° C, 5% CO2 overnight. This well contained bladder cells only, bathed in
culture media + gentamicin. This again was to make sure that no bacteria
grew in these wells as a control.
Triplicate 6: Serial dilutions of the solution in the well were performed to a
dilution of x1000 and plated on CBA and incubated at 37° C, 5% CO2
overnight. This would give the intracellular bacterial count (invasive bacteria).
Triplicate 7: 100µL trypsin was added to the well and incubated for 2-3
minutes. 20µL of trypan blue was added to 20µL of the well suspension. This
gave a viable bladder epithelial cell count.
7.4 Results from invasion assay incubating with Gentamicin
100µg/ml for 2 hours
The viable urothelial cell counts obtained at the end of the assay were
between 1.6-2x105 cells.
All control wells were negative for bacterial growth; wells 1 and wells 3. The
bacterial wells (2) grew a lawn of bacteria, even at x 1000 dilution and after
washing 10 times and adding Triton X.
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After incubation with antibiotics, the media removed from wells 6 showed
bacterial growth, for all bacterial isolates. After washing the attached cells in
the well 10 times, again, with each bacterium, the wells still showed bacterial
growth. After the addition of Triton X, bacteria were retrieved from all wells for
each bacteria tested.
7.5 Conclusions from invasion assay incubating with
Gentamicin 100µg/ml for 2 hours
The results of the experiment showed bacterial growth even after the addition
of gentamicin. This meant that the assay could not differentiate intracellular
from extracellular bacteria. This was a little surprising as various authors in
the literature have consistently used a 2 hour incubation period for bacterial
kills of similar numbers of bacteria. This meant that the gentamicin was
possibly only bacteriostatic at 2 hours or not active against the bacterial
isolates used. The same isolates had been used in chapter 6 and those
experiments had shown these isolates to be sensitive to gentamicin at 24
hours.
Therefore, I tested the isolates by inoculating them with gentamicin 100µg/mL
for 2 hours, 12 hours and 24 hours to test the ability of the gentamicin to kill
the bacteria at variable time intervals.
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7.6 Method development inoculating with gentamicin for
variable lengths of time
The experiment was conducted as above but wells 3,6,7 were inoculated with
gentamicin 100µg/mL for 2 hours, 12 hours and 24 hours. Enterococcus.
faecalis was used in this experiment.
7.7 Results of variable antibiotic inoculation times
The viable urothelial cell counts obtained at the end of the assay were
between 1.4-1.6x105 cells.
All control wells were negative for bacterial growth; wells 1 and wells 3. The
bacterial wells (2) grew a lawn of bacteria, even at x 1000 dilution and after
washing 5 times and adding Triton X.
Incubation at 2 hrs. with gentamicin confirmed bacterial growth. At 12 hours
and 24 hours incubation with gentamicin, again there was bacterial growth. At
12 hours there was an average of 65 bacteria per ml and at 24 hours there
was an average of 6 bacteria per ml.
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7.8 Conclusion from variable antibiotic inoculation times
The experiment showed that the greater incubation time gave a greater kill.
However, at 24 hours there was still not a total kill achieved. This would make
it difficult to feel confident that growth post cell lysis implied that invasion was
occurring. I decided to use different antibiotic concentrations. In my previous
experiments in chapter 6, I had used 200µg per ml of gentamicin. This was
because there was an indeterminate amount of bacteria in the human
samples but in this experiment, I had control over the number of bacteria that
were added to the assay (100 bacteria per epithelial cell). I decided to repeat
the experiment, using an incubation period of 24 hours but with 100µg, 150µg,
200µg per ml of gentamicin to test the different concentrations to achieve a
complete kill after incubation.
7.9 Method improvement. Incubating with different
concentrations of gentamicin
The above experiment was repeated, incubating for 24 hours in gentamicin
100µg/ml, 150µg/ml and 200µg/ml in wells 3,6,7. Enterococcus. faecalis was
used in the experiment.
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7.10 Results of incubating with different concentrations of
gentamicin
The viable urothelial cell counts obtained at the end of the assay were
between 1.4-2x105 cells.
All control wells were negative for bacterial growth; wells 1 and wells 3. The
bacterial wells (2) grew a lawn of bacteria, even at x 1000 dilution and after
washing 5 times and adding Triton X.
At 100µg/ml the average growth was 60 bacterial per ml, at 150µg/ml the
average growth was 43 bacteria per ml and at 200µg/ml there was no
bacterial growth.
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7.11 Conclusion from invasion assay improvement; using
different concentrations of gentamicin.
This experiment showed incomplete kills at 100µg/ml and 150µg/ml. There
was not much difference between the two concentrations. At 200µg/ml,
however, there was complete kill, confirmed in all triplicate wells. For this
reason, I conducted all further experiments using gentamicin 200µg/ml with an
incubation period of 24 hours.
7.12 Methods with improved invasion assay using gentamicin
200µg/ml
The experiment was repeated as per section 7.3 using Eschericia. coli,
Enterococcus. faecalis, Streptococcus. anginosus, Proteus. mirabilis or
Lactobacillus. gaseri.Wells 3,6,7 were incubated with gentamicin 200µg/ml for
24 hours.
7.13 Results from improved assay using gentamicin 200µg/ml.
The viable urothelial cell counts obtained at the end of the assay were
between 1.4-2x105 cells.
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All control wells were negative for bacterial growth; wells 1 and wells 3. The
bacterial wells (2) grew a lawn of bacteria, even at x 1000 dilution and after
washing 10 times and adding Triton X.
Figures 7.1-7.5 below show the bacterial counts at different stages of the
assay for each bacterium. The graphs demonstrate a complete kill of
extracellular bacteria after the addition of Gentamicin 200µg/ml for 24 hours.
They also demonstrate the release of intracellular bacteria after cell lysis with
the addition of triton X in all cases except for Lactobacillus.gaseri, in which no
bacterial growth is shown after cell lysis. The average bacterial counts post
cell lysis (intracellular bacterial count) were: E.coli 1.8x10 cfu ml-1, E.faecalis
1.02x104cfu ml-1, Strep.anginosus 2.69x103cfu ml-1, Proteus.mirabilus 3.20
x103cfu ml-1, Lactobacillus. Gaserri 0 cfu ml-1.
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Figure 7.1 Total bacterial counts (cfu/ml-1) at different stages of the Intracellular bacterial
invasion assay for Eshericia.coli. Start=Initial bacterial count before incubation with the antibiotics,
2hrs= Bacterial count after 2hrs incubation without antibiotics, mixed=Adhesion and invasion count,
Gent=Bacterial count after addition of Gentamicin and incubation for 24hrs, Wash= Bacterial count after
washing with PBS 10 times to remove any adherent bacteria, Invasion=Bacterial count after cell lysis
with Triton X.
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Figure 7.2 Total bacterial counts (cfu/ml-1) at different stages of the Intracellular bacterial
invasion assay for Enterococcus.faecalis. Start=Initial bacterial count before incubation with the
antibiotics, 2hrs= Bacterial count after 2hrs incubation without antibiotics, mixed=Adhesion and invasion
count, Gent=Bacterial count after addition of Gentamicin and incubation for 24hrs, Wash= Bacterial
count after washing with PBS 10 times to remove any adherent bacteria, Invasion=Bacterial count after
cell lysis with Triton X.
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Figure 7.3 Total bacterial counts (cfu/ml-1) at different stages of the Intracellular bacterial
invasion assay for Streptococcus.anginosus. Start=Initial bacterial count before incubation with the
antibiotics, 2hrs= Bacterial count after 2hrs incubation without antibiotics, mixed=Adhesion and invasion
count, Gent=Bacterial count after addition of Gentamicin and incubation for 24hrs, Wash= Bacterial
count after washing with PBS 10 times to remove any adherent bacteria, Invasion=Bacterial count after
cell lysis with Triton X.
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Figure 7.4 Total bacterial counts (cfu/ml-1) at different stages of the Intracellular bacterial
invasion assay for Proteus.mirabilus. Start=Initial bacterial count before incubation with the
antibiotics, 2hrs= Bacterial count after 2hrs incubation without antibiotics, mixed=Adhesion and invasion
count, Gent=Bacterial count after addition of Gentamicin and incubation for 24hrs, Wash= Bacterial
count after washing with PBS 10 times to remove any adherent bacteria, Invasion=Bacterial count after
cell lysis with Triton X.
Stage in assay experiment
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Figure 7.5 Total bacterial counts (cfu/ml-1) at different stages of the Intracellular bacterial
invasion assay for Lactobacillus.gasseri. Start=Initial bacterial count before incubation with the
antibiotics, 2hrs= Bacterial count after 2hrs incubation without antibiotics, mixed=Adhesion and invasion
count, Gent=Bacterial count after addition of Gentamicin and incubation for 24hrs, Wash= Bacterial
count after washing with PBS 10 times to remove any adherent bacteria, Invasion=Bacterial count after
cell lysis with Triton X.
Stage in assay experiment
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7.14 Discussion
These experiments confirm intracellular invasion of a cell line by prominent
bacteria isolated from patients suffering with overactive bladder symptoms. It
is interesting that this did not occur in the Lactobacillus. gasseri species
isolated from a control volunteer. However, all species from both patients and
controls should be scrutinised in this manner to fully understand the
differences in invasion ability and invasion frequency manifest by the various
bacteria isolated. It is too premature to assume that all isolates from patients
will invade bladder epithelia in vitro and all isolates from control volunteers will
not.
This experiment features some additional interesting findings. The inability of
gentamicin at 100µg/ml for 2 hours to achieve a complete bacterial kill of each
isolate suggests an adaptation of these bacteria for gentamicin resistance at
low concentrations. Enterococci are well known for their ability to adapt to an
antibiotic exposure, mainly due to their natural resistant to low-level
concentrations of ß-lactams and aminoglycosides (250) Kobayashi et al
(251); Bujdáková et al (252). Resistance to aminoglycosides is mostly thought
to be caused by the production of many aminoglycoside-modifying enzymes
with the prevalence of the enzyme 6'-acetyltransferase–2"-
phosphotransferase (253)
A recent study by Mulvey et al. 2010 (254), showed the persistence of
uropathogenic E.coli in vitro and in vivo in a mouse model, despite the use of
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multiple antibiotics including gentamicin. E.coli resistance to gentamicin,
although acknowledged, is poorly understood. One study by Kühberger et al.,
1979 (255), showed that gentamicin resistant E.coli strains contained
mutations correlating to an altered L6 ribosomal protein, requiring an
increased minimal inhibitory concentration of the drug by about 5 to 10-fold.
High level resistance to aminoglycosides has been reported in various
Streptococcal spp, including Group B Streptococcus. This also occurs in
Proteus. mirabilis, the resistance genes aph(3 ')-III gene and aminoglycoside-
modifying enzymes being identified as the cause. It is well established that a
transposable sequence of DNA encoding resistance to various antibiotics is
capable of transposing to other plasmids that exist within the same cell (256)
(257;258) and this may account for aminoglycoside resistance in urinary
pathogens and in the isolates used in this study, particularly, where there is a
large commensal community of bacteria, providing opportunistic pathogens.
Urothelial invasion by E.coli and Proteus. mirabilis has been studied as a
model for UTI by Allison et al. (259). Urothelial invasion by Streptococcal Spp
and Enterococcus Spp has not been widely studied. Biofilm formation as a
mechanism of pathogenesis has been widely documented in the Enterococcal
spp and Enterococcus UTI is often associated with the use of a urinary
catheter (260) and so it is difficult to speculate on a mechanism for
intracellular invasion for these bacteria. However, there are various
mechanisms reported in the literature responsible for bacterial adhesion and
invasion of various human cells. Streptococci are known to colonise different
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sites in the human body because they express multiple adhesin proteins that
recognize specific receptors, often sugars or oligosaccharides, expressed at
various body sites. Following initial adherence processes, bacteria grow and
survive depending upon the physical and chemical environment. The initial
adherence of a single cell gives rise to micro-colonies. This results in the
formation of what has been termed a linking film. Further cell division leads to
the generation of a small society with the incorporation and accumulation of
other bacterial cells to establish a community. In a dental plaque community,
for example, there may be over 100 different kinds of bacteria present.
Multiple adhesive and metabolic interactions occur between bacterial cells in
these communities. Fimbriae are present on the surfaces of some
streptococcal cells which allow long range adhesion to occur (261).
Many urinary pathogens, including E.coli, use quorum sensing genes in order
to regulate virulence genes during bacterial invasion. Three systems of
quorum sensing exist in bacteria. The first uses acyl homoserine lactone (acyl
HSL) molecules for signalling. This system is used by gram-negative bacteria.
The second system is found in gram-positive bacteria that uses short cyclic
peptides and a receptor kinase signalling pathway. The third system, used by
both gram negative and gram positive bacteria uses elements of both the first
and second systems (262).
These communications systems control various host–pathogen interactions.
Of the entire complement of genes that contribute to virulence in bacterial
pathogens, quorum sensing molecules are a major regulator. Up to 15% of
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the open reading frames of bacteria are controlled by quorum sensing
molecules. Quorum sensing can promote the growth of related strains of
bacteria and simultaneously inhibit the growth of other bacterial or even fungi
competing for the same ecologic niche. Critical virulence determinants such
as toxin production, sporulation, plasmid transfer, invasion gene synthesis,
and various immune evasion mechanisms of bacteria are controlled by
quorum sensing genes. This is certainly a possible mechanism of bacterial
survival and disease in the bladder, considering the vast commensal
community of the perineum.
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Chapter 8
General Discussions and Conclusion
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8.1 Introduction
I set out to explore a key problem that manifests clinically as an attenuated
response of patients with the Overactive Bladder syndrome to the widely used
antimuscarinic agents developed for this condition. This resistant response
could be attributed to the lack of drug efficacy other than the fact there have
been many cases of symptom recrudescence whilst on medication in patients
who previously had responded very well (263-266). If we accept that the
antimuscarinics are not associated with tachyphylaxis then another
explanation must be sought.
A reasonable proposition would be that the problems are being caused by
undiagnosed infection although many would claim that this has been ruled out
by urinalysis and culture. This position is predicated on the premise that the
tests being used are capable of ruling out infection. I asked the questions are
the tests sufficiently sensitive? If not how can we search for bacteria as
aetiological agents in the Overactive Bladder if they exist?
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8.2 Limitations and criticisms of the study
I have been able to present several pilot studies, identifying and questioning
inconsistencies in the literature with regards to the identification and exclusion
of infection in patients with the Overactive bladder. Although the total number
of subjects studied was large, the subgroups in each of the studies was small,
making it difficult to draw final conclusions from these studies. In addition,
because of the reliance on catheter specimens of urine and the exclusion in
the studies of volunteers with any bladder symptoms, the asymptomatic
volunteer groups were small and not age matched. Although, in the literature,
Lactobacillus spp are reported to reduce after the menopause (267;268),
there is no consensus on predominance of other species and no studies on
the presence of Streptococcus spp in the post-menopausal state.
Nevertheless, the ideal standard would be to compare the patient group with a
similar age matched group.
Only a few men were investigated in this study. At the time of the study,
women made up the majority of patients presenting as new referrals to the
clinic and therefore this was the most practical approach, although the
prevalence of Overactive bladder is similar in both men and women and it is
difficult to generalise these findings to men.
The role of bacterial infection in the aetiology of the overactive bladder
212
8. 3 The reliability of existing tests to exclude urine infection
in patients with OAB
I produced evidence of the serious limitations in the sensitivity of current
dipstick testing to exclude infection in patients with OAB which are very similar
to other data on patients with acute frequency/dysuria (68;202-205).
Suspicion has been raised not just over the surrogate markers but the culture
systems used to detect infection (179;206). I assimilated the criticisms that
have been levelled at the routine MSU, that it produces a contaminated
sample for microbiological analysis, particularly in women (76;80;180;181). I
attempted a number of new methods in the hope of obviating the problems:
An enhanced threshold (102 cfu ml-1) applied to CSU sent to the NHS
laboratory demonstrated that there was territory to explore but with an
understanding that any threshold reduction would always mean that there
would be increased identification of apparent pathology. Thus controls and the
differentiation of the patient groups became very important to the
interpretation of a pathological signal.
I next used CSU, the enhanced threshold and non-selective media and that
produced an increased isolation of microbes. The proportion of patients
identified by these means was not as great as I might have expected, given
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the clinical narratives and the experience with the use of antibiotics in the
clinical service. It seemed that despite the very best circumstances for
detecting microbes the results were still insufficiently reassuring.
8.4 Evidence of an inflammatory response in the bladder
If bacterial infection was to be implicated in the aetiology of the Overactive
bladder, as well as examining the existing tests that are used to exclude urine
infection in these patients, it was important to show some evidence of
inflammation in the bladder, which is unlikely to exist if the existing ‘theories’
of the Overactive bladder are to be upheld. I studied the acute phase cytokine
IL-6 signal in the urine of patients with Overactive bladder syndrome as
compared to normal volunteers as a marker of inflammation. Pyuria in
patients with OAB symptoms was associated with urinary expression of IL-6.
This finding was supportive of the view that OAB symptoms in some patients
was associated with a urothelial inflammatory reaction and further basis to the
premise that bacterial infection, as a cause of inflammation, should be
excluded.
8.5 The urine cellular sediment
Whilst studying the urine sediment as part of the exploration of the surrogate
markers, I was struck by the common occurrence of clue cells and the
apparent clustering of microbes around urothelial cells, possibly adhering to
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them. The Hultgren groups had also published on their murine model and
thereby raised the question of bacteria avoiding detection through intracellular
colonisation (151;152;247).
The first step in this new road was to extract the urothelial cells and culture
those. If the bacteria were adherent to the cells then their numbers should be
increased considerably in cell concentrates much as bound antibodies are
used to extract proteins and cells of particular interest. Perhaps sampling of
the ordinary urine failed to trap cells in significant numbers and the urine
represented a dilute suspension of planktonic bacteria.
The very first non-selective cultures of spun sediment started to produce
extraordinary results with very clear quantitative and qualitative discrimination
between the patient groups and the controls. It was interesting to note that the
bacteria isolated, although implicated in urinary tract infection, were not the
most abundant bacteria reported in cases of acute urine infection, notably,
E.coli. The largest group of bacteria isolated were the Streptococcus spp. and
Enterococcus spp. These are known vaginal commensals but also implicated
in disease states, particularly urine infection and in the case of Streptococcus
spp. in vaginal infection and neonatal sepsis in pregnant women
(104;186;195;248;261;269). These were not the largest groups identified in
the control volunteers.
It would be tempting to stop here and promote a new culture method with the
associated clinical data justifying the case. This however would not be
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satisfactory as a pathophysiological mechanism and explanation would be
lacking. If bacterial adhesion were part of the process of cell invasion then the
identification of viable intracellular colonisation would present a suitable
target. Whilst the Hultgren group have used Electron microscopy to identify
intracellular colonisation their case was far more convincing in the murine
model than were the data that they presented in acute cystitis in humans
(151;152). Commensal organisms are a ubiquitous manifestation of the lower
urinary tract, and given the evolutionary history of the eukaryocyte, the
harmless colonisation of cells would not be a preposterous proposition. It
would be far more informative if the study of colonisation were rooted in the
careful identification of the microbes concerned so that species differences
could be studied between controls and patients and the findings analysed in
the light of what we know about the pathological properties of the isolated
microbes.
In addition, we are less sure that the imaging studies to date have shown
intracellular colonisation of human urothelial cells beyond reasonable doubt.
There remains the question of whether the bacteria visualised are only
attached to the cells. I therefore proposed a culture based analysis of the
colonisation of urothelial cells from patients and controls. This was then to be
followed by an investigation of the invasion properties of the bacteria isolated
from patients and controls. Imaging studies would have been very welcome
adjuncts to these experiments but a very great deal of work needed to be
conducted on differential staining methods before suitable confocal
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microscopic methods could be deployed. Given the time constraints I elected
to focus on the microbiological approach.
I hence had to invent a whole new set of methods to achieve my goals and
much of my work has focused on method development and validation,
nevertheless, despite the many difficulties the data present a very convincing
case of a pathological colonisation of urothelial cells and a possible cause of
OAB. The data reflected other studies of other, non-bladder, epithelial cells,
showing intracellular colonisation of different body surfaces by these
pathogens in the disease state (191;232;248;261;270). Another important
finding, whilst developing the intracellular invasion assays, was the resistance
of the bacteria retrieved from patients to lytic enzymes, again reflecting a
possible immune adaptation for intracellular survival.
8.6 Future Work
This study raises many questions. Future work should include looking more
closely at a larger cohort of patients, including men, with age matched control
volunteers and be directed particularly at the imaging of intracellular bacterial
pathogens in patients with the overactive bladder, longitudinal cohort studies
of the microbiological ecology in patients with the Overactive bladder and any
changes in the ecology over time; the symptoms in relation to colonisation
patterns over time, the effect of antibiotic intervention and a proper
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widespread analysis of the innate immune interactions so as to explain the
pathophysiology and the microbial adaption. The innate immune system might
well prove to be a rich source of new surrogate markers and measures of
disease progress or regression under treatment.
8.7 Conclusion
The hypothesis that this thesis set out to test were as follows:
The presence of pyuria ≥ 10 wbc µl-1 in patients with OAB is associated with
other evidence of an inflammatory response.
The traditional diagnostic methods deployed to exclude urinary infection in
OAB patients are missing genuine infection.
OAB is associated with intracellular bacterial colonisation of uroepithelial cells
by pathogenic bacteria
All three hypotheses are supported by the work in this thesis. The role of
bacterial infection in the overactive bladder syndrome cannot be reliably
excluded by the current tests available in routine practice. Patients with
overactive bladder syndrome display an IL-6 inflammatory signal in the urine,
not shown previously; suggesting that core to the aetiology of the condition is
an inflammatory mechanism from the urothelium. This finding is supported by
the urothelial biopsies taken from these patients, invariably showing
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histopathological inflammatory changes. Intracellular bacterial colonisation,
particularly by the Streptococcus spp and Enterococcus spp. is predominantly
found in patients with overactive bladder as compared with control volunteers.
These bacteria not only show the ability to invade the bladder epithelium but
possibly an ability to evade immune defences as evidenced by their
resistance to lytic enzymes.
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Appendix 1
A 10-Item Scale to Measure Urinary Urgency
Question YesScore No Score
Do you suffer from urgency 1 0
Do you suffer from urge incontinence 1 0
Do you have urgency on rising after waking in the morning 1 0
Do you have urge incontinence on rising after waking in the morning 1 0
Do you have urgency on putting a key in the front door when
arriving home (latchkey urgency) 1 0
Do you have urge incontinence on putting a key in the front door
when arriving home (latchkey urgency) 1 0
Do you have urgency aggravated by the sound of running water 1 0
Do you have urge incontinence aggravated by the sound of running
water 1 0
Are your urge symptoms aggravated by cold 1 0
Are your urge symptoms aggravated by fatigue or anxiety 1 0
Possible Maximum and Minimum Scores 10 0
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Appendix 2
Midstream Urine Specimen
For correct test results, follow instructions carefully.
A bowl, a plastic container, and hand wipe and a wet gauze will be
given to you
Cleansing before collecting the urine specimen
1. Wipe your hands with the hand towel that we give you and
discard it
2. Thoroughly cleanse the entire genital area using the special
gauze that we give you
 Females – Hold the outer edges of labia apart and
cleanse from front to back with the gauze
 Males – retract foreskin if not circumcised and wipe the
end of the penis with the gauze
Do not throw the gauze into the toilet bowl throw it into the
yellow bin available in the toilet
Collecting the urine specimen
 Females – continue to hold labia apart while urinating
 Males – continue to retract foreskin while urinating
1. Urinate (pee) a small amount of urine into the toilet.
2. Then without stopping, catch some urine into the bowl
by passing it into the urine stream.
3. As the stream comes to the end move the bowl away
and urinate (pee) the rest into the toilet
4. Pour the urine in the bowl into the plastic container and
screw the lid down
Wash hands after collecting the urine specimen
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Appendix 3
PATIENT INFORMATION SHEET
10/08/06 (Cystoscopy) Ver 2
A study of bladder and patient symptoms
You are being invited to take part in a research study. Before you decide
whether participation is right for you, please take time to read the
following information carefully and discuss it with friends, relatives and
your GP if you wish. Ask us if there is anything that is not clear or if you
would like more information. Take time to decide whether or not you
wish to take part.
You may also obtain information from the hospital Patient Advice and
Liaison Service (PALS), Whittington Hospital, Tel 020 7288 5956 or 020
7288 5957
Thank you for taking the time to read this information and for considering helping us
with our research project.
What is the purpose of the project?
Many people suffer with urinary incontinence (leaking from the bladder).
It is a very unpleasant problem, which affects people’s lives at home, at
work and their general well-being. The aim of this study is to examine
samples of the bladder to better understand how the bladder works and
relate these findings to patient symptoms. This involves studying both
patients who have urinary symptoms and those that do not, in order to
make a comparison.
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Why have I been chosen?
The urologist who is currently treating you is carrying out a procedure
which involves an examination of the inside of the bladder via
cystoscopy (key hole procedure).
This provides an opportunity for the surgeon to take a sample (biopsy)
of the bladder lining. We should like to do this so as to use the sample
for research purposes.
Do I have to take part?
It is up to you if you decide whether or not to take part. If you do decide
to take part you will be given a copy of this information sheet to keep.
You will be asked to sign a consent form a copy of which will be given to
you. If you decide to take part you are still free to withdraw at any time
and without giving a reason. This will not affect the standard of care you
receive.
What will happen to me if I take part?
If you decide to take part in the project the research clinician will
arrange to see you before your operation takes place. You will be asked
you some questions about your bladder and how well it works for you.
Your answers will be recorded on a form stored on a computer. This will
take about 30-45 minutes. The computer record is closely guarded by
the NHS security system so there is no unauthorised access to you
record. Blood samples may be taken as part of your normal clinical care.
We should like to record the results on these in you research record.
When you have the cystoscopy, the doctor will take a very small sample
of bladder tissue (about 2-3mm or a quarter inch in size) in addition to
any that may be needed in order to check your condition or make a
diagnosis.
What will be done with the biopsy tissue that is taken for this study?
The bladder sample taken at biopsy will be studied and the tissue
sample will be destroyed once the research is complete. The use of your
specimen, where it goes and the results of any experiments that are
conducted on it will be kept on the record and could be made available
to you should you so wish. In effect there will be the full story of your
specimen.
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What are the alternatives to participating in the study
It is entirely your decision if you wish to take part in the study and it will
not affect your future care if you do not wish to do so. If you do not wish
to take part you will have your operation in the usual way, a biopsy may
be taken (as a routine), but no extra research sample will be taken.
What are the possible disadvantages and risks of taking part?
Taking an extra sample of bladder tissue means that the procedure will take a
bit longer than usual. With each biopsy is a risk of a small amount of bleeding
after the surgery, this will require no further treatment and stops after a day or
so.
What are the possible benefits of taking part?
The sample of bladder tissue taken for this research will be considered
as a ‘gift’ to the university. There are no benefits directly to you for
taking part. But your participation will help us to have a better
understanding of how the bladder works and may lead to better
treatments being available to people with bladder problems in the future.
What happens if something goes wrong?
If taking part in this research project harms you, there are no special
compensation arrangements. If you are harmed due to someone’s
negligence, then you may have grounds for legal action but you may
have to pay for it. Regardless of this, if you wish to complain about any
aspect of the way you have been approached or treated during the
course of this study, the normal National Health Service complaints
mechanisms will be available to you.
What if I want to withdraw from the study?
You are free to withdraw from the study at any time before and after
signing the consent form without needing to give any explanations. If
you wish to withdraw after the bladder sample has been taken then you
may contact us and we will not use the sample for any experiments.
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Will my taking part in this study be kept confidential?
All information, which is collected about you, during the course of the
research will be kept strictly confidential. Any information about you
which leaves the hospital / surgery will have your name and address
removed so that you cannot be recognised from it.
Your GP will be notified of your involvement in the study unless you do
not wish us to do so.
What will happen to the results of the research?
The results of the experiments made on the samples of bladder muscle
will be published in scientific journals so that other researchers working
on improving treatments for people with incontinence will benefit from
our knowledge. You will not be identified on any publications.
Who is organising and funding the research?
This study is organised by the Institute of Urology and Nephrology and
the Department of Medicine at the Whittington Hospital.
Who has reviewed the study?
The Moorfields and Whittington Research Ethics Committee has
reviewed this study.
Contact for further information
If you have any questions please don’t hesitate to contact us.
Professor James Malone-Lee MD FRCP
Professor of Medicine
The Department of Medicine,
Clerkenwell Building,
Whittington Hospital,
Archway Campus,
Highgate Hill,
London, N19 5LW
Telephone 0207 288 3010
0207 288 3135
0207 679 9112
0207 288 5301
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